FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Santos, AJ
   Pina, LTS
   Galvao, JG
   Trindade, GGG
   Nunes, RKV
   Santos, JS
   Santos, CP
   Gonsalves, JKMC
   Lira, AAM
   Cavalcanti, SCH
   Santos, RLC
   Sarmento, VHV
   Nunes, RS
AF Santos, Adriana J.
   Pina, Licia T. S.
   Galvao, Juliana G.
   Trindade, Gabriela G. G.
   Nunes, Rafaela K. V.
   Santos, Jeferson S.
   Santos, Cochiran P.
   Gonsalves, Joyce Kelly M. C.
   Lira, Ana Amelia M.
   Cavalcanti, Socrates C. H.
   Santos, Roseli L. C.
   Sarmento, Victor H. V.
   Nunes, Rogeria S.
TI Clay/PVP nanocomposites enriched with Syzygium aromaticum essential oil
   as a safe formulation against Aedes aegypti larvae
SO APPLIED CLAY SCIENCE
LA English
DT Article
DE Bentonite; Hydrophilic polymer; Nanocomposite; Larvae alternative
   control; Eugenol
ID CHEMICAL-COMPOSITION; SYSTEMS; DISPERSIONS; EXTRACTS; CLAYS; CLOVE; BUD
AB Clay-polymer composites represent the possibility to stabilize, protect volatile and easily oxidized compounds such as essential oils. Thus, the aim of this study was to develop an eco-friendly formulation based on bentonite/PVP nanocomposites to incorporate Syzygium aromaticum essential oil (SAEO) in for controlling Aedes aegypti larvae. The bentonite/PVP nanocomposites were prepared with different ratios 1:2, 1:1, 2:1 in both absence (INano) or presence of SAEO (NanoSAEO), and evaluated by X-ray diffraction (XRD), small angle X-ray scattering (SAXS), differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and Fourier transformed infrared spectroscopy (FTIR). Finally, larvicidal activity was performed. XRD indicated an intercalated structure because of the displacement of reflections at low angle range and an increase in INano interlayer space (d). After SAEO incorporation, the interlayer space (d) did not changed, therefore suggesting that SAEO may be associated to the nanocomposite-intercalated layers. SAXS also demonstrated the composite intercalated structure that in presence of SAEO induced a reflection displacement and change in the curve profile suggesting a structure transition to accommodate SAEO. This structure transition after SAEO incorporation was enough to shift the nanocomposite endothermic peak to lower temperatures (T-peak = 68 degrees C) in DSC analysis. NanoSAEO demonstrated a LC50 of 27.34 ppm, while eugenol and SAEO presented 48.19 ppm and 40.74 ppm, respectively. Furthermore, SAEO incorporated in the nanocomposite was not harmful to non-target organisms, being not toxic up to 1000 ppm. Thus, bentonite/PVP nanocomposites containing SAEO is a promising formulation for controlling Aedes aegypti larvae.
C1 [Santos, Adriana J.; Galvao, Juliana G.; Trindade, Gabriela G. G.; Nunes, Rafaela K. V.; Santos, Jeferson S.; Lira, Ana Amelia M.; Cavalcanti, Socrates C. H.; Nunes, Rogeria S.] Univ Fed Sergipe, Postgrad Program Pharmaceut Sci, Sao Cristovao, SE, Brazil.
   [Santos, Adriana J.; Pina, Licia T. S.; Galvao, Juliana G.; Trindade, Gabriela G. G.; Nunes, Rafaela K. V.; Santos, Jeferson S.; Lira, Ana Amelia M.; Cavalcanti, Socrates C. H.; Nunes, Rogeria S.] Univ Fed Sergipe, Dept Pharm, Sao Cristovao, SE, Brazil.
   [Santos, Cochiran P.] Univ Fed Sergipe, Dept Phys, Sao Cristovao, SE, Brazil.
   [Gonsalves, Joyce Kelly M. C.] Fed Univ Vale do Sao Francisco, Coll Pharm, Petrolina, PE, Brazil.
   [Santos, Roseli L. C.] Univ Fed Sergipe, Dept Morphol, Sao Cristovao, SE, Brazil.
   [Sarmento, Victor H. V.] Fed Univ Sergipe UFS, Dept Chem, BR-49100000 Itabaiana, SE, Brazil.
RP Nunes, RS (corresponding author), Univ Fed Sergipe, Postgrad Program Pharmaceut Sci, Sao Cristovao, SE, Brazil.
EM rogeria.ufs@hotmail.com
RI Nunes, Rogeria RSN/R-5248-2018; Santos, Roseli LC/F-1735-2015; Lira,
   Ana/Y-8196-2019; Cavalcanti, Socrates/AAQ-7004-2020; Sarmento, Victor
   Hugo/AAL-1496-2020; Galvao, Juliana Gouveia/AAI-9737-2020
OI Nunes, Rogeria RSN/0000-0001-6681-2042; Lira, Ana/0000-0003-3451-9049;
   Sarmento, Victor Hugo/0000-0001-6882-002X; Galvao, Juliana
   Gouveia/0000-0002-5471-4530
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Pronex Dengue, FAPITEC; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES)CAPES [001]
FX The authors acknowledge CNPq and Pronex Dengue, FAPITEC and the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES - Finance Code 001) for supporting funds. CMNano, Department of
   Physics, Chemistry and Materials Engineering for carrying out analysis.
CR Aguzzi C, 2007, APPL CLAY SCI, V36, P22, DOI 10.1016/j.clay.2006.06.015
   Akat H, 2008, EUR POLYM J, V44, P1949, DOI 10.1016/j.eurpolymj.2008.04.018
   Alekseeva OV, 2014, PROT MET PHYS CHEM+, V50, P300, DOI 10.1134/S2070205114030022
   Alma MH, 2007, BIORESOURCES, V2, P265
   Araujo S.S, 2004, MATERIA, V9, P426
   Arbaoui F, 2014, APPL CLAY SCI, V91-92, P6, DOI 10.1016/j.clay.2014.02.001
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Bhattacharya S.N, 2008, NANOCOMPOSITES, pI, DOI [10.3139/9783446418523, DOI 10.3139/9783446418523]
   Bilgic C, 2014, INT J ADHES ADHES, V50, P204, DOI 10.1016/j.ijadhadh.2014.01.033
   Casariego A, 2009, FOOD HYDROCOLLOID, V23, P1895, DOI 10.1016/j.foodhyd.2009.02.007
   Chadha R, 2006, J SCI IND RES INDIA, V65, P459
   Chahal RP, 2010, OPTOELECTRON ADV MAT, V4, P1546
   Cheng SS, 2013, IND CROP PROD, V47, P310, DOI 10.1016/j.indcrop.2013.03.016
   D'Amelia R.P., 2016, WORLD J CHEM ED, V4, P25, DOI DOI 10.12691/wjce-4-2-1
   De Medeiros K.M, 2013, REV ELETRONICA MAT P, V8, P36
   Rodrigues LAD, 2013, COLLOID SURFACE B, V103, P642, DOI 10.1016/j.colsurfb.2012.10.068
   Dornelas CB, 2010, POLIMEROS, V20, P275, DOI 10.1590/S0104-14282010005000047
   Fan MD, 2017, APPL CLAY SCI, V144, P1, DOI 10.1016/j.clay.2017.04.022
   Fayemiwo Kehinde Adenike, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P30, DOI 10.1016/S2221-1691(14)60204-5
   Finney D. J., 1971, PROBIT ANAL
   Galvao J.G, 2018, PEST MANAG SCI, P1, DOI [10.1002/adsc.201, DOI 10.1002/ADSC.201]
   Ghrab S, 2018, APPL CLAY SCI, V156, P169, DOI 10.1016/j.clay.2018.02.002
   Giannakas A, 2017, APPL CLAY SCI, V146, P362, DOI 10.1016/j.clay.2017.06.018
   Giri N., 2011, ARCH APPL SCI RES, V3, P624
   Gupta P, 2004, PHARM RES-DORDR, V21, P1762, DOI 10.1023/B:PHAM.0000045226.42859.b8
   Istrate OM, 2018, APPL CLAY SCI, V156, P144, DOI 10.1016/j.clay.2018.01.039
   Jesus CRN, 2018, ACS APPL MATER INTER, V10, P19059, DOI 10.1021/acsami.8b04559
   Kristensen A.B, 2004, SOLID CLEANING COMPO
   Lavorgna M, 2010, CARBOHYD POLYM, V82, P291, DOI 10.1016/j.carbpol.2010.04.054
   Lima TC, 2014, CHEMOSPHERE, V104, P37, DOI 10.1016/j.chemosphere.2013.10.035
   Lin-Gibson S, 2004, J COLLOID INTERF SCI, V274, P515, DOI 10.1016/j.jcis.2004.03.039
   Meiorin C, 2014, EUR POLYM J, V53, P90, DOI 10.1016/j.eurpolymj.2014.01.018
   MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236
   Morozov VN, 2012, J MEMBRANE SCI, V403, P110, DOI 10.1016/j.memsci.2012.02.028
   Moussout H, 2018, THERMOCHIM ACTA, V659, P191, DOI 10.1016/j.tca.2017.11.015
   Murphy E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-22
   Panahi Y, 2014, J MICROBIOL IMMUNOL, V47, P211, DOI 10.1016/j.jmii.2012.10.002
   Pavela R, 2019, ACTA TROP, V193, P236, DOI 10.1016/j.actatropica.2019.01.019
   Prado AGS, 2005, QUIM NOVA, V28, P544, DOI 10.1590/S0100-40422005000300030
   Scarfato P, 2016, COMPOS PART B-ENG, V98, P444, DOI 10.1016/j.compositesb.2016.05.053
   Sedlakova Z, 2009, POLYM BULL, V63, P365, DOI 10.1007/s00289-009-0097-0
   Shaalan EAS, 2005, ENVIRON INT, V31, P1149, DOI 10.1016/j.envint.2005.03.003
   Shah J, 2009, J INCL PHENOM MACRO, V63, P69, DOI 10.1007/s10847-008-9490-9
   Silva AA, 2011, APPL CLAY SCI, V54, P151, DOI 10.1016/j.clay.2011.08.002
   Van Ekert E, 2014, J INSECT PHYSIOL, V64, P62, DOI 10.1016/j.jinsphys.2014.03.001
   Vanhaecke P., 1981, REPORT INTERCALIBRAT, V106, P359
   Viseras C, 2010, APPL CLAY SCI, V48, P291, DOI 10.1016/j.clay.2010.01.007
   Wang KH, 2001, POLYMER, V42, P9819, DOI 10.1016/S0032-3861(01)00509-2
   Wu YW, 2008, J MOL STRUCT, V882, P107, DOI 10.1016/j.molstruc.2007.09.018
   Yang YC, 2014, J CHROMATOGR A, V1323, P18, DOI 10.1016/j.chroma.2013.10.098
NR 51
TC 2
Z9 2
U1 7
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0169-1317
EI 1872-9053
J9 APPL CLAY SCI
JI Appl. Clay Sci.
PD FEB
PY 2020
VL 185
AR 105394
DI 10.1016/j.clay.2019.105394
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy
SC Chemistry; Materials Science; Mineralogy
GA KH1IH
UT WOS:000510399600007
DA 2020-12-08
ER

PT J
AU Costa, ACF
   Cavalcanti, SCH
   Santana, AS
   Lima, APS
   Brito, TB
   Oliveira, RRB
   Macedo, NA
   Cristaldo, PF
   Araujo, APA
   Bacci, L
AF Costa, Angela C. F.
   Cavalcanti, Socrates C. H.
   Santana, Alisson S.
   Lima, Ana P. S.
   Brito, Thaysnara B.
   Oliveira, Rafael R. B.
   Macedo, Nathalia A.
   Cristaldo, Paulo F.
   Araujo, Ana Paula A.
   Bacci, Leandro
TI Insecticidal activity of indole derivatives against Plutella xylostella
   and selectivity to four non-target organisms
SO ECOTOXICOLOGY
LA English
DT Article
DE Chemical control; Pest control; Pesticides; Tryptamine
ID LEPIDOPTERA PLUTELLIDAE; PHYSIOLOGICAL SELECTIVITY; DIAMONDBACK MOTH;
   DESIGN; LARVAE; 3-HYDROXYKYNURENINE; RESISTANCE; LINNAEUS; L.
AB The diamondback moth Plutella xylostella (Linnaeus, 1758) (Lepidoptera: Plutellidae) is a destructive pest of brassica crops of economic importance that have resistance to a range of insecticides. Indole derivates can exert diverse biological activities, and different effects may be obtained from small differences in their molecular structures. Indole is the parent substance of a large number of synthetic and natural compounds, such as plant and animal hormones. In the present study, we evaluate the insecticidal activity of 20 new synthesized indole derivatives against P. xylostella, and the selectivity of these derivatives against non-target hymenopteran beneficial arthropods: the pollinator Apis mellifera (Linnaeus, 1758) (Hymenoptera: Apidae), and the predators Polybia scutellaris (White, 1841), Polybia sericea (Olivier, 1791) and Polybia rejecta (Fabricius, 1798) (Hymenoptera: Vespidae). Bioassays were performed in the laboratory to determine the lethal and sublethal effects of the compounds on P. xylostella and to examine their selectivity to non-target organisms by topical application and foliar contact. The treatments consisted of two synthesized derivatives (most and least toxic), the positive control (deltamethrin) and the negative control (solvent). The synthesized compound 4e [1-(1H-indol-3-yl)hexan-1-one] showed high toxicity (via topical application and ingestion) and decreased the leaf consumption by P. xylostella, displaying a higher efficiency than the pyrethroid deltamethrin, widely used to control this pest. In addition, the synthesized indole derivatives were selective to the pollinator A. mellifera and the predators P. scutellaris, P. sericea and P. rejecta, none of which were affected by deltamethrin. Our results highlight the promising potential of the synthesized indole derivatives for the generation of new chemical compounds for P. xylostella management.
C1 [Costa, Angela C. F.; Santana, Alisson S.; Lima, Ana P. S.; Bacci, Leandro] Univ Fed Sergipe, Programa Posgrad Agr & Biodiversidade, Sao Cristovao, SE, Brazil.
   [Cavalcanti, Socrates C. H.; Brito, Thaysnara B.; Oliveira, Rafael R. B.; Macedo, Nathalia A.] Univ Fed Sergipe, Dept Farm, Sao Cristovao, SE, Brazil.
   [Cristaldo, Paulo F.] Univ Fed Rural Pernambuco, Dept Agron, Programa Posgrad Entomol Agr, Recife, PE, Brazil.
   [Araujo, Ana Paula A.] Univ Fed Sergipe, Dept Ecol, Sao Cristovao, SE, Brazil.
   [Bacci, Leandro] Univ Fed Sergipe, Dept Engn Agron, Sao Cristovao, SE, Brazil.
RP Bacci, L (corresponding author), Univ Fed Sergipe, Programa Posgrad Agr & Biodiversidade, Sao Cristovao, SE, Brazil.; Bacci, L (corresponding author), Univ Fed Sergipe, Dept Engn Agron, Sao Cristovao, SE, Brazil.
EM bacci.ufs@gmail.com
RI Cristaldo, Paulo/A-1247-2013; Cavalcanti, Socrates/AAQ-7004-2020;
   SANTANA, Alisson S/S-4545-2018; Bacci, Leandro/F-4571-2017
OI Cristaldo, Paulo/0000-0003-4939-0487; SANTANA, Alisson
   S/0000-0002-9713-275X; Bacci, Leandro/0000-0002-8198-6080
CR Ahuja I, 2015, J EXP BOT, V66, P579, DOI 10.1093/jxb/eru490
   Bacci L, 2009, CIENC AGROTEC, V33, P2045, DOI 10.1590/S1413-70542009000700058
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Barros EC, 2015, J ENVIRON SCI HEAL B, V50, P45, DOI 10.1080/03601234.2015.965621
   Nguyen BCQ, 2015, MOLECULES, V20, P16741, DOI 10.3390/molecules200916741
   Bortoli SA, 2013, WEED PEST CONTROL CO, P31
   Cerstiaens A, 2003, BIOCHEM BIOPH RES CO, V312, P1171, DOI 10.1016/j.bbrc.2003.11.051
   Chiou SJ, 1998, BIOCHEM BIOPH RES CO, V246, P457, DOI 10.1006/bbrc.1998.8644
   Correa-Cuadros J.P, 2014, Univ. Sci., V19, P277, DOI 10.11144/Javeriana.SC19-2.spxl
   Correia AA, 2009, NEOTROP ENTOMOL, V38, P83, DOI 10.1590/S1519-566X2009000100008
   de Alvarenga ES, 2012, MOLECULES, V17, P13989, DOI 10.3390/molecules171213989
   Fernandes MED, 2008, SOCIOBIOLOGY, V51, P765
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   Endersby NM, 2011, B ENTOMOL RES, V101, P393, DOI 10.1017/S0007485310000684
   Feng ML, 2012, PEST MANAG SCI, V68, P986, DOI 10.1002/ps.3243
   Gallardo E, 2016, MOLECULES, V21, DOI 10.3390/molecules21050656
   Galvan TL, 2002, PESQUI AGROPECU BRAS, V37, P117, DOI 10.1590/S0100-204X2002000200001
   Guirado MM, 2009, B EPIDEMIOL PAULISTA, V6, P5
   Han Q, 2002, J BIOL CHEM, V277, P15781, DOI 10.1074/jbc.M201202200
   Han Q, 2007, J INSECT PHYSIOL, V53, P254, DOI 10.1016/j.jinsphys.2006.09.004
   Hasler CM, 1998, FOOD TECHNOL-CHICAGO, V52, P63
   Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009
   ING H R, 1964, Fortschr Arzneimittelforsch, V7, P305
   Kaushik NK, 2013, MOLECULES, V18, P6620, DOI 10.3390/molecules18066620
   Lima TC, 2015, PARASITOL RES, V114, P2883, DOI 10.1007/s00436-015-4489-9
   Lin CL, 2017, PESTIC BIOCHEM PHYS, V141, P65, DOI 10.1016/j.pestbp.2016.11.008
   Nansen C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149994
   Novo MDDS, 2010, HORTIC BRAS, V28, P321, DOI 10.1590/S0102-05362010000300014
   Okuda S, 1998, J NEUROCHEM, V70, P299
   Oliveira RRB, 2014, MED CHEM, V10, P580, DOI 10.2174/1573406409666131202144010
   Ottoni O, 2001, ORG LETT, V3, P1005, DOI 10.1021/ol007056i
   Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007
   RAISON CG, 1955, BRIT J PHARM CHEMOTH, V10, P191, DOI 10.1111/j.1476-5381.1955.tb00082.x
   Ramya SL, 2016, BRAZ J MICROBIOL, V47, P327, DOI 10.1016/j.bjm.2016.01.012
   Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899
   Rossi F, 2006, P NATL ACAD SCI USA, V103, P5711, DOI 10.1073/pnas.0510233103
   Roszkowski P, 2005, J MOL CATAL A-CHEM, V232, P143, DOI 10.1016/j.molcata.2005.01.044
   Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009
   Santos L. P., 2003, Revista Brasileira de Zoociencias, V5, P33
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   SAS Institute, 2008, US MAN VERS 9 2
   Sharma Devinder, 2005, Journal of Asia-Pacific Entomology, V8, P113, DOI 10.1016/S1226-8615(08)60079-5
   Song Z, 2016, EUR J MED CHEM, V124, P809, DOI 10.1016/j.ejmech.2016.09.005
   SOUZA P. H. M, 2003, REV SBCTA, V37, P127
   Sun JL, 2015, MOLECULES, V20, P5625, DOI 10.3390/molecules20045625
   Troczka B, 2012, INSECT BIOCHEM MOLEC, V42, P873, DOI 10.1016/j.ibmb.2012.09.001
   Yang JC, 2016, BIOORGAN MED CHEM, V24, P383, DOI 10.1016/j.bmc.2015.09.030
   Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107
   Zhang CL, 2015, J AGR FOOD CHEM, V63, P4527, DOI 10.1021/acs.jafc.5b01225
   Zhou S, 2014, J AGR FOOD CHEM, V62, P11054, DOI 10.1021/jf503513n
NR 50
TC 1
Z9 1
U1 5
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0963-9292
EI 1573-3017
J9 ECOTOXICOLOGY
JI Ecotoxicology
PD OCT
PY 2019
VL 28
IS 8
BP 973
EP 982
DI 10.1007/s10646-019-02095-1
PG 10
WC Ecology; Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA JG9SG
UT WOS:000492415700011
PM 31420785
DA 2020-12-08
ER

PT J
AU Costa, ACF
   Cavalcanti, SCH
   Santana, AS
   Lima, APS
   Santana, EDR
   Brito, TB
   Oliveira, RRB
   Macedo, NA
   Cristaldo, PF
   Bacci, L
AF Costa, Angela C. F.
   Cavalcanti, Socrates C. H.
   Santana, Alisson S.
   Lima, Ana P. S.
   Santana, Emile D. R.
   Brito, Thaysnara B.
   Oliveira, Rafael R. B.
   Macedo, Nathalia A.
   Cristaldo, Paulo F.
   Bacci, Leandro
TI Formicidal activity of indole derivatives on Atta opaciceps (Borgmeier):
   Lethal, behavioural and locomotive effects
SO JOURNAL OF APPLIED ENTOMOLOGY
LA English
DT Article
DE Attini; behaviour; indole; locomotion
ID LEAF-CUTTING ANT; INSECTICIDAL ACTIVITY; DESIGN; 3-HYDROXYKYNURENINE;
   AGGRESSION; PATCHOULI; PROFILES; TOXICITY; QSAR; OIL
AB The leaf-cutting ants of the genus Atta are of extreme importance for agriculture and forestry. Few active products can be employed to control these pests and, therefore, the discovery of new insecticidal products represents a fundamental strategy for its management. In this study, we evaluated the mortality, behaviour and locomotion of workers of Atta opaciceps (Borgmeier) exposed to synthesized indole derivatives. The most active compound was 4d [1-(1H-indol-3-yl)pentan-1-one] (LD50 = 0.018 mu g/mg), while the 4e [1-(1H-indol-3-yl)hexan-1-one] (LD50 = 3.82 mu g/mg) was the least active compound. These two derivatives reduced the survival of A. opaciceps over time and altered the behaviour and locomotion of these ants. This study demonstrates the potential of indole derivatives to produce new formicidal products, since, in addition to being effective, it also affects the ant's behaviour and locomotion.
C1 [Costa, Angela C. F.; Santana, Alisson S.; Lima, Ana P. S.; Santana, Emile D. R.; Cristaldo, Paulo F.; Bacci, Leandro] Univ Fed Sergipe, Programa Posgrad Agr & Biodiversida, Sergipe, Brazil.
   [Cavalcanti, Socrates C. H.; Macedo, Nathalia A.] Univ Fed Sergipe, Dept Farm, Sergipe, Brazil.
   [Brito, Thaysnara B.; Oliveira, Rafael R. B.] Univ Fed Sergipe, Programa Posgrad Ciencias Farmaceut, Sergipe, Brazil.
   [Bacci, Leandro] Univ Fed Sergipe, Dept Engn Agron, Sao Cristovao, Sergipe, Brazil.
RP Bacci, L (corresponding author), Univ Fed Sergipe, Dept Engn Agron, Sao Cristovao, Sergipe, Brazil.
EM bacci.ufs@gmail.com
RI Cristaldo, Paulo/A-1247-2013; SANTANA, Alisson S/S-4545-2018; Lima, Ana
   Paula/U-3456-2019; Cavalcanti, Socrates/AAQ-7004-2020; Bacci,
   Leandro/F-4571-2017
OI Cristaldo, Paulo/0000-0003-4939-0487; SANTANA, Alisson
   S/0000-0002-9713-275X; Bacci, Leandro/0000-0002-8198-6080
FU Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de
   Sergipe; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de
   Sergipe; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
CR Agerbirk N, 2009, PHYTOCHEM REV, V8, P101, DOI 10.1007/s11101-008-9098-0
   Bacci L, 2015, ENTOMOL EXP APPL, V156, P66, DOI 10.1111/eea.12317
   Barbosa J. C., 2018, THESIS
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   BHALLA M, 1994, EUR J MED CHEM, V29, P713, DOI 10.1016/0223-5234(94)90034-5
   Nguyen BCQ, 2015, MOLECULES, V20, P16741, DOI 10.3390/molecules200916741
   Boulogne I, 2014, SUSTAINABLE AGR REV, P1
   Britto J. S., 2016, INT J RES ENVIRON ST, V3, P11
   Burd M, 2003, INSECT SOC, V50, P3, DOI 10.1007/s000400300001
   Burd M, 2002, AM NAT, V159, P283, DOI 10.1086/338541
   Campos RD, 2016, J INSECT PHYSIOL, V86, P25, DOI 10.1016/j.jinsphys.2015.12.008
   Cantarelli EB, 2008, CIENC FLOREST, V18, P39, DOI 10.5902/19805098509
   Cerstiaens A, 2003, BIOCHEM BIOPH RES CO, V312, P1171, DOI 10.1016/j.bbrc.2003.11.051
   Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006
   de Alvarenga ES, 2012, MOLECULES, V17, P13989, DOI 10.3390/molecules171213989
   Dejean A, 2014, CR BIOL, V337, P642, DOI 10.1016/j.crvi.2014.08.008
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Feng ML, 2012, PEST MANAG SCI, V68, P986, DOI 10.1002/ps.3243
   Forest Stewardship Council, 2015, IND THRESH ID HIGHL
   Forti LC, 1997, FORMIGAS CORTADEIRAS
   Forti LC, 2017, INSECTS, V8, DOI 10.3390/insects8020039
   FOWLER HG, 1989, ENVIRON MANAGE, V13, P671, DOI 10.1007/BF01868306
   Frizzi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137919
   Gallardo E, 2016, MOLECULES, V21, DOI 10.3390/molecules21050656
   Galvanho JP, 2013, J INSECT BEHAV, V26, P1, DOI 10.1007/s10905-012-9328-6
   Gill RIS, 2003, J CHEM ECOL, V29, P779, DOI 10.1023/A:1022983529555
   Gouvea S.M., 2010, SOCIOBIOLOGY, V56, P1
   Han Q, 2002, J BIOL CHEM, V277, P15781, DOI 10.1074/jbc.M201202200
   Han Q, 2007, J INSECT PHYSIOL, V53, P254, DOI 10.1016/j.jinsphys.2006.09.004
   Hernandez Jose V., 1995, Anais da Sociedade Entomologica do Brasil, V24, P287
   Hojo MK, 2015, CURR BIOL, V25, P2260, DOI 10.1016/j.cub.2015.07.016
   Hudson TM, 2009, SOIL BIOL BIOCHEM, V41, P1088, DOI 10.1016/j.soilbio.2009.02.014
   ING H R, 1964, Fortschr Arzneimittelforsch, V7, P305
   Johnson K, 2006, J THEOR BIOL, V241, P360, DOI 10.1016/j.jtbi.2005.12.003
   KOSTOWSKI W, 1975, PHARMACOL BIOCHEM BE, V3, P337, DOI 10.1016/0091-3057(75)90040-4
   Krause D, 2011, AM J PATHOL, V179, P1360, DOI 10.1016/j.ajpath.2011.05.048
   Lima TC, 2015, PARASITOL RES, V114, P2883, DOI 10.1007/s00436-015-4489-9
   Marinho CGS, 2005, ENTOMOL EXP APPL, V117, P89, DOI 10.1111/j.1570-7458.2005.00338.x
   Mueller UG, 2011, P NATL ACAD SCI USA, V108, P4053, DOI 10.1073/pnas.1015806108
   Okuda S, 1998, J NEUROCHEM, V70, P299
   Oliveira RRB, 2014, MED CHEM, V10, P580, DOI 10.2174/1573406409666131202144010
   Ottoni O, 2001, ORG LETT, V3, P1005, DOI 10.1021/ol007056i
   Oxenkrug GF, 2010, ISR J PSYCHIATR REL, V47, P56
   RAISON CG, 1955, BRIT J PHARM CHEMOTH, V10, P191, DOI 10.1111/j.1476-5381.1955.tb00082.x
   Reis Filho W., 2011, Pesquisa Florestal Brasileira, V31, P37, DOI 10.4336/2011.pfb.31.65.37
   Richard FJ, 2004, CHEMOECOLOGY, V14, P9, DOI 10.1007/s00049-003-0251-3
   Rossi F, 2006, P NATL ACAD SCI USA, V103, P5711, DOI 10.1073/pnas.0510233103
   Roszkowski P, 2005, J MOL CATAL A-CHEM, V232, P143, DOI 10.1016/j.molcata.2005.01.044
   Santos AA, 2017, ECOTOX ENVIRON SAFE, V145, P436, DOI 10.1016/j.ecoenv.2017.07.057
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos Viviane Martins Rebello dos, 2007, Quím. Nova, V30, P159, DOI 10.1590/S0100-40422007000100028
   SAS Institute, 2008, SAS STAT 9 2 US GUID
   Shimshoni JA, 2017, N-S ARCH PHARMACOL, V390, P15, DOI 10.1007/s00210-016-1297-4
   Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x
   Sun JL, 2015, MOLECULES, V20, P5625, DOI 10.3390/molecules20045625
   Tavares LC, 2004, QUIM NOVA, V27, P631, DOI 10.1590/S0100-40422004000400018
   Valadares L, 2015, INSECTS, V6, P141, DOI 10.3390/insects6010141
   Viana-Bailez A. M., 2011, FORMIGAS CORTADEIRAS, P141
   WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587
   Yaguchi H, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150574
   Yang JC, 2016, BIOORGAN MED CHEM, V24, P383, DOI 10.1016/j.bmc.2015.09.030
   Zanetti R, 2014, FORESTS, V5, P439, DOI 10.3390/f5030439
   Zhang CL, 2015, J AGR FOOD CHEM, V63, P4527, DOI 10.1021/acs.jafc.5b01225
   Zhou S, 2014, J AGR FOOD CHEM, V62, P11054, DOI 10.1021/jf503513n
   Zhu BCR, 2003, J AGR FOOD CHEM, V51, P4585, DOI 10.1021/jf0301495
NR 65
TC 1
Z9 1
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0931-2048
EI 1439-0418
J9 J APPL ENTOMOL
JI J. Appl. Entomol.
PD FEB
PY 2019
VL 143
IS 1-2
BP 58
EP 68
DI 10.1111/jen.12569
PG 11
WC Entomology
SC Entomology
GA HI0VD
UT WOS:000456161400007
DA 2020-12-08
ER

PT J
AU Galvao, JG
   Cerpe, P
   Santos, DA
   Gonsalves, JKMC
   Santos, AJ
   Nunes, RKV
   Lira, AAM
   Alves, PB
   La Corte, R
   Blank, AF
   Silva, GF
   Cavalcanti, SCH
   Nunes, RS
AF Galvao, Juliana G.
   Cerpe, Patricia
   Santos, Darlisson A.
   Gonsalves, Joyce K. M. C.
   Santos, Adriana J.
   Nunes, Rafaela K. V.
   Lira, Ana A. M.
   Alves, Pericles B.
   La Corte, Roseli
   Blank, Arie F.
   Silva, Gabriel F.
   Cavalcanti, Socrates C. H.
   Nunes, Rogeria S.
TI Lippia gracilis essential oil in -cyclodextrin inclusion complexes: an
   environmentally safe formulation to control Aedes aegypti larvae
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE Aedes aegypti; inclusion complexes; larvicidal activity; arboviruses;
   Artemia sp
ID ENCAPSULATION; AGENT
AB BACKGROUNDOne of the most efficient ways to prevent arboviruses, such as dengue fever, yellow fever, chikungunya and Zika, is by controlling their vector, the Aedes aegypti. Because this vector is becoming resistant to most larvicides used, the development of new larvicides should be considered. -Cyclodextrin (-CD) complexes have been investigated as an interesting way of enabling the use of essential oils in water as larvicides. This study comprised the development of Lippia gracilis essential oil (LGEO) and -CD inclusion complexes for control of Ae. aegypti.
   RESULTSThermal analysis clearly showed the formation of complexes using kneading and co-evaporation methods. Gas chromatography analysis showed that kneading without co-solvent (KW) gave the highest content (approximate to 15%) of the LGEO major component. Moreover, KW showed that the complex had a 50% lethal concentration (LC50; 33ppm) lower than that of pure LGEO (39ppm); in other words, complexing LGEO with -CD improved the larvicidal activity. In addition, LGEO complexed with -CD (KW) was not harmful to non-target organisms at the concentrations needed to control Ae. aegypti larvae.
   CONCLUSIONThe inclusion complex with LGEO was a feasible formulation, being economically viable, easy-to-apply and without impact on non-target organisms and, therefore, is a potential alternative larvicide for Ae. aegypti control. (c) 2018 Society of Chemical Industry
C1 [Galvao, Juliana G.; Cerpe, Patricia; Gonsalves, Joyce K. M. C.; Santos, Adriana J.; Nunes, Rafaela K. V.; Lira, Ana A. M.; Cavalcanti, Socrates C. H.; Nunes, Rogeria S.] Univ Fed Sergipe, Pharm Dept, Av Marechal Rondon S-N, BR-49000100 Sao Cristovao, Sergipe, Brazil.
   [Santos, Darlisson A.; Alves, Pericles B.] Univ Fed Sergipe, Chem Dept, Sao Cristovao, Brazil.
   [La Corte, Roseli] Univ Fed Sergipe, Morphol Dept, Sao Cristovao, Brazil.
   [Blank, Arie F.] Univ Fed Sergipe, Agron Dept, Sao Cristovao, Brazil.
   [Silva, Gabriel F.] Univ Fed Sergipe, Chem Engn Dept, Sao Cristovao, Brazil.
RP Nunes, RS (corresponding author), Univ Fed Sergipe, Pharm Dept, Av Marechal Rondon S-N, BR-49000100 Sao Cristovao, Sergipe, Brazil.
EM rogeria.ufs@hotmail.com
RI Santos, Darlisson A/E-2970-2016; Cavalcanti, Socrates/AAQ-7004-2020; da
   Cunha Gonsalves, Joyce Kelly Marinheiro/S-2297-2018; Lira,
   Ana/Y-8196-2019; Alves, Pericles/S-8768-2019; Nunes, Rogeria
   RSN/R-5248-2018; de Alexandria Santos, Darlisson/AAV-8587-2020; Santos,
   Roseli LC/F-1735-2015; Galvao, Juliana Gouveia/AAI-9737-2020
OI Santos, Darlisson A/0000-0001-5817-5792; Lira, Ana/0000-0003-3451-9049;
   Alves, Pericles/0000-0002-8955-9614; Nunes, Rogeria
   RSN/0000-0001-6681-2042; de Alexandria Santos,
   Darlisson/0000-0001-5817-5792; Galvao, Juliana
   Gouveia/0000-0002-5471-4530
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/Brazil)CAPES; Fundacao de Amparo a Pesquisa do Estado de
   Sergipe (FAPITEC/SE)
FX The authors acknowledge the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq/Brazil), the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil) and the
   Fundacao de Amparo a Pesquisa do Estado de Sergipe (FAPITEC/SE) for
   supporting funds, Herbarium of the Federal University of Sergipe (ASE)
   and CMNano for SEM analysis.
CR Adams RP, 2007, IDENTIFICATION ESSEN, V804
   Anjali CH, 2012, PEST MANAG SCI, V68, P158, DOI 10.1002/ps.2233
   Boonyarattanakalin KS, 2011, J INCL PHENOM MACRO, V70, P279, DOI 10.1007/s10847-010-9913-2
   Marques HMC, 2010, FLAVOUR FRAG J, V25, P313, DOI 10.1002/ffj.2019
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cruz EMD, 2013, VET PARASITOL, V195, P198, DOI 10.1016/j.vetpar.2012.12.046
   Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9
   Dias CN, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/490765
   Ezeonu FC, 2001, BIORESOURCE TECHNOL, V76, P273, DOI 10.1016/S0960-8524(00)00120-6
   Ferreira SG, 2015, J COLLOID INTERF SCI, V456, P190, DOI 10.1016/j.jcis.2015.06.012
   Finney D.J, 1971, PROBIT ANAL, P31
   Galvao JG, 2015, THERMOCHIM ACTA, V608, P14, DOI 10.1016/j.tca.2015.04.001
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Hadaruga NG, 2012, FOOD CHEM, V132, P1741, DOI 10.1016/j.foodchem.2011.11.003
   Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P212
   Jun SW, 2007, EUR J PHARM BIOPHARM, V66, P413, DOI 10.1016/j.ejpb.2006.11.013
   Li N, 2005, J PHARMACEUT BIOMED, V39, P824, DOI 10.1016/j.jpba.2005.05.011
   Macedo OFL, 2012, SPECTROCHIM ACTA A, V86, P101, DOI 10.1016/j.saa.2011.10.010
   Marreto RN, 2008, THERMOCHIM ACTA, V475, P53, DOI 10.1016/j.tca.2008.06.015
   Menezes PP, 2012, THERMOCHIM ACTA, V548, P45, DOI 10.1016/j.tca.2012.08.023
   MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236
   Moretti M. D. L., 2002, AAPS PHARMSCITECH, V3, P13, DOI DOI 10.1208/PT030213
   Scalia S, 2002, J PHARMACEUT BIOMED, V30, P1181, DOI 10.1016/S0731-7085(02)00433-8
   Scalia S, 2006, INT J PHARMACEUT, V320, P79, DOI 10.1016/j.ijpharm.2006.04.008
   Serafini MR, 2012, J THERM ANAL CALORIM, V109, P951, DOI 10.1007/s10973-011-1736-x
   Shrestha M, 2017, FOOD CHEM, V221, P1474, DOI 10.1016/j.foodchem.2016.11.003
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Songkro S, 2012, J INCL PHENOM MACRO, V72, P339, DOI 10.1007/s10847-011-9985-7
   Teles TV, 2010, AFR J BIOTECHNOL, V9, P8800
   van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340
   Venturini CDG, 2008, QUIM NOVA, V31, P360, DOI 10.1590/S0100-40422008000200032
   Wang J, 2011, FOOD CHEM, V127, P1680, DOI 10.1016/j.foodchem.2011.02.036
NR 32
TC 6
Z9 6
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD FEB
PY 2019
VL 75
IS 2
BP 452
EP 459
DI 10.1002/ps.5138
PG 8
WC Agronomy; Entomology
SC Agriculture; Entomology
GA HH0KM
UT WOS:000455405500017
PM 29998608
OA Bronze
DA 2020-12-08
ER

PT J
AU Nunes, RKV
   Martins, UN
   Brito, TB
   Nepel, A
   Costa, EV
   Barison, A
   Santos, RLC
   Cavalcanti, SCH
AF Nunes, Rafaela K. V.
   Martins, Ulisses N.
   Brito, Thaysnara B.
   Nepel, Angelita
   Costa, Emmanoel V.
   Barison, Andersson
   Santos, Roseli L. C.
   Cavalcanti, Socrates C. H.
TI Evaluation of (-)-borneol derivatives against the Zika vector, Aedes
   aegypti and a non-target species, Artemia sp.
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Dengue; Larvicidal activity; Microcephaly; Terpenes; QSAR; Borneol
   esters
ID STRUCTURE-TOXICITY RELATIONSHIPS; ESSENTIAL OILS; LARVICIDAL ACTIVITY;
   DIPTERA-CULICIDAE; MOSQUITO VECTORS; LARVAE; MONOTERPENES; DENGUE;
   DIFLUBENZURON; INSECTICIDES
AB Zika, dengue, and chikungunya are vector-borne diseases of pronounced concern transmitted by the mosquito Aedes aegypti Linn. (Diptera: Culicidae). The most important method to avoid outbreaks is to control mosquito spreading by the employment of insecticides and larvicides. Failure to control mosquito dispersal is mostly accounted to Ae. aegypti resistance to currently available larvicides and insecticides, encouraging the development of novel pesticides. In addition, the excessive use of larvicides poses serious threats to human health and the environment. Evaluation of natural products as larvicides in an attempt to overcome this situation is often found in the literature because products originated from nature are considered less toxic to non-target species and more eco-friendly. (-)-Borneol is a bicyclic monoterpene present in essential oils with moderate larvicidal activity. On account of these facts, it was of our interest to synthesize (-)-borneol ester derivatives aiming to study its structure-activity relationships against Ae. aegypti larvae. With the goal to estimate toxicity to a non-target species, evaluation of the lethal concentration 50% (LC50) on Artemia sp. (Artemiidae) and calculation of selectivity towards Ae. aegypti were carried out. The most potent derivative, (-)-Bornyl chloroacetate, exhibited the highest suitability index, demonstrating lower environmental toxicity than other borneol ester derivatives. A parabolic relationship between (-)-borneol esters larvicidal activity and partition coefficient (Log P) was achieved and a correlation equation obtained, validating the importance of lipophilicity to the larvicidal activity of these compounds.
C1 [Nunes, Rafaela K. V.; Martins, Ulisses N.; Brito, Thaysnara B.; Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Med Chem Lab, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
   [Nepel, Angelita; Barison, Andersson] Univ Fed Parana, Nucl Magnet Resonance Lab, Dept Chem, POB 19081, BR-81531990 Curitiba, PR, Brazil.
   [Costa, Emmanoel V.] Univ Fed Amazonas, Dept Chem, Inst Appl Sci, Manaus, Amazonas, Brazil.
   [Santos, Roseli L. C.] Univ Fed Sergipe, Parasitol Lab, Dept Morphol, BR-49100000 Sao Cristovao, SE, Brazil.
RP Cavalcanti, SCH (corresponding author), Univ Fed Sergipe, Med Chem Lab, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
EM socratescavalcanti@yahoo.com.br
RI Barison, Andersson/F-7134-2012; Cavalcanti, Socrates/AAQ-7004-2020;
   Santos, Roseli LC/F-1735-2015
OI Barison, Andersson/0000-0001-9381-8239; Costa,
   Emmanoel/0000-0002-0153-822X
FU Brazilian National Scientific and Development Council (CNPq)
   [47601/2013-2]
FX The authors would like to acknowledge the Brazilian National Scientific
   and Development Council (CNPq) for supporting grant number 47601/2013-2.
   We also extend our gratefulness to Norberto Peporine Lopes and Jose
   Carlos Tomaz for mass spectra analyses.
CR Abe FR, 2014, J TOXICOL ENV HEAL A, V77, P37, DOI 10.1080/15287394.2014.865581
   Acerson MJ, 2015, TETRAHEDRON LETT, V56, P3277, DOI 10.1016/j.tetlet.2015.02.071
   Alencar EB, 2016, MED CHEM RES, V25, P2171, DOI 10.1007/s00044-016-1650-7
   Alves PB, 2007, J ESSENT OIL RES, V19, P89, DOI 10.1080/10412905.2007.9699236
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, PARASITOL INT, V66, P166, DOI 10.1016/j.parint.2017.01.012
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Catelan T. B. S., 2015, ADV INFECT DIS, V5, P48, DOI [10.4236/aid.2015.51005, DOI 10.4236/AID.2015.51005]
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cristani M, 2007, J AGR FOOD CHEM, V55, P6300, DOI 10.1021/jf070094x
   da Silva JJ, 2007, REV SOC BRAS MED TRO, V40, P612, DOI 10.1590/S0037-86822007000600002
   DEO P G, 1988, International Pest Control, V30, P118
   Finney D. J., 1971, PROBIT ANAL
   Marcelino PRF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187125
   Gamal Zakia A, 2012, J Egypt Soc Parasitol, V42, P1
   Gartenstein Simon, 2006, Australasian Journal of Ecotoxicology, V12, P83
   Gilliom J, 2017, 1291 US DEP INT US G, P1291
   Govindarajan M, 2018, ENVIRON SCI POLLUT R, V25, P10555, DOI 10.1007/s11356-018-1203-3
   Govindarajan M, 2018, ENVIRON SCI POLLUT R, V25, P10272, DOI 10.1007/s11356-017-8822-y
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   GROVER S, 1992, BIOCHEM BIOPH RES CO, V187, P1350, DOI 10.1016/0006-291X(92)90451-P
   Hansch C, 2009, EUR J MED CHEM, V44, P260, DOI 10.1016/j.ejmech.2008.02.040
   He K, 1997, PLANTA MED, V63, P158, DOI 10.1055/s-2006-957635
   KIVIRANTA J, 1993, ENVIRON TOXIC WATER, V8, P63, DOI 10.1002/tox.2530080107
   La Corte R, 2018, REV SOC BRAS MED TRO, V51, P284, DOI 10.1590/0037-8682-0449-2017
   Lau KW, 2015, J MED ENTOMOL, V52, P199, DOI 10.1093/jme/tju019
   Lee SJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23980-5
   Lewis DFV, 2004, XENOBIOTICA, V34, P501, DOI 10.1080/00498250410001691316
   Lopez MD, 2010, IND CROP PROD, V31, P284, DOI 10.1016/j.indcrop.2009.11.005
   Lu Y, 2013, ADV MATER RES-SWITZ, V726-731, P230, DOI 10.4028/www.scientific.net/AMR.726-731.230
   Lucia A, 2013, PARASITOL RES, V112, P4267, DOI 10.1007/s00436-013-3618-6
   Minguez L, 2016, ENVIRON SCI POLLUT R, V23, P4992, DOI 10.1007/s11356-014-3662-5
   Miron D, 2014, REV BRAS FARMACOGN, V24, P660, DOI 10.1016/j.bjp.2014.10.014
   Monnerat R., 2012, BIOASSAY, V7, P1, DOI DOI 10.14295/BA.V7.0.73
   Murugan K, 2007, BIORESOURCE TECHNOL, V98, P198, DOI 10.1016/j.biortech.2005.12.009
   Nanyonga S. K., 2013, African Journal of Pharmacy and Pharmacology, V7, P360
   Nascimento AMD, 2017, NEOTROP ENTOMOL, V46, P223, DOI 10.1007/s13744-016-0457-z
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   Perumalsamy H, 2009, J MED ENTOMOL, V46, P1420, DOI 10.1603/033.046.0624
   Picollo MI, 2008, FITOTERAPIA, V79, P271, DOI 10.1016/j.fitote.2008.01.005
   Pirsaheb M, 2017, TOXIN REV, V36, P210, DOI 10.1080/15569543.2016.1269810
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Radwan M. A., 2008, International Journal of Tropical Insect Science, V28, P61, DOI 10.1017/S1742758408962366
   Rajeswary M, 2018, ENVIRON SCI POLLUT R, V25, P10307, DOI 10.1007/s11356-017-9093-3
   Rajkumar S, 2010, J ASIA-PAC ENTOMOL, V13, P107, DOI 10.1016/j.aspen.2010.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Scotti L, 2014, MED CHEM, V10, P201, DOI 10.2174/15734064113099990005
   Shrivastava SR, 2017, ANN TROP MED PUBLIC, V10, P764, DOI 10.4103/1755-6783.213140
   Silva VB, 2017, J ARTHROPOD-BORNE DI, V11, P315
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Songa EA, 2016, TALANTA, V155, P289, DOI 10.1016/j.talanta.2016.04.046
   Stevenson PC, 2017, IND CROP PROD, V110, P2, DOI 10.1016/j.indcrop.2017.08.034
   Vanhaecke P., 1981, REPORT INTERCALIBRAT, V106, P359
   Vehovszky A, 2015, AQUAT TOXICOL, V167, P172, DOI 10.1016/j.aquatox.2015.08.009
   Santos VSV, 2017, J TOXICOL ENV HEAL A, V80, P155, DOI 10.1080/15287394.2016.1266721
   Volpe PLO, 1997, J BRAZIL CHEM SOC, V8, P1, DOI 10.1590/S0103-50531997000400005
   Weerasinghe AJ, 2015, INT J PHARM PHARM SC, V7, P459
   YOURNO J, 1981, BLOOD, V58, P939
NR 69
TC 1
Z9 1
U1 0
U2 15
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD NOV
PY 2018
VL 25
IS 31
SI SI
BP 31165
EP 31174
DI 10.1007/s11356-018-2809-1
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GW8IQ
UT WOS:000447220700038
PM 30187415
DA 2020-12-08
ER

PT J
AU Machado, JR
   Pereira, GN
   de Oliveira, PD
   Zenevicz, MC
   Lerin, L
   de Oliveira, RDB
   Cavalcanti, SCD
   Ninow, JL
   de Oliveira, D
AF Machado, Juliana Ribeiro
   Pereira, Gabriela Nayana
   de Oliveira, Priscilla dos Santos
   Zenevicz, Mara Cristina
   Lerin, Lindomar
   Barreto de Oliveira, Rafael dos Reis
   de Holanda Cavalcanti, Socrates Cabral
   Ninow, Jorge Luiz
   de Oliveira, Debora
TI Synthesis of eugenyl acetate by immobilized lipase in a packed bed
   reactor and evaluation of its larvicidal activity
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Eugenol; Eugenyl acetate; Lipase; Packed bed reactor
ID AEGYPTI DIPTERA-CULICIDAE; ESSENTIAL OIL; CATALYZED SYNTHESIS; ENZYMATIC
   REACTORS; MOSQUITO VECTORS; SOYBEAN OIL; BATCH; ESTERS; LARVAE;
   DERIVATIVES
AB Eugenol esters, including eugenyl acetate, has been intensively investigated because of its beneficial antioxidant, antimicrobial, antitumor and potential larvicidal properties. Recent studies verified that small amounts of eugenol esters are effective against the development of larvae of Aedes egytpti. Packed bed reactors (PBR) have been employed for the synthesis of a variety of esters, as it is essential to assess some process parameters such as molar ratio of substrates, operating temperature and reaction residence time. Based on these aspects, the objective of this study was to evaluate the effect of molar ratio of eugenol and acetic anhydride, reaction temperature and substrates flow rate on the synthesis of eugenyl acetate esters in a packed bed reactor, using Lipozyme TL IM lipase as catalyst, and to determine the larvicidal activity of the obtained ester against larvae of A. aegypti. The optimal condition was obtained with flow rate of 0.1 mL min(-1), 55 degrees C and 1:5.82 (eugenol:acetic anhydride) molar ratio, affording a conversion value of about 93%. Further, the potential toxicity of A. aegypti larvae increased under the effect of eugenyl acetate, presenting a LC50 of 0.102 mg mL(-1), which demonstrates its usability as a natural compound that can be employed in commercial larvicidal formulations.
C1 [Machado, Juliana Ribeiro; Pereira, Gabriela Nayana; de Oliveira, Priscilla dos Santos; Zenevicz, Mara Cristina; Lerin, Lindomar; Ninow, Jorge Luiz; de Oliveira, Debora] Univ Fed Santa Catarina, Dept Chem Engn & Food Engn, BR-88040900 Florianopolis, SC, Brazil.
   [Barreto de Oliveira, Rafael dos Reis; de Holanda Cavalcanti, Socrates Cabral] Univ Fed Sergipe, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
RP de Oliveira, D (corresponding author), Univ Fed Santa Catarina, Dept Chem Engn & Food Engn, BR-88040900 Florianopolis, SC, Brazil.
EM debora.oliveira@ufsc.br
RI Lerin, Lindomar Alberto/M-6935-2019; Cavalcanti, Socrates/AAQ-7004-2020;
   Oliveira, Debora/S-3820-2018; Oliveira, Debora/AAO-9811-2020
OI Lerin, Lindomar Alberto/0000-0001-7411-8974; Oliveira,
   Debora/0000-0001-7544-5045; Picoli Zenevicz, Mara
   Cristina/0000-0001-7137-0103
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX The authors wish to acknowledge CAPES and CNPq for the financial support
   for this study and the scholarships.
CR Affonso RS, 2014, REV VIRTUAL QUIM, V6, P1316, DOI 10.5935/1984-6835.20140086
   B. R. Ministerio da Sande, 2016, INF EP 57 SEM EP SE
   Balcao VM, 1996, ENZYME MICROB TECH, V18, P392, DOI 10.1016/0141-0229(95)00125-5
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Chang SW, 2007, PROCESS BIOCHEM, V42, P1362, DOI 10.1016/j.procbio.2007.06.008
   Chiaradia V, 2012, APPL BIOCHEM BIOTECH, V168, P742, DOI 10.1007/s12010-012-9814-5
   Costa J. G. M., 2005, REV BRAS FARMACOGN, V15, P304, DOI DOI 10.1590/S0102-695X2005000400008
   Dahlan I., 2005, INT J ENG, V18, P153
   Dalla Rosa C, 2009, BIORESOURCE TECHNOL, V100, P5818, DOI 10.1016/j.biortech.2009.06.081
   Damnjanovic JJ, 2012, J MOL CATAL B-ENZYM, V75, P50, DOI 10.1016/j.molcatb.2011.11.009
   de Morais SM, 2014, BIOORGAN MED CHEM, V22, P6250, DOI 10.1016/j.bmc.2014.08.020
   EFSA, 2011, EFSA J
   Finney D. J., 1971, PROBIT ANAL
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Guan WQ, 2007, FOOD CHEM, V101, P1558, DOI 10.1016/j.foodchem.2006.04.009
   Horchani H, 2010, BIORESOURCE TECHNOL, V101, P2809, DOI 10.1016/j.biortech.2009.10.082
   Jakovetic SM, 2013, IND ENG CHEM RES, V52, P16689, DOI 10.1021/ie402069c
   Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2005, WHO TECHN REP SER, V934, P7
   Khan NR, 2015, PROCESS BIOCHEM, V50, P1793, DOI 10.1016/j.procbio.2015.07.014
   Lee KG, 2001, FOOD CHEM, V74, P443, DOI 10.1016/S0308-8146(01)00161-3
   Lerin LA, 2015, RSC ADV, V5, P76898, DOI 10.1039/c5ra08457a
   Lopes WA, 2004, QUIM NOVA, V27, P670, DOI 10.1590/S0100-40422004000400025
   Lucchesi ME, 2004, J CHROMATOGR A, V1043, P323, DOI 10.1016/j.chroma.2004.05.083
   Matte CR, 2016, J MOL CATAL B-ENZYM, V127, P67, DOI 10.1016/j.molcatb.2016.02.016
   Ministerio da Saflde Brazil, 2017, B EPIDEMIOL, V48
   Pandey SK, 2013, PEST MANAG SCI, V69, P1235, DOI 10.1002/ps.3488
   Perry R.H., 2008, PERRYS CHEM ENG HDB
   Poppe JK, 2015, BIOTECHNOL ADV, V33, P511, DOI 10.1016/j.biotechadv.2015.01.011
   Rahman NFA, 2011, BIORESOURCE TECHNOL, V102, P2168, DOI 10.1016/j.biortech.2010.10.034
   Romero MD, 2007, J BIOTECHNOL, V127, P269, DOI 10.1016/j.jbiotec.2006.07.009
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Shukri R, 2010, FOOD CHEM, V122, P1116, DOI 10.1016/j.foodchem.2010.03.094
   Silva MJA, 2015, APPL BIOCHEM BIOTECH, V176, P782, DOI 10.1007/s12010-015-1611-5
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Sutili FK, 2013, J MOL CATAL B-ENZYM, V85-86, P37, DOI 10.1016/j.molcatb.2012.08.004
   Trindade FTT, 2013, REV BRAS FARMACOGN, V23, P464, DOI [10.1590/S0102-695X2013005000038, 10.1590/S0102-695X2013000300010]
   THANGAM TS, 1991, BOT MAR, V34, P433, DOI 10.1515/botm.1991.34.5.433
   Vadgama Rajeshkumar N, 2015, Biotechnol Rep (Amst), V8, P105, DOI 10.1016/j.btre.2015.10.005
   Xu XB, 2002, J AM OIL CHEM SOC, V79, P561, DOI 10.1007/s11746-002-0522-6
   Yang HL, 2014, CHINESE J CHEM ENG, V22, P1016, DOI 10.1016/j.cjche.2014.06.027
NR 42
TC 10
Z9 10
U1 3
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD JUL
PY 2017
VL 58
BP 114
EP 119
DI 10.1016/j.procbio.2017.04.031
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA EZ4VN
UT WOS:000404710700015
DA 2020-12-08
ER

PT J
AU Silva, ARST
   Scher, R
   Santos, FV
   Ferreira, SR
   Cavalcanti, SCH
   Correa, CB
   Bueno, LL
   Alves, RJ
   Souza, DP
   Fujiwara, RT
   Dolabella, SS
AF Silva, Audrey R. S. T.
   Scher, Ricardo
   Santos, Flaviane V.
   Ferreira, Sebastiao R.
   Cavalcanti, Socrates C. H.
   Correa, Cristiane B.
   Bueno, Lilian L.
   Alves, Ricardo J.
   Souza, Damiao P.
   Fujiwara, Ricardo T.
   Dolabella, Silvio S.
TI Leishmanicidal Activity and Structure-Activity Relationships of
   Essential Oil Constituents
SO MOLECULES
LA English
DT Article
DE monoterpenes; Leishmania amazonensis; leishmanicidal activity; essential
   oil
ID RICH ESSENTIAL OIL; ANTILEISHMANIAL ACTIVITY; MAJOR COMPONENTS; LIPPIA;
   AGENTS; MONOTERPENES; DERIVATIVES; CARVACROL; DIAGNOSIS; GENOTYPES
AB Several constituents of essential oils have been shown to be active against pathogens such as bacteria, fungi, and protozoa. This study demonstrated the in vitro action of ten compounds present in essential oils against Leishmania amazonensis promastigotes. With the exception of p-cymene, all evaluated compounds presented leishmanicidal activity, exhibiting IC50 between 25.4 and 568.1 mu g mL(-1). Compounds with the best leishmanicidal activity presented a phenolic moiety (IC50 between 25.4 and 82.9 mu g mL(-1)). Alicyclic alcohols ((-)-menthol and isoborneol) and ketones ((-)-carvone) promoted similar activity against the parasite (IC50 between 190.2 and 198.9 mu g mL(-1)). Most of the compounds showed low cytotoxicity in L929 fibroblasts. Analysis of the structure-activity relationship of these compounds showed the importance of the phenolic structure for the biological action against the promastigote forms of the parasite.
C1 [Silva, Audrey R. S. T.; Cavalcanti, Socrates C. H.; Dolabella, Silvio S.] Univ Fed Sergipe, Dept Pharm, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Scher, Ricardo; Santos, Flaviane V.; Correa, Cristiane B.] Univ Fed Sergipe, Dept Morphol, Lab Mol Biol Pathogen Bioagents, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Ferreira, Sebastiao R.; Bueno, Lilian L.; Fujiwara, Ricardo T.] Univ Fed Minas Gerais, Dept Parasitol, Biol Sci Inst, BR-31270901 Belo Horizonte, MG, Brazil.
   [Ferreira, Sebastiao R.] Univ Fed Roraima, Hlth Sci Ctr, Av Cap Ene Garcez, BR-69310000 Boa Vista, Roraima, Brazil.
   [Alves, Ricardo J.] Univ Fed Minas Gerais, Dept Pharmaceut Prod, BR-31270901 Belo Horizonte, MG, Brazil.
   [Souza, Damiao P.] Univ Fed Paraiba, Dept Pharmaceut Sci, BR-58051900 Joao Pessoa, Paraiba, Brazil.
   [Dolabella, Silvio S.] Univ Fed Sergipe, Dept Morphol, Lab Parasitol & Trop Entomol, BR-49100000 Sao Cristovao, Sergipe, Brazil.
RP Dolabella, SS (corresponding author), Univ Fed Sergipe, Dept Pharm, BR-49100000 Sao Cristovao, Sergipe, Brazil.; Dolabella, SS (corresponding author), Univ Fed Sergipe, Dept Morphol, Lab Parasitol & Trop Entomol, BR-49100000 Sao Cristovao, Sergipe, Brazil.
EM audreytavares2@gmail.com; scher@ufs.br; flavianevieirah@gmail.com;
   ferreirasr2008@hotmail.com; socratescavalcanti@yahoo.com.br;
   crisbani@gmail.com; lilacerdabueno@gmail.com;
   ricardodylan@farmacia.ufmg.br; damiao_desousa@yahoo.com.br;
   fujiwara@icb.ufmg.br; dolabella@ufs.br
RI Alves, Ricardo J/I-7978-2015; Ferreira, Sebastiao Rodrigo/AAU-5852-2020;
   de Sousa, Damiao Pergentino/B-2580-2018; Dolabella, Silvio/X-4351-2019;
   Bueno, Lilian/AAQ-1939-2020; Correa, Cristiane Bani/AAR-9384-2020; de
   Sousa, Damiao Pergentino/AAY-1244-2020; Cavalcanti,
   Socrates/AAQ-7004-2020
OI Ferreira, Sebastiao Rodrigo/0000-0002-1531-4980; de Sousa, Damiao
   Pergentino/0000-0002-7180-4896; Bueno, Lilian/0000-0003-3510-4590;
   Vieira Santos, Flaviane/0000-0002-3431-8864; Santana Dolabella,
   Silvio/0000-0001-5576-3214
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Apoio a Pesquisa e Inovacao Tecnologica do
   Estado de Sergipe (FAPITEC)
FX We gratefully acknowledge financial support received from the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and
   Fundacao de Apoio a Pesquisa e Inovacao Tecnologica do Estado de Sergipe
   (FAPITEC).
CR [Anonymous], 2009, BIOL EV MED DEV 5, P10993
   Anthony JP, 2005, TRENDS PARASITOL, V21, P462, DOI 10.1016/j.pt.2005.08.004
   Arruda DC, 2009, BIOMED PHARMACOTHER, V63, P643, DOI 10.1016/j.biopha.2009.02.004
   Bahmani M. P., 2016, DER PHARM CHEM, V8, P134
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Ben Arfa A, 2006, LETT APPL MICROBIOL, V43, P149, DOI 10.1111/j.1472-765X.2006.01938.x
   Camargos HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104429
   Castano M, 2009, MOLECULES, V14, P2491, DOI 10.3390/molecules14072491
   de Azevedo AF, 2014, PARASITOL RES, V113, P19, DOI 10.1007/s00436-013-3621-y
   de Melo JO, 2013, ACTA TROP, V128, P110, DOI 10.1016/j.actatropica.2013.06.024
   de Moraes J, 2013, PLANTA MED, V79, P253, DOI 10.1055/s-0032-1328173
   de Morais SM, 2014, BIOORGAN MED CHEM, V22, P6250, DOI 10.1016/j.bmc.2014.08.020
   de Sousa DP, 2016, PLANTA MED, V82, P1346, DOI 10.1055/s-0042-107082
   de Vries HJC, 2015, AM J CLIN DERMATOL, V16, P99, DOI 10.1007/s40257-015-0114-z
   Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x
   Dutra FL, 2016, ACTA TROP, V164, P69, DOI 10.1016/j.actatropica.2016.08.026
   Ejazi SA, 2013, EXPERT REV ANTI-INFE, V11, P79, DOI [10.1586/eri.12.148, 10.1586/ERI.12.148]
   Escobar P, 2010, MEM I OSWALDO CRUZ, V105, P184, DOI 10.1590/S0074-02762010000200013
   Farias PA, 2012, BIOL RES, V45, P399, DOI 10.4067/S0716-97602012000400012
   de Medeiros MDF, 2011, PARASITOL INT, V60, P237, DOI 10.1016/j.parint.2011.03.004
   Giudice A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-7
   Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]
   Hui X, 2017, MED CHEM RES, V26, P442, DOI 10.1007/s00044-016-1762-0
   Jones SFA, 1996, EUR J GASTROEN HEPAT, V8, P1227, DOI 10.1097/00042737-199612000-00018
   Kevric I, 2015, DERMATOL CLIN, V33, P579, DOI 10.1016/j.det.2015.03.018
   Kobets T, 2012, CURR MED CHEM, V19, P1443, DOI 10.2174/092986712799828300
   Koziol A, 2014, MINI-REV MED CHEM, V14, P1156
   Kulshrestha A, 2013, PARASITOL RES, V112, P825, DOI 10.1007/s00436-012-3212-3
   Machado M, 2014, VET PARASITOL, V200, P39, DOI 10.1016/j.vetpar.2013.11.016
   Mafud AC, 2016, CHEM-BIOL INTERACT, V244, P129, DOI 10.1016/j.cbi.2015.12.003
   Monzote L, 2009, TOXICOL APPL PHARM, V240, P337, DOI 10.1016/j.taap.2009.08.001
   Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451
   Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055
   Ollbert-Majkut A, 2008, J PHYS CHEM A, V112, P5691, DOI 10.1021/jp801430d
   Osorio Edison, 2006, Acta Farmaceutica Bonaerense, V25, P405
   Peixoto MG, 2015, VET PARASITOL, V210, P118, DOI 10.1016/j.vetpar.2015.03.010
   Pizzolitto Romina P, 2015, Microorganisms, V3, P851, DOI 10.3390/microorganisms3040851
   Reis S. L., 2014, BMC P, V8, P115, DOI [10.1186/1753-6561-8-S4-P115, DOI 10.1186/1753-6561-8-S4-P115]
   Rios MC, 2015, GENET MOL RES, V14, P7113, DOI 10.4238/2015.June.29.4
   Robledo S, 2005, ANTIMICROB AGENTS CH, V49, P1652, DOI 10.1128/AAC.49.4.1652-1655.2005
   Rodrigues FAR, 2014, CHEM BIOL DRUG DES, V83, P126, DOI 10.1111/cbdd.12210
   Rosa MDS, 2003, ANTIMICROB AGENTS CH, V47, P1895, DOI 10.1128/AAC.47.6.1895-1901.2003
   Sanchez C, 2015, INT J FOOD MICROBIOL, V192, P72, DOI 10.1016/j.ijfoodmicro.2014.09.028
   Savoia D, 2015, J INFECT DEV COUNTR, V9, P588, DOI 10.3855/jidc.6833
   Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005
   Ueda-Nakamura T, 2006, PARASITOL INT, V55, P99, DOI 10.1016/j.parint.2005.10.006
   Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002
   WHO, LEISHM FACT SHEET
   Winter R., 2009, CONSUMERS DICT FOOD, P142
   Zheljazkov VD, 2008, J AGR FOOD CHEM, V56, P380, DOI 10.1021/jf0725629
NR 50
TC 10
Z9 11
U1 0
U2 4
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD MAY
PY 2017
VL 22
IS 5
AR 815
DI 10.3390/molecules22050815
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA EZ2EP
UT WOS:000404522900136
PM 28509873
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Silva, VB
   Travassos, DL
   Nepel, A
   Barison, A
   Costa, EV
   Scotti, L
   Scotti, MT
   Mendonca, FJB
   dos Santos, RL
   Cavalcanti, SCD
AF Silva, Viviane Barros
   Travassos, Daniele Lima
   Nepel, Angelita
   Barison, Andersson
   Costa, Emmanoel Vilaca
   Scotti, Luciana
   Scotti, Marcus Tulius
   Bezerra Mendonca-Junior, Francisco Jaime
   dos Santos, Roseli La Corte
   de Holanda Cavalcanti, Socrates Cabral
TI Synthesis and Chemometrics of Thymol and Carvacrol Derivatives as
   Larvicides against Aedes aegypti
SO JOURNAL OF ARTHROPOD-BORNE DISEASES
LA English
DT Article
DE Chemometry; SAR; Dengue; Thymol derivatives; Carvacrol derivatives
ID VOLSURF
AB Background: Thymol and carvacrol have previously demonstrated larvicidal activity against Aedes aegypti (Diptera: Culicidae). In view of this fact, it was of our interest to obtain synthetic derivatives and evaluate their larvicidal activity on Ae. aegypti larvae.
   Methods: Structural modifications were performed on thymol and carvacrol in an effort to understand the functional groups necessary for modulating their activities and to lead possibly to more effective larvae control agents. The derivatives were further subjected to SAR and computational studies (molecular modeling and chemometric tools (CPCA and PCA)) to extract structural information regarding their larvicidal properties. Field collected and Rocke-feller populations of Ae. aegypti were used.
   Results: Carvacrol and thymol exhibited LC50 of 51 and 58ppm for field collected larvae, respectively. Carvacrol derivatives exhibited LC50 ranging from 39 to 169ppm, while thymol derivatives exhibited LC50 ranging from 18 to 465ppm. Substitution of the acidic proton of carvacrol by esters, ethers, and acetic acid resulted in either maintenance or reduction of potency.
   Conclusion: Thymol derivatives were, to a certain extent, more efficient larvicides against Ae. aegypti than carvacrol derivatives, particularly to Rockefeller larvae. The chemometrics tools applied in this study showed that the independent variables indicate a mixed profile. Nevertheless, hydrophobic interactions increased the larvicidal activity.
C1 [Silva, Viviane Barros; Travassos, Daniele Lima; de Holanda Cavalcanti, Socrates Cabral] Univ Fed Sergipe, Pharm Dept, Med Chem Lab, Sao Cristovao, Brazil.
   [Nepel, Angelita; Barison, Andersson] Univ Fed Parana, Chem Dept, Nucl Magnet Resonance Lab, Curitiba, Parana, Brazil.
   [Costa, Emmanoel Vilaca] Univ Fed Amazonas, Inst Sci, Chem Dept, Manaus, Amazonas, Brazil.
   [Scotti, Luciana; Scotti, Marcus Tulius] Univ Fed Paraiba, Biotechnol Ctr, Campus 1, Joao Pessoa, Paraiba, Brazil.
   [Bezerra Mendonca-Junior, Francisco Jaime] State Univ Paraiba, Lab Synth & Delivery Mol, Biol Sci Dept, Joao Pessoa, Paraiba, Brazil.
   [dos Santos, Roseli La Corte] Univ Fed Sergipe, Morphol Dept, Parasitol & Trop Entomol Lab, Sao Cristovao, Brazil.
RP Cavalcanti, SCD (corresponding author), Univ Fed Sergipe, Pharm Dept, Med Chem Lab, Sao Cristovao, Brazil.
EM socratescavalcanti@yahoo.com.br
RI Scotti, Luciana/C-7811-2013; Barison, Andersson/F-7134-2012; Nepel,
   Angelita/J-2796-2016; Cavalcanti, Socrates/AAQ-7004-2020; JUNIOR,
   FRANCISCO JAIME BEZERRA MENDONCA/J-2926-2015; Santos, Roseli
   LC/F-1735-2015
OI Scotti, Luciana/0000-0003-1866-4107; Barison,
   Andersson/0000-0001-9381-8239; Nepel, Angelita/0000-0002-7426-0927;
   JUNIOR, FRANCISCO JAIME BEZERRA MENDONCA/0000-0003-3588-833X; 
FU DECIT; CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPITEC-SE [471729/2010-8, 477428/2007-0, 550116-2010-9-Rede
   Dengue]
FX The authors wish to acknowledge DECIT, CNPq, and FAPITEC-SE for
   supporting funds (471729/2010-8, 477428/2007-0, 550116-2010-9-Rede
   Dengue). We extend our acknowledgement to Prof Norberto Peporine Lopes
   for mass spectra analyses. The authors declare that there is no conflict
   of interest.
CR Agra-Neto AC, 2014, PARASITOL RES, V113, P175, DOI 10.1007/s00436-013-3640-8
   ALLINGER NL, 1977, J AM CHEM SOC, V99, P8127, DOI 10.1021/ja00467a001
   [Anonymous], 2015, WHOCDSNTDWHOPESGCDPP
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Baser KHC, 2008, CURR PHARM DESIGN, V14, P3106, DOI 10.2174/138161208786404227
   Ben Arfa A, 2006, LETT APPL MICROBIOL, V43, P149, DOI 10.1111/j.1472-765X.2006.01938.x
   Cianchetta G, 2004, J MED CHEM, V47, P3193, DOI 10.1021/jm030986y
   Cohen N. C., 1996, GUIDEBOOK MOL MODELI
   COOLEN HKAC, 1995, J AM CHEM SOC, V117, P11906, DOI 10.1021/ja00153a012
   Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17, DOI 10.1016/S0166-1280(99)00360-7
   Cruciani G, 2002, J MED CHEM, V45, P2685, DOI 10.1021/jm0011326
   Cruciani G, 2000, EUR J PHARM SCI, V11, pS29, DOI 10.1016/S0928-0987(00)00162-7
   de Morais SM, 2014, BIOORGAN MED CHEM, V22, P6250, DOI 10.1016/j.bmc.2014.08.020
   DEWAR MJS, 1993, J AM CHEM SOC, V115, P5348, DOI 10.1021/ja00065a080
   Dolly, 2003, TETRAHEDRON, V59, P9161, DOI 10.1016/j.tet.2003.09.051
   Finney D. J., 1971, PROBIT ANAL
   Goncalves RLS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007854
   Grodnitzky JA, 2002, J AGR FOOD CHEM, V50, P4576, DOI 10.1021/jf0201475
   Hypercube, 2009, HYP PROGR REL 8 0
   Knight PD, 2005, J ORGANOMET CHEM, V690, P5125, DOI 10.1016/j.jorganchem.2005.03.043
   Leach A. R., 2001, MOL MODELING PRINCIP
   Lima TC, 2014, CHEMOSPHERE, V104, P37, DOI 10.1016/j.chemosphere.2013.10.035
   Nikumbh VP, 2003, J SCI IND RES INDIA, V62, P1086
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005
   Riedl R, 1998, J AM CHEM SOC, V120, P8994, DOI 10.1021/ja980183d
   Samarasekera R, 2008, PEST MANAG SCI, V64, P290, DOI 10.1002/ps.1516
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Scotti L, 2014, MED CHEM, V10, P201, DOI 10.2174/15734064113099990005
   SINGH IP, 1989, INDIAN J CHEM B, V28, P692
   VARMA RL, 1985, INDIAN J CHEM B, V24, P302
   WHO, 2006, PEST THEIR APPL CONT
NR 33
TC 15
Z9 15
U1 1
U2 6
PU IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY
PI TEHRAN
PA SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL
   SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN
SN 2322-1984
EI 2322-2271
J9 J ARTHROPOD-BORNE DI
JI J. Arthropod.-Borne Dis.
PD MAY
PY 2017
VL 11
IS 2
BP 315
EP 330
PG 16
WC Public, Environmental & Occupational Health; Parasitology
SC Public, Environmental & Occupational Health; Parasitology
GA EY2TG
UT WOS:000403823700015
PM 29062856
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Nascimento, AMD
   Maia, TDS
   Soares, TES
   Menezes, LRA
   Scher, R
   Costa, EV
   Cavalcanti, SCH
   La Corte, R
AF Nascimento, A. M. D.
   Maia, T. D. S.
   Soares, T. E. S.
   Menezes, L. R. A.
   Scher, R.
   Costa, E. V.
   Cavalcanti, S. C. H.
   La Corte, R.
TI Repellency and Larvicidal Activity of Essential oils from Xylopia
   laevigata, Xylopia frutescens, Lippia pedunculosa, and Their Individual
   Compounds against Aedes aegypti Linnaeus
SO NEOTROPICAL ENTOMOLOGY
LA English
DT Article
DE Essential oils; mosquitoes; repellency; vector control
ID INSECTICIDAL ACTIVITIES; MALARIAL VECTOR; DIPTERA; ANOPHELES; PLANTS;
   CONSTITUENTS; EXTRACTS; LEAVES
AB In order to find new alternatives for vector control and personal protection, we evaluated the larvicidal and repellent activity of essentials oils from plants found in the Northeast of Brazil against Aedes aegypti Linnaeus mosquitoes. The plants tested include Xylopia laevigata, Xylopia frutescens, and Lippia pedunculosa and their major compounds, piperitenone oxide, and (R)-limonene. The essential oil of L. pedunculosa and its major volatile compounds were shown to be toxic for Ae. aegypti larvae with a LC50 lower than 60 ppm. The essential oil of plants from the Xylopia genus, on the other hand, showed no activity against Ae. aegypti, proving to be toxic to mosquito larvae only when concentrations were higher than 1000 ppm. All plants tested provided some degree of protection against mosquitoes landing, but only the essential oil of L. pedunculosa and the volatile compound piperitenone oxide suppressed 100% of mosquitoes landing on human skin, in concentrations lower than 1%. Among the plants studied, the essential oil of L. pedunculosa and its volatiles compounds have shown the potential for the development of safe alternative for mosquito larvae control and protection against Ae. aegypti mosquito bites.
C1 [Nascimento, A. M. D.] Univ Fed Minas Gerais, Adv Grad Program Parasitol, Belo Horizonte, MG, Brazil.
   [Maia, T. D. S.; Soares, T. E. S.; Scher, R.; La Corte, R.] Univ Fed Sergipe, Dept Morphol, Sao Cristovao, Sergipe, Brazil.
   [Menezes, L. R. A.] Univ Fed Sergipe, Dept Chem, Sao Cristovao, Sergipe, Brazil.
   [Costa, E. V.] Univ Fed Amazonas, Dept Chem, Manaus, Amazonas, Brazil.
   [Cavalcanti, S. C. H.] Univ Fed Sergipe, Dept Pharm, Sao Cristovao, Sergipe, Brazil.
RP Nascimento, AMD (corresponding author), Rua Boaventura 1319,Bloco7,Apto 202, BR-31270310 Belo Horizonte, MG, Brazil.
EM ana.dia@ufs.br
RI Menezes, Leociley/AAA-4324-2020; Menezes, Leociley R. A./P-4160-2015;
   Santos, Roseli LC/F-1735-2015; Cavalcanti, Socrates/AAQ-7004-2020
OI Menezes, Leociley/0000-0001-8631-8607; Menezes, Leociley R.
   A./0000-0001-8631-8607; Costa, Emmanoel/0000-0002-0153-822X
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPITEC/SE, Brazil
FX The authors are grateful to Prof. Dr. Ana Paula do Nascimento Prata
   (UFS), Brazil, for the botanical identification, and to Prof. John
   Stolze for the help with the translation. We also are grateful to CAPES,
   CNPq, and FAPITEC/SE, Brazil, for financial support.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Barnard DR, 2005, J AM MOSQUITO CONTR, V21, P12, DOI 10.2987/8756-971X(2005)21[12:BAMFMR]2.0.CO;2
   Bianco EM, 2013, IND CROP PROD, V43, P270, DOI 10.1016/j.indcrop.2012.07.032
   Bueno V.S, 2010, Rev. bras. plantas med., V12, P215, DOI 10.1590/S1516-05722010000200014
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P452, DOI 10.1016/j.biortech.2008.02.038
   Corrêa J.C.R., 2011, Rev. bras. plantas med., V13, P500, DOI 10.1590/S1516-05722011000400016
   Porto KRD, 2008, REV SOC BRAS MED TRO, V41, P586, DOI 10.1590/S0037-86822008000600008
   Environmental Protection Agency, 1994, EPA738F94030, P1
   European Commission, 2015, RAP RISK ASS ZIK VIR, P1
   Feitosa EMA, 2009, J BRAZIL CHEM SOC, V20, P375, DOI 10.1590/S0103-50532009000200024
   Ferraz RPC, 2013, FOOD CHEM, V141, P196, DOI 10.1016/j.foodchem.2013.02.114
   Finney D. J., 1971, PROBIT ANAL
   Garcez WS, 2013, REV VIRTUAL QUIM, V5, P363, DOI 10.5935/1984-6835.20130034
   Gleiser RM, 2011, PARASITOL RES, V108, P69, DOI 10.1007/s00436-010-2042-4
   Gomes S.V.F., 2011, ECLET QUIM, V36, P64, DOI DOI 10.1590/S0100-
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P941, DOI 10.1016/S1995-7645(11)60223-X
   Guedes DN, 2004, BRAZ J MED BIOL RES, V37, P1881, DOI 10.1590/S0100-879X2004001200014
   Hazarika S, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.0501
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101
   Kalita B., 2013, INT J RES DEV PHARM, V3, P741
   Kim SI, 2003, J STORED PROD RES, V39, P293, DOI 10.1016/S0022-474X(02)00017-6
   Koliopoulos G, 2010, PARASITOL RES, V107, P327, DOI 10.1007/s00436-010-1865-3
   Kweka EJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-59
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   Miot Hélio Amante, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P253, DOI 10.1590/S0036-46652004000500004
   Moreira IC, 2013, CHEM BIODIVERS, V10, P1921, DOI 10.1002/cbdv.201100308
   Moreira MF, 2012, I NAC CIENC TECNOL E, V15, P1
   Motulsky H, 2003, FITTING MODELS BIOL
   Oliveira CL, 2007, ARQ CIENC SAUDE UNIP, V11, P211
   Quintans JDS, 2013, PLANTA MED, V79, P123, DOI 10.1055/s-0032-1328091
   SANTANA HT., 2015, Rev. bras. plantas med., V17, P105, DOI 10.1590/1983-084X/13_052
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Silva DM, 2012, QUIM NOVA, V35, P1570, DOI 10.1590/S0100-40422012000800015
   SILVEIRA J.C., 2012, ENCICLOPEDIA BIOSFER, V8, P2038
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thach LN, 2013, J ESSENT OIL RES, V25, P39, DOI 10.1080/10412905.2013.759360
   Tripathi AK, 2004, J MED ENTOMOL, V41, P691, DOI 10.1603/0022-2585-41.4.691
   Utsunomiya HSM, 2008, REB, V1, P21
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   WHO, 2009, GUID EFF TEST MOSQ R
   Zahran HEM, 2011, J ASIA-PAC ENTOMOL, V14, P46, DOI 10.1016/j.aspen.2010.11.013
NR 47
TC 12
Z9 12
U1 0
U2 20
PU ENTOMOLOGICAL SOC BRASIL
PI LONDRINA,
PA CAIXA POSTAL 481, 86001-970 LONDRINA,, PR, BRAZIL
SN 1519-566X
EI 1678-8052
J9 NEOTROP ENTOMOL
JI Neotrop. Entomol.
PD APR
PY 2017
VL 46
IS 2
BP 223
EP 230
DI 10.1007/s13744-016-0457-z
PG 8
WC Entomology
SC Entomology
GA ER6MP
UT WOS:000398919700012
PM 27844468
DA 2020-12-08
ER

PT J
AU Alencar, EB
   Silva, JWC
   Cavalcanti, SCH
AF Alencar Filho, Edilson B.
   Castro Silva, Joseph W.
   Cavalcanti, Scrates C. H.
TI Quantitative structure-toxicity relationships and molecular highlights
   about Aedes aegypti larvicidal activity of monoterpenes and related
   compounds
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Article
DE QSAR; OPS/MLR; Monoterpenoids; Aedes aegypti; Larvicidal
ID QSAR; PHENYLPROPANOIDS; DESCRIPTORS; REGRESSION; SELECTION
AB Dengue is a viral tropical disease transmitted to humans via the bite of Aedes aegypti L. (Diptera: Culicidae) mosquitoes. Since there is no specific treatment for dengue, the only method for preventing virus transmission is to control its vector by using environmental management and chemical methods. In this work, we propose a quantitative structure-toxicity relationships study of 31 monoterpenes and structurally related compounds which are bioactive against Aedes aegypti larvae, aiming to identify structural features responsible for the compounds activity, with the goal to support lead optimization. After conformational studies and complete geometry optimizations in DFT level, 1666 descriptors were calculated by E-Dragon online platform. The ordered predictors selection algorithm selected nine important descriptors, which were reduced to three after further analysis (R8e+, MAXDN, nCt), considering twenty-four and seven compounds in training and test sets, respectively. The validation parameters of final MLR modeling for these variables were: R (2) = 0.83; Q (2) (loo) = 0.77; Q (2) (ext) = 0.83, showing that a robust and predictive model was obtained.
C1 [Alencar Filho, Edilson B.; Castro Silva, Joseph W.] Fed Univ San Francisco Valley, Coll Pharm, Petrolina, PE, Brazil.
   [Alencar Filho, Edilson B.] Fed Univ Western Bahia, Postgrad Program Pure & Appl Chem, Barreiras, BA, Brazil.
   [Cavalcanti, Scrates C. H.] Univ Fed Sergipe, Dept Pharm, Med Chem Lab, Sao Cristovao, Brazil.
RP Alencar, EB (corresponding author), Fed Univ San Francisco Valley, Coll Pharm, Petrolina, PE, Brazil.; Alencar, EB (corresponding author), Fed Univ Western Bahia, Postgrad Program Pure & Appl Chem, Barreiras, BA, Brazil.
EM edilson.beserra@univasf.edu.br
RI Alencar Filho, Edilson B./D-8775-2016; Cavalcanti,
   Socrates/AAQ-7004-2020
OI Alencar Filho, Edilson B./0000-0002-1000-0114; 
CR Alencar EB, 2014, MED CHEM RES, V23, P5328, DOI 10.1007/s00044-014-1077-y
   BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098
   Beebe KR, 1998, CHEMOMETRICS PRACTIC
   Consonni V, 2002, J CHEM INF COMP SCI, V42, P682, DOI 10.1021/ci015504a
   Dashtbozorgi Z, 2012, CHROMATOGRAPHIA, V75, P701, DOI 10.1007/s10337-012-2257-x
   de Oliveira DB, 2001, QUANT STRUCT-ACT REL, V19, P599
   Dennington R., 2009, GAUSSVIEW VERSION 5
   Ferreira MMC, 2002, J BRAZIL CHEM SOC, V13, P742, DOI 10.1590/S0103-50532002000600004
   Filho EBA, 2012, J MOL STRUCT, V1022, P72, DOI 10.1016/j.molstruc.2012.04.051
   Frisch MJ, 2009, GAUSSIAN 09 REVISION
   Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098
   Gramatica P, 2000, CHEMOSPHERE, V41, P763, DOI 10.1016/S0045-6535(99)00463-4
   Hansch C., 1995, EXPLORING QSAR FUNDA
   Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412
   Kim NJ, 2008, PEST MANAG SCI, V64, P857, DOI 10.1002/ps.1557
   Kiralj R, 2009, J BRAZIL CHEM SOC, V20, P770, DOI 10.1590/S0103-50532009000400021
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Martins JPA, 2013, QUIM NOVA, V36, P554, DOI 10.1590/S0100-40422013000400013
   Pandey SK, 2013, PEST MANAG SCI, V69, P1235, DOI 10.1002/ps.3488
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208
   Teixeira RR, 2010, PEST MANAG SCI, V66, P196, DOI 10.1002/ps.1855
   Teofilo RF, 2009, J CHEMOMETR, V23, P32, DOI 10.1002/cem.1192
   Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y
   VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159
   Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1
NR 28
TC 11
Z9 12
U1 0
U2 14
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD OCT
PY 2016
VL 25
IS 10
BP 2171
EP 2178
DI 10.1007/s00044-016-1650-7
PG 8
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA EA5WZ
UT WOS:000386697200008
DA 2020-12-08
ER

PT J
AU Araujo, AFD
   Ribeiro-Paes, JT
   de Deus, JT
   Cavalcanti, SCD
   Nunes, RD
   Alves, PB
   Macoris, MDD
AF de Oliveira Araujo, Adriana Faraco
   Ribeiro-Paes, Joao Tadeu
   de Deus, Juliana Telles
   de Holanda Cavalcanti, Sorates Cabral
   Nunes, Rogeria de Souza
   Alves, Pericles Barreto
   da Graca Macoris, Maria de Lourdes
TI Larvicidal activity of Syzygium aromaticum (L.) Merr and Citrus sinensis
   (L.) Osbeck essential oils and their antagonistic effects with temephos
   in resistant populations of Aedes aegypti
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Syzygium aromaticum; Citrus sinensis; Aedes aegypti; vector control;
   larvicide; dengue
ID INSECTICIDE RESISTANCE; CHEMICAL-COMPOSITION; DIPTERA-CULICIDAE; PLANTS
AB Environmentally friendly botanical larvicides are commonly considered as an alternative to synthetic larvicides against Aedes aegypti Linn. In addition, mosquito resistance to currently used larvicides has motivated research to find new compounds acting via different mechanisms of action, with the goal of controlling the spread of mosquitos. Essential oils have been widely studied for this purpose. This work aims to evaluate the larvicidal potential of Syzygium aromaticum and Citrus sinensis essential oils, either alone or in combination with temephos, on Ae. aegypti populations having different levels of organophosphate resistance. The 50% lethal concentration (LC50) of the essential oils alone and in combination with temephos and the influence of essential oils on vector oviposition were evaluated. The results revealed that essential oils exhibited similar larvicidal activity in resistant populations and susceptible populations. However, S. aromaticum and C. sinensis essential oils in combination with temephos did not decrease resistance profiles. The presence of the evaluated essential oils in oviposition sites significantly decreased the number of eggs compared to sites with tap water. Therefore, the evaluated essential oils are suitable for use in mosquito resistance management, whereas their combinations with temephos are not recommended. Additionally, repellency should be considered during formulation development to avoid mosquito deterrence.
C1 [de Oliveira Araujo, Adriana Faraco; Ribeiro-Paes, Joao Tadeu] Univ Estadual Paulista, Fac Ciencias & Letras, Dept Ciencias Biol, Assis, SP, Brazil.
   [de Deus, Juliana Telles; da Graca Macoris, Maria de Lourdes] Superintendencia Controle Endemias, Marilia, SP, Brazil.
   [de Holanda Cavalcanti, Sorates Cabral; Nunes, Rogeria de Souza] Univ Fed Sergipe, Dept Farm, Sao Cristovao, SE, Brazil.
   [Alves, Pericles Barreto] Univ Fed Sergipe, Dept Quim, Sao Cristovao, SE, Brazil.
RP Araujo, AFD (corresponding author), Univ Estadual Paulista, Fac Ciencias & Letras, Dept Ciencias Biol, Assis, SP, Brazil.
EM adrifaracofb@yahoo.com.br
RI Cavalcanti, Socrates/AAQ-7004-2020; Ribeiro-Paes, Joao
   Tadeu/E-9616-2015; Alves, Pericles/S-8768-2019
OI Ribeiro-Paes, Joao Tadeu/0000-0002-7645-5891; Alves,
   Pericles/0000-0002-8955-9614
FU FAPITEC-SE; CNPqNational Council for Scientific and Technological
   Development (CNPq) [550116-2010-9-Rede Dengue]
FX FAPITEC-SE, CNPq (550116-2010-9-Rede Dengue).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Bisset JA, 2011, MED VET ENTOMOL, V25, P233, DOI 10.1111/j.1365-2915.2011.00959.x
   Bliss CI, 1935, ANN APPL BIOL, V22, P134, DOI 10.1111/j.1744-7348.1935.tb07713.x
   BRINDLEY WA, 1984, ENVIRON ENTOMOL, V13, P348, DOI 10.1093/ee/13.2.348
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124
   Coelho GE, 2012, REV INST MED TROP SP, V54, pS13, DOI 10.1590/S0036-46652012000700006
   Corrêa J.C.R., 2011, Rev. bras. plantas med., V13, P500, DOI 10.1590/S1516-05722011000400016
   Costa J.G.M., 2005, Rev. bras. farmacogn., V15, P304, DOI 10.1590/S0102-695X2005000400008
   Fayemiwo Kehinde Adenike, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P30, DOI 10.1016/S2221-1691(14)60204-5
   Fisher R. A., 1935, ANN APPL BIOL, V22, P164
   *LEORA SOFTW, 1987, POLO PC PROB LOG AN
   Brandao MDL, 2013, ENVIRON MONIT ASSESS, V185, P7013, DOI 10.1007/s10661-013-3081-y
   Machado BFMT, 2011, CAD ACAD, V3, P105
   Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020
   MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315
   Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015
   Mittal M., 2014, INT J PHARM PHARM SC, V6, P67
   Marques GRAM, 2013, REV SAUDE PUBL, V47, P579, DOI 10.1590/S0034-8910.2013047004289
   Muhammetoglu A, 2010, ENVIRON FORENSICS, V11, P179, DOI 10.1080/15275920903559180
   Murugan K, 2012, PARASITOL RES, V111, P1757, DOI 10.1007/s00436-012-3021-8
   Novaes P, 2013, PHYTOCHEM REV, V12, P839, DOI 10.1007/s11101-013-9315-3
   Palazzolo E, 2013, CURR ORG CHEM, V17, P3042, DOI 10.2174/13852728113179990122
   Pocquet N, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-299
   Sharp TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108445
   Simas NK, 2004, QUIM NOVA, V27, P46, DOI 10.1590/S0100-40422004000100009
   Warikoo Radhika, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P152, DOI 10.1016/S2221-1691(11)60211-6
   WHO, 2005, GUID LAB FIELD TEST
NR 29
TC 7
Z9 9
U1 2
U2 23
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUL
PY 2016
VL 111
IS 7
BP 443
EP 449
DI 10.1590/0074-02760160075
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DR7XH
UT WOS:000380112500004
PM 27384083
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Dolabella, SS
   Santos, RLC
   Silva, MCN
   Steffler, LM
   Ribolla, PEM
   Cavalcanti, SCH
   Jain, S
   Martins, AJ
AF Dolabella, S. S.
   Santos, R. L. C.
   Silva, M. C. N.
   Steffler, L. M.
   Ribolla, P. E. M.
   Cavalcanti, S. C. H.
   Jain, S.
   Martins, A. J.
TI Detection and Distribution of V1016I(kdr) Mutation in the Voltage-Gated
   Sodium Channel Gene in Aedes aegypti (Diptera: Culicidae) Populations
   From Sergipe State, Northeast Brazil
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; kdr mutation; pyrethroid resistance; sodium channel
ID INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; NATURAL-POPULATIONS;
   MOSQUITO; KDR; ASSOCIATION; MARKERS; VECTOR
AB Aedes aegypti (L.) resistance to pyrethroids was recorded in Brazil few years after its introduction as the adulticide in the National Dengue Control Program campaigns. Altered susceptibility to pyrethroids had been reported in the state of Sergipe, northeast Brazil, through biological assays, even before its use against Ae. aegypti in the state. Metabolic and target-site resistance mechanisms were also revealed in samples from Aracaju, the capital of Sergipe. Herein, we investigated the presence and distribution of the kdr mutation V1016I(kdr) in Ae. aegypti populations from different municipalities of the state. Aedes aegypti eggs were collected from seven municipalities located in areas showing different climatic types and infestation levels. Approximately 20 Ae. aegypti females from each municipality (total of 135 subjects) were individually submitted to allele-specific polymerase chain reaction (AS-PCR) for the 1016 site of the voltage-gated sodium channel (NaV). The V1016I(kdr) mutation was found in subjects from all the municipalities under study with a high frequency of heterozygotes in several locations. Homozygous recessive subjects (resistant kdr genotype) were found only in one municipality. The results suggest a wide distribution of the V1016I(kdr) mutation in the northeast Brazil, which indicates urgent need for monitoring the effectiveness of the pyrethroids currently used for vector control.
C1 [Dolabella, S. S.; Santos, R. L. C.; Silva, M. C. N.; Steffler, L. M.; Jain, S.] Univ Fed Sergipe, Dept Morfol, Lab Entomol & Parasitol Trop, Sao Cristovao, Sergipe, Brazil.
   [Ribolla, P. E. M.] Univ Estadual Paulista, Inst Biociencias, Dept Parasitol, Botucatu, SP, Brazil.
   [Cavalcanti, S. C. H.] Univ Fed Sergipe, Dept Farm, Lab Quim Med, Sao Cristovao, Sergipe, Brazil.
   [Martins, A. J.] IOC Fiocruz, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, Brazil.
RP Dolabella, SS (corresponding author), Univ Fed Sergipe, Dept Morfol, Lab Entomol & Parasitol Trop, Sao Cristovao, Sergipe, Brazil.
EM dolabella@ufs.br; rlacorte@ufs.br; massia_consuelo@hotmail.com;
   liza.ms@ig.com.br; pribolla@ibb.unesp.br; socrates@ufs.br;
   sonajain24@yahoo.com; ademir.fiocruz@gmail.com
RI Martins, Ademir/W-3251-2019; Ribolla, Paulo EM/B-9122-2012; Ribolla,
   Paulo/AAH-3354-2020; Dolabella, Silvio/X-4351-2019; Cavalcanti,
   Socrates/AAQ-7004-2020; Martins, Ademir J./B-4117-2009; Santos, Roseli
   LC/F-1735-2015
OI Martins, Ademir/0000-0001-5739-1215; Ribolla, Paulo
   EM/0000-0001-8735-6090; Santana Dolabella, Silvio/0000-0001-5576-3214;
   Jain, Sona/0000-0002-5999-931X
FU CAPES (Acordo) [CAPES/FAPITEC 2345/2012]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX This project was supported by CAPES (Acordo CAPES/FAPITEC 2345/2012) and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). We
   are grateful to Dr. Douglas F. R. Alves for his help with the figures.
CR Ayres CFJ, 2004, J AM MOSQUITO CONTR, V20, P350
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011681
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Macoris MDD, 2007, MEM I OSWALDO CRUZ, V102, P895, DOI 10.1590/S0074-02762007000800001
   da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017
   Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x
   Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   KNIPPLE DC, 1994, P NATL ACAD SCI USA, V91, P2483, DOI 10.1073/pnas.91.7.2483
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Liu ZQ, 2000, INSECT BIOCHEM MOLEC, V30, P991, DOI 10.1016/S0965-1748(00)00074-6
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   Martins AJ, 2012, INSECTICIDES BASIC O, P17
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Paduan KS, 2009, MOL ECOL RESOUR, V9, P114, DOI 10.1111/j.1755-0998.2008.02282.x
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Rasic G, 2015, EVOL APPL, V8, P901, DOI 10.1111/eva.12301
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Silva APB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-450
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 25
TC 4
Z9 4
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2016
VL 53
IS 4
BP 967
EP 971
DI 10.1093/jme/tjw053
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DQ4WL
UT WOS:000379204800032
PM 27113110
OA Green Published
DA 2020-12-08
ER

PT J
AU Santos, IGD
   Scher, R
   Rott, MB
   Menezes, LR
   Costa, EV
   Cavalcanti, SCD
   Blank, AF
   Aguiar, JD
   da Silva, TG
   Dolabella, SS
AF de Amorim Santos, Israel Gomes
   Scher, Ricardo
   Rott, Marilise Brittes
   Menezes, Leociley Rocha
   Costa, Emmanoel Vilaca
   de Holanda Cavalcanti, Socrates Cabral
   Blank, Arie Fitzgerald
   Aguiar, Jaciana dos Santos
   da Silva, Teresinha Goncalves
   Dolabella, Silvio Santana
TI Amebicidal activity of the essential oils of Lippia spp. (Verbenaceae)
   against Acanthamoeba polyphaga trophozoites
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Acanthamoeba polyphaga; Lippia spp.; Carvacrol; Carvone; Rotundifolone;
   Amebicidal activity
ID CHEMICAL-COMPOSITION; KERATITIS DIAGNOSIS; CASTELLANII CYSTS; COLOMBIAN
   LIPPIA; CARVACROL; SIDOIDES; UPDATE
AB Amoebic keratitis and granulomatous amoebic encephalitis are caused by some strains of free-living amoebae of the genus Acanthamoeba. In the case of keratitis, one of the greatest problems is the disease recurrence due to the resistance of parasites, especially the cystic forms, to the drugs that are currently used. Some essential oils of plants have been used as potential active agents against this protist. Thus, the aim of this study was to determine the amebicidal activity of essential oils from plants of the genus Lippia against Acanthamoeba polyphaga trophozoites. To that end, 8x10(4) trophozoites were exposed for 24 h to increasing concentrations of essential oils from Lippia sidoides, Lippia gracilis, Lippia alba, and Lippia pedunculosa and to their major compounds rotundifolone, carvone, and carvacrol. Nearly all concentrations of oils and compounds showed amebicidal activity. The IC50 values for L. sidoides, L. gracilis L. alba, and L. pedunculosa were found to be 18.19, 10.08, 31.79, and 71.47 mu g/mL, respectively. Rotundifolone, carvacrol, and carvone were determined as the major compounds showing IC50 of 18.98, 24.74, and 43.62 mu g/mL, respectively. With the exception of oil from L. alba, the other oils evaluated showed low cytotoxicity in the NCI-H292 cell line. Given these results, the oils investigated here are promising sources of compounds for the development of complementary therapy against amoebic keratitis and granulomatous amoebic encephalitis and can also be incorporated into cleaning solutions to increase their amebicidal efficiency.
C1 [de Amorim Santos, Israel Gomes; Dolabella, Silvio Santana] Univ Fed Sergipe, Lab Entomol & Parasitol Trop, Dept Morfol, Av Marechal Rondon S-N, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Scher, Ricardo] Univ Fed Sergipe, Lab Biol Mol Bioagentes Patogen, Dept Morfol, Sao Cristovao, Sergipe, Brazil.
   [Rott, Marilise Brittes] Univ Fed Rio Grande do Sul, Dept Microbiol Imunol & Parasitol, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil.
   [Menezes, Leociley Rocha] Univ Fed Sergipe, Dept Quim, Sao Cristovao, Sergipe, Brazil.
   [Costa, Emmanoel Vilaca] Univ Fed Amazonas, Dept Quim, Manaus, Amazonas, Brazil.
   [de Holanda Cavalcanti, Socrates Cabral] Univ Fed Sergipe, Dept Farm, Lab Quim Farmaceut, Sao Cristovao, Sergipe, Brazil.
   [Blank, Arie Fitzgerald] Univ Fed Sergipe, Dept Agron, Lab Fitotecnia, Sao Cristovao, Sergipe, Brazil.
   [Aguiar, Jaciana dos Santos; da Silva, Teresinha Goncalves] Univ Fed Pernambuco, Dept Antibiot, Lab Bioensaios Pesquisa Farmacos, Recife, PE, Brazil.
RP Dolabella, SS (corresponding author), Univ Fed Sergipe, Lab Entomol & Parasitol Trop, Dept Morfol, Av Marechal Rondon S-N, BR-49100000 Sao Cristovao, Sergipe, Brazil.
EM dolabella@ufs.br
RI Cavalcanti, Socrates/AAQ-7004-2020; Menezes, Leociley R. A./P-4160-2015;
   Rott, Marilise Brittes/D-8152-2011; Menezes, Leociley/AAA-4324-2020;
   Aguiar, Jaciana/W-7804-2019; Dolabella, Silvio/X-4351-2019; Rott,
   Marilise/R-4761-2019
OI Menezes, Leociley R. A./0000-0001-8631-8607; Rott, Marilise
   Brittes/0000-0002-5227-4594; Menezes, Leociley/0000-0001-8631-8607;
   Aguiar, Jaciana/0000-0002-6097-8065; Rott, Marilise/0000-0002-5227-4594;
   Costa, Emmanoel/0000-0002-0153-822X; Santana Dolabella,
   Silvio/0000-0001-5576-3214
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Apoio a Pesquisa e Inovacao Tecnologica do
   Estado de Sergipe (FAPITEC) [Acordo CAPES/FAPITEC 2345/2012]
FX The authors thank Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) and Fundacao de Apoio a Pesquisa e Inovacao Tecnologica
   do Estado de Sergipe (FAPITEC) for their financial support to conduct
   this research (Acordo CAPES/FAPITEC 2345/2012).
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Menezes LRA, 2014, NAT PROD COMMUN, V9, P737
   Botelho MA, 2007, BRAZ J MED BIOL RES, V40, P349, DOI 10.1590/S0100-879X2007000300010
   Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194
   Clarke DW, 2006, TRENDS PARASITOL, V22, P175, DOI 10.1016/j.pt.2006.02.004
   Dart JKG, 2009, AM J OPHTHALMOL, V148, P487, DOI 10.1016/j.ajo.2009.06.009
   de Melo JO, 2013, ACTA TROP, V128, P110, DOI 10.1016/j.actatropica.2013.06.024
   Degerli S, 2012, EXP PARASITOL, V131, P20, DOI 10.1016/j.exppara.2012.02.020
   Ocazionez RE, 2010, MEM I OSWALDO CRUZ, V105, P304, DOI 10.1590/S0074-02762010000300010
   Escobar P, 2010, MEM I OSWALDO CRUZ, V105, P184, DOI 10.1590/S0074-02762010000200013
   Farias PA, 2012, BIOL RES, V45, P399, DOI 10.4067/S0716-97602012000400012
   de Lima GPG, 2013, PARASITOL RES, V112, P1953, DOI 10.1007/s00436-013-3351-1
   Khan NA, 2009, INT J PARASITOL, V39, P1611, DOI 10.1016/j.ijpara.2009.06.004
   Lorenzo-Morales J, 2015, PARASITE, V22, DOI 10.1051/parasite/2015010
   Vunda SLL, 2012, PARASITOL RES, V111, P961, DOI 10.1007/s00436-012-2918-6
   Malatyali E, 2012, PARASITOL RES, V110, P167, DOI 10.1007/s00436-011-2466-5
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Petry F, 2006, J CLIN MICROBIOL, V44, P1903, DOI 10.1128/JCM.44.5.1903-1904.2006
   Polat ZA, 2008, J OCUL PHARMACOL TH, V24, P8, DOI 10.1089/jop.2007.0035
   Rodrigues FAR, 2014, CHEM BIOL DRUG DES, V83, P126, DOI 10.1111/cbdd.12210
   Sauter IP, 2012, IND CROP PROD, V40, P292, DOI 10.1016/j.indcrop.2012.03.025
   Sauter IP, 2011, PARASITOL RES, V109, P1367, DOI 10.1007/s00436-011-2383-7
   Scheid P, 2008, PARASITOL RES, V102, P945, DOI 10.1007/s00436-007-0858-3
   Sifaoui I, 2013, PARASITOL RES, V113, P755
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   Visvesvara GS, 2010, CURR OPIN INFECT DIS, V23, P590, DOI 10.1097/QCO.0b013e32833ed78b
NR 26
TC 8
Z9 8
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD FEB
PY 2016
VL 115
IS 2
BP 535
EP 540
DI 10.1007/s00436-015-4769-4
PG 6
WC Parasitology
SC Parasitology
GA DE8EO
UT WOS:000370868800009
PM 26446087
DA 2020-12-08
ER

PT J
AU Ferreira, SG
   Conceicao, V
   Gouveia, NS
   Santos, GS
   Santos, RLC
   Lira, AAM
   Cavalcanti, SCH
   Sarmento, VHV
   Nunes, RS
AF Ferreira, S. G.
   Conceicao, Vs
   Gouveia, N. S.
   Santos, G. S.
   Santos, R. L. C.
   Lira, A. A. M.
   Cavalcanti, S. C. H.
   Sarmento, V. H. V.
   Nunes, R. S.
TI An environmentally safe larvicide against Aedes aegypti based on in situ
   gelling nanostructured surfactant systems containing an essential oil
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Liquid crystal; Microemulsion; In situ gelling; Citrus sinensis; Dengue;
   Aedes aegypti
ID LIQUID-CRYSTAL; MICROEMULSION; RELEASE; RESISTANCE
AB Hypothesis: Liquid crystalline precursors, which are in situ gelling nanostructured surfactant systems, can undergo phase transition in aqueous solution and become more structured aggregates, controlling release of larvicides and acting as biotechnology alternatives for dengue control. Such systems can contain bioactive substances as Citrus sinensis essential oil (CSEO) which exhibits biological activity against Aedes aegypti (Ae. aegypti) larvae.
   Experiments: The formulations were composed by fixed concentration of CSEO stabilized by Polyoxypropylene (5) Polyoxyethylene (20) Cetyl Ether (PPG-5 CETETH-20): oleic acid (OA) 2:1, increasing water content. The phase diagram was established and systems structure was evaluated by polarized light microscopy (PLM), small angle X-ray scattering (SAXS) and rheology. Median lethal concentration was determined against Ae. aegypti larvae.
   Findings: The phase diagram exhibited four regions: liquid crystal (LC), emulsion, microemulsion (ME) and phase separation. The PLM and SAXS distinguished microemulsions, lamellar and hexagonal LC structures. Flow and oscillatory tests showed that increasing water content increases elasticity from Newtonian to non-newtonian behavior confirming the in situ gelation behavior. The larvicidal activity of formulations indicates that these nanostructured systems improved the oil solubility in aqueous medium and in addition are potential environmental larvicide against Ae. aegypti larvae. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ferreira, S. G.; Conceicao, Vs; Gouveia, N. S.; Santos, G. S.; Lira, A. A. M.; Cavalcanti, S. C. H.; Nunes, R. S.] Univ Fed Sergipe, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
   [Sarmento, V. H. V.] Univ Fed Sergipe, Dept Chem, BR-49500000 Itabaiana, SE, Brazil.
   [Santos, R. L. C.] Univ Fed Sergipe, Dept Morphol, BR-49100000 Sao Cristovao, SE, Brazil.
RP Nunes, RS (corresponding author), Univ Fed Sergipe, Dept Farm, Lab Desenvolvimento Farmacotecn, Av Marechal Rondon S-N,Cidade Univ, BR-49100000 Sao Cristovao, Sergipe, Brazil.
EM rogeria.ufs@hotmail.com
RI Sarmento, Victor Hugo/AAL-1496-2020; Nunes, Rogeria RSN/R-5248-2018;
   Lira, Ana/Y-8196-2019; Santos, Roseli LC/F-1735-2015; Cavalcanti,
   Socrates/AAQ-7004-2020
OI Sarmento, Victor Hugo/0000-0001-6882-002X; Nunes, Rogeria
   RSN/0000-0001-6681-2042; Lira, Ana/0000-0003-3451-9049; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX The authors acknowledge CNPq and CAPES for their financial support,
   Danubia Cristina Gaya from IQ/UNESP for help in rheology measurements
   and LNLS, especially to SAXS staff for technical support.
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   Ashley EA, 2011, TRENDS ANAESTH CRIT, V1, P39, DOI 10.1016/j.tacc.2010.10.002
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P295, DOI [10.5123/S1679-49742007000400007, DOI 10.5123/S1679-49742007000400007]
   Capeletti LB, 2014, LANGMUIR, V30, P7456, DOI 10.1021/la4046435
   Carvalho FC, 2010, J PHARM SCI-US, V99, P2367, DOI 10.1002/jps.22005
   Carvalho FC, 2013, EUR J PHARM BIOPHARM, V84, P219, DOI 10.1016/j.ejpb.2012.11.021
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   Chorilli M, 2011, COLLOID SURFACE B, V85, P182, DOI 10.1016/j.colsurfb.2011.02.027
   Costa J. G. M., 2005, REV BRAS FARMACOGN, V15, P304, DOI DOI 10.1590/S0102-695X2005000400008
   Djekic L, 2011, J MOL LIQ, V160, P81, DOI 10.1016/j.molliq.2011.02.010
   El Maghraby GM, 2010, COLLOID SURFACE B, V75, P595, DOI 10.1016/j.colsurfb.2009.10.003
   Rossi YE, 2013, ACTA TROP, V127, P33, DOI 10.1016/j.actatropica.2013.03.009
   Fanun M, 2012, CURR OPIN COLLOID IN, V17, P306, DOI 10.1016/j.cocis.2012.06.001
   Fong C, 2012, CHEM SOC REV, V41, P1297, DOI 10.1039/c1cs15148g
   Formariz TP, 2007, COLLOID SURFACE B, V60, P28, DOI 10.1016/j.colsurfb.2007.05.017
   Galvao JG, 2015, THERMOCHIM ACTA, V608, P14, DOI 10.1016/j.tca.2015.04.001
   Geris R., 2012, STUD NAT PROD CHEM
   Goddeeris C, 2010, EUR J PHARM SCI, V40, P110, DOI 10.1016/j.ejps.2010.03.005
   Gonsenca M., 2013, EUR J PHARM SCI, V50, P114
   Guo CY, 2010, DRUG DISCOV TODAY, V15, P1032, DOI 10.1016/j.drudis.2010.09.006
   Hathout RM, 2010, EUR J PHARM SCI, V40, P188, DOI 10.1016/j.ejps.2010.03.008
   Holmberg K, 2002, SURFACTANTS POLYM AQ
   Hyde S. T., 2001, HDB APPL SURFACE COL, V1, P299
   Kumar Sarita, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P85, DOI 10.1016/S2221-1691(11)60001-4
   Lawrence MJ, 2012, ADV DRUG DELIVER REV, V64, P175, DOI 10.1016/j.addr.2012.09.018
   Libster D, 2011, J COLLOID INTERF SCI, V356, P375, DOI 10.1016/j.jcis.2011.01.047
   Liu KH, 2012, J FOOD ENG, V110, P390, DOI 10.1016/j.jfoodeng.2011.12.033
   Luna JED, 2004, REV SAUDE PUBL, V38, P842, DOI [10.1590/S0034-89102004000600013, 10.1590/s0034-89102004000600013]
   MUELLERGOYMANN CC, 1993, J CONTROL RELEASE, V23, P165, DOI 10.1016/0168-3659(93)90042-4
   Polizelli MA, 2006, COLLOID SURFACE A, V281, P230, DOI 10.1016/j.colsurfa.2006.02.043
   Ren XZ, 2012, INT J PHARMACEUT, V431, P130, DOI 10.1016/j.ijpharm.2012.04.020
   Sahoo S, 2014, COLLOID SURFACE B, V120, P193, DOI 10.1016/j.colsurfb.2014.05.022
   Santana RC, 2012, COLLOID SURFACE A, V398, P54, DOI 10.1016/j.colsurfa.2012.02.009
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Singh P, 2010, FOOD CHEM TOXICOL, V48, P1734, DOI 10.1016/j.fct.2010.04.001
   Soto-Guzman A, 2013, PROSTAG LEUKOTR ESS, V88, P243, DOI 10.1016/j.plefa.2012.12.003
   Svoboda K. P., 2003, International Journal of Aromatherapy, V13, P23, DOI 10.1016/S0962-4562(03)00048-1
   United States Department of Agriculture (USDA), 2014, CITR WORLD MARK TRAD
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wei G, 2002, J CONTROL RELEASE, V83, P65, DOI 10.1016/S0168-3659(02)00175-X
   WHO, 2006, PEST THEIR APPL CONT
   Wright WF, 2012, DIAGN MICR INFEC DIS, V73, P215, DOI 10.1016/j.diagmicrobio.2012.03.021
   Xiao JX, 2011, FOOD CHEM, V125, P1267, DOI 10.1016/j.foodchem.2010.10.063
   Zheng MY, 2011, COLLOID SURFACE A, V385, P47, DOI 10.1016/j.colsurfa.2011.05.040
NR 44
TC 11
Z9 11
U1 1
U2 68
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD OCT 15
PY 2015
VL 456
BP 190
EP 196
DI 10.1016/j.jcis.2015.06.012
PG 7
WC Chemistry, Physical
SC Chemistry
GA CN5GT
UT WOS:000358458500025
PM 26125515
OA Bronze
DA 2020-12-08
ER

PT J
AU Lima, TC
   Santos, SRL
   Uliana, MP
   Santos, RL
   Brocksom, TJ
   Cavalcanti, SCD
   de Sousa, DP
AF Lima, Tamires Cardoso
   Lima Santos, Sandra Regina
   Uliana, Marciana P.
   Santos, Roseli La Corte
   Brocksom, Timothy John
   de Holanda Cavalcanti, Socrates Cabral
   de Sousa, Damiao Pergentino
TI Oxime derivatives with larvicidal activity against Aedes aegypti L.
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Oxime; Dengue; Aedes aegypti; Larvicidal activity; Structure-activity
ID DIPTERA-CULICIDAE; ESSENTIAL OIL; ETHER; BENZOYLPHENYLUREAS;
   BENZOQUINONE; DESIGN; SAR
AB Oximes containing secondary metabolites constitute an important group of bioactive compounds and have been described and frequently updated in the literature due to their pharmacological properties. Thus, the aim of this study was to evaluate the larvicidal activity of a series of fourteen structurally related [1,4]-Benzoquinone mono-oximes on third-instar Aedes aegypti larvae and to investigate structure-activity relationships (SAR) of these compounds. Results of larvicidal assay revealed that all oximes were found to have larvicidal activity. Compound 2,6-dimethyl-[1,4]-benzoquinone oxime tosylate (11) was the most bioactive (LC50 = 9.858 ppm), followed by 2-methyl-[1,4]-benzoquinone oxime tosylate (9) (LC50 = 14.450 ppm). [1,4]-benzoquinone oxime (1) exhibited the lowest potency, with an LC50 = 121.181 ppm. The molecular characteristics which may help to understand the assayed compounds larvicidal activity were identified. SAR indicates that the addition of alkyl groups attached to the ring, number, position in the unsaturated cyclic structure, and size of these groups influence the larvicidal activity. Moreover, the lipophilicity seems to play an important role in increasing the larvicidal effect, because, in general, tosyl-containing products were more potent than products containing free OH.
C1 [Lima, Tamires Cardoso; Lima Santos, Sandra Regina; Santos, Roseli La Corte; de Holanda Cavalcanti, Socrates Cabral] Univ Fed Sergipe, Dept Pharm, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Uliana, Marciana P.; Brocksom, Timothy John] Univ Fed Sao Carlos, Dept Chem, Bioorgan Chem Lab, BR-13565905 Sao Carlos, SP, Brazil.
   Univ Fed Sergipe, Dept Morphol, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [de Sousa, Damiao Pergentino] Univ Fed Paraiba, Dept Pharmaceut Sci, BR-58051970 Joao Pessoa, Paraiba, Brazil.
RP de Sousa, DP (corresponding author), Univ Fed Paraiba, Dept Pharmaceut Sci, BR-58051970 Joao Pessoa, Paraiba, Brazil.
EM damiao_desousa@yahoo.com.br
RI Cavalcanti, Socrates/AAQ-7004-2020; de Sousa, Damiao
   Pergentino/AAY-1244-2020; de Sousa, Damiao Pergentino/B-2580-2018;
   Santos, Roseli LC/F-1735-2015; Uliana, Marciana/K-9447-2014
OI de Sousa, Damiao Pergentino/0000-0002-7180-4896; Uliana,
   Marciana/0000-0003-4370-1619
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); Federal University of Sergipe; Federal University of
   Paraiba
FX The authors thank the CAPES, CNPq, Federal University of Sergipe, and
   Federal University of Paraiba for the financial support.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Aliyu HD, 2008, INTERNET J TOXICOL, V5
   Aliyu HD, 2007, J CHEM SOC NIGERIA, V32, P292
   Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002
   Cheng SS, 2008, BIORESOURCE TECHNOL, V99, P3617, DOI 10.1016/j.biortech.2007.07.038
   da Silva FC, 2013, PARASITOL RES, V112, P2367, DOI 10.1007/s00436-013-3401-8
   De Sousa DP, 2010, PARASITOL RES, V107, P741, DOI 10.1007/s00436-010-1942-7
   de Sousa DP, 2006, MOLECULES, V11, P148, DOI 10.3390/11020148
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   Finney D. J., 1971, PROBIT ANAL
   Garcia M, 2005, PEST MANAG SCI, V61, P612, DOI 10.1002/ps.1028
   Karakurt A, 2001, EUR J MED CHEM, V36, P421, DOI 10.1016/S0223-5234(01)01223-5
   Kiprono CP, 2004, B CHEM SOC ETHIOPIA, V18, P45
   Li YQ, 2014, J AGR FOOD CHEM, V62, P3064, DOI 10.1021/jf500461a
   Lima TC, 2014, CHEMOSPHERE, V104, P37, DOI 10.1016/j.chemosphere.2013.10.035
   Lopez O, 2005, GREEN CHEM, V7, P431, DOI 10.1039/b500733j
   Lucia A, 2013, PARASITOL RES, V112, P4267, DOI 10.1007/s00436-013-3618-6
   Mathew N, 1996, INDIAN J CHEM B, V35, P40
   Michaelakis A, 2009, PARASITOL RES, V104, P657, DOI 10.1007/s00436-008-1242-7
   Morimoto M, 2002, PHYTOCHEMISTRY, V60, P163, DOI 10.1016/S0031-9422(02)00095-X
   NORRIS RK, 1969, AUST J CHEM, V22, P935, DOI 10.1071/CH9690935
   Pan American Health Organization, 2014, STAT MAPS DENG
   Praba GO, 2007, INDIAN J BIOCHEM BIO, V44, P470
   Rodrigues AMS, 2005, FITOTERAPIA, V76, P755, DOI 10.1016/j.fitote.2005.08.015
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Schenone S, 2000, FARMACO, V55, P495, DOI 10.1016/S0014-827X(00)00065-3
   Soga S, 2001, CANCER CHEMOTH PHARM, V48, P435, DOI 10.1007/s002800100373
   Sun RF, 2010, BIOORG MED CHEM LETT, V20, P4693, DOI 10.1016/j.bmcl.2010.04.144
   Sun RF, 2008, J AGR FOOD CHEM, V56, P11376, DOI 10.1021/jf801901h
   Torres RC, 2014, ASIAN PAC J TROP MED, V7, pS167, DOI 10.1016/S1995-7645(14)60225-X
   Yang YC, 2003, J AGR FOOD CHEM, V51, P7629, DOI 10.1021/jf034727t
   Zareen F, 2011, BMC MICROBIOL, V11, P1
NR 33
TC 9
Z9 9
U1 1
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD AUG
PY 2015
VL 114
IS 8
BP 2883
EP 2891
DI 10.1007/s00436-015-4489-9
PG 9
WC Parasitology
SC Parasitology
GA CN4OV
UT WOS:000358410600009
PM 25956398
DA 2020-12-08
ER

PT J
AU Peixoto, MG
   Costa, LM
   Blank, AF
   Lima, AD
   Menezes, TSA
   Santos, DD
   Alves, PB
   Cavalcanti, SCD
   Bacci, L
   Arrigoni-Blank, MD
AF Peixoto, Magna Galvao
   Costa-Junior, Livio Martins
   Blank, Arie Fitzgerald
   Lima, Aldilene da Silva
   Alves Menezes, Thays Saynara
   Santos, Darlisson de Alexandria
   Alves, Pericles Barreto
   de Holanda Cavalcanti, Socrates Cabral
   Bacci, Leandro
   Arrigoni-Blank, Maria de Fatima
TI Acaricidal activity of essential oils from Lippia alba genotypes and its
   major components carvone, limonene, and citral against Rhipicephalus
   microplus
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Lippia alba; Volatile oil; Carvone; Citral; Cattle tick
ID CONSTITUENTS; VERBENACEAE; RESISTANCE; TOXICITY
AB The goal of the present study was to evaluate the acaricidal potential of Lippia alba essential oil, citral chemotypes (LA-10 and LA-44 genotypes) and carvone chemotypes (LA-13 and LA-57 genotypes), as well as purified citral and enantiomers of carvone and limonene. Efficacy against Rhipicephalus microplus was assessed by the larval packet and the engorged female immersion tests. Citral chemotypes had greater larvicidal activity than carvone chemotypes, and this was further supported by larvicidal and adulticidal activity of purified citral with LC50 values of 7.0 and 29.8 mg/mL, respectively. While purified enantiomers of carvone exhibited greater larvicidal activity than those of limonene, enantioselectivity of limonene was observed with R-(+) displaying significantly higher efficacy (LC50 of 31.2 mg/mL) than S-(-) (LC50 of 54.5 mg/mL). The essential oils and purified compounds were much less toxic toward engorged adult females, with the exception of citral, and this may be due to limited cuticular penetration. Published by Elsevier B.V.
C1 [Peixoto, Magna Galvao; Blank, Arie Fitzgerald; Alves Menezes, Thays Saynara; Bacci, Leandro; Arrigoni-Blank, Maria de Fatima] Univ Fed Sergipe, Dept Agron, BR-49100000 Sao Cristovao, SE, Brazil.
   [Costa-Junior, Livio Martins; Lima, Aldilene da Silva] Univ Fed Maranhao, Dept Anim Sci, BR-65500000 Chapadinha, MA, Brazil.
   [Santos, Darlisson de Alexandria; Alves, Pericles Barreto] Univ Fed Sergipe, Dept Chem, BR-49100000 Sao Cristovao, SE, Brazil.
   [de Holanda Cavalcanti, Socrates Cabral] Univ Fed Sergipe, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
RP Arrigoni-Blank, MD (corresponding author), Univ Fed Sergipe, Dept Agron, Ave Marechal Rondon S-N, BR-49100000 Sao Cristovao, SE, Brazil.
EM fatima.blank@gmail.com
RI Santos, Darlisson A/E-2970-2016; de Alexandria Santos,
   Darlisson/AAV-8587-2020; Costa-Junior, Livio M/H-7530-2012; Bacci,
   Leandro/F-4571-2017; Alves, Pericles/S-8768-2019; Cavalcanti,
   Socrates/AAQ-7004-2020
OI Santos, Darlisson A/0000-0001-5817-5792; de Alexandria Santos,
   Darlisson/0000-0001-5817-5792; Costa-Junior, Livio
   M/0000-0002-1475-049X; Bacci, Leandro/0000-0002-8198-6080; Alves,
   Pericles/0000-0002-8955-9614; Arrigoni-Blank, Maria de
   Fatima/0000-0002-4907-505X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPITEC/SE; CAPESCAPES; RENORBIO
FX The authors wish to acknowledge CNPq, FAPITEC/SE, CAPES, and RENORBIO
   for supporting funds.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Agnolin C.A., 2014, Rev. bras. plantas med., V16, P77, DOI 10.1590/S1516-05722014000100011
   Alves WV, 2012, REV BRAS AGROP SUSTE, V2, P14
   Atti-Serafini L., 2002, Revista Brasileira de Plantas Medicinais, V4, P72
   Castro-Janer E, 2010, VET PARASITOL, V173, P300, DOI 10.1016/j.vetpar.2010.06.036
   CHAGAS ACS, 2002, BRAZ J VET RES ANIM, V39, P247, DOI DOI 10.1590/S1413-95962002000500006
   Corrêa J.C.R., 2011, Rev. bras. plantas med., V13, P500, DOI 10.1590/S1516-05722011000400016
   Lage TCD, 2013, PARASITOL RES, V112, P863, DOI 10.1007/s00436-012-3209-y
   de Carvalho CCCR, 2006, FOOD CHEM, V95, P413, DOI 10.1016/j.foodchem.2005.01.003
   Cruz EMD, 2013, VET PARASITOL, V195, P198, DOI 10.1016/j.vetpar.2012.12.046
   DRUMMOND RO, 1973, J ECON ENTOMOL, V66, P130, DOI 10.1093/jee/66.1.130
   FAO, 1971, FAO PLANT PROTECT B, V19, P15
   Ferrarini SR, 2008, VET PARASITOL, V157, P149, DOI 10.1016/j.vetpar.2008.07.006
   Fraga AB, 2003, REV BRAS ZOOTECN, V32, P1578, DOI 10.1590/S1516-35982003000700006
   Hennebelle T, 2006, CHEM BIODIVERS, V3, P1116, DOI 10.1002/cbdv.200690113
   Jannuzzi H, 2010, HORTIC BRAS, V28, P412, DOI 10.1590/S0102-05362010000400006
   Kalita B., 2013, INT J RES DEV PHARM, V3, P741
   Leite RC, 1988, THESIS UFMG BELO HOR, P151
   Liu WP, 2005, P NATL ACAD SCI USA, V102, P701, DOI 10.1073/pnas.0408847102
   Mendes MC, 2011, VET PARASITOL, V178, P383, DOI 10.1016/j.vetpar.2011.01.006
   Miresmailli S, 2006, PEST MANAG SCI, V62, P366, DOI 10.1002/ps.1157
   Roditakis E, 2005, PEST MANAG SCI, V61, P577, DOI 10.1002/ps.1029
   Senatore F, 2001, FLAVOUR FRAG J, V16, P169, DOI 10.1002/ffj.972
   Sette-de-Souza P.H., 2014, AFR J MICROBIOL RES, V8, P2783
   Simas NK, 2004, QUIM NOVA, V27, P46, DOI 10.1590/S0100-40422004000100009
   Singh Rajwinder, 2009, International Journal of Tropical Insect Science, V29, P93, DOI 10.1017/S1742758409990087
   STONE B. F., 1962, Bulletin of Entomological Research, V53, P563, DOI 10.1017/S000748530004832X
   Tavares I.B., 2011, PESQ APLIC AGROTECHN, V4, P204, DOI DOI 10.5777/PAET.V4.N1.12
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
NR 29
TC 36
Z9 38
U1 0
U2 18
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD MAY 30
PY 2015
VL 210
IS 1-2
BP 118
EP 122
DI 10.1016/j.vetpar.2015.03.010
PG 5
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA CI8UF
UT WOS:000355046500017
PM 25837783
DA 2020-12-08
ER

PT J
AU Galvao, JG
   Silva, VF
   Ferreira, SG
   Franca, FRM
   Santos, DA
   Freitas, LS
   Alves, PB
   Araujo, AAS
   Cavalcanti, SCH
   Nunes, RS
AF Galvao, J. G.
   Silva, V. F.
   Ferreira, S. G.
   Franca, F. R. M.
   Santos, D. A.
   Freitas, L. S.
   Alves, P. B.
   Araujo, A. A. S.
   Cavalcanti, S. C. H.
   Nunes, R. S.
TI beta-cyclodextrin inclusion complexes containing Citrus sinensis (L.)
   Osbeck essential oil: An alternative to control Aedes aegypti larvae
SO THERMOCHIMICA ACTA
LA English
DT Article
DE Citrus sinensis essential oil; beta-cyclodextrin; Inclusion complexes;
   Aqueous solubility
ID RESISTANCE; TEMEPHOS; ENCAPSULATION; SELECTION; ORANGE
AB The development of beta-cyclodextrin (beta-CD) complexes is an interesting way for increasing the aqueous solubility of essential oils. The aim of this study was to prepare inclusion complexes of Citrus sinensis essential oil (CSEO) with beta-CD using paste complexation (with and without co-solvent) and co-precipitation methods. Additionally, the physicochemical properties of the inclusion complexes using thermal analysis, X-ray diffraction, Fourier transform infrared spectroscopy, and scanning electron microscopy were evaluated. Furthermore, CSEO content (%) and solubility of complexes were measured. The biological activity against the Aedes aegypti Linn. larvae was further evaluated. For comparison purposes, a physical mixture between beta-CD and CSEO was prepared and evaluated. Thermal analysis clearly indicated the formation of complexes by paste and co-precipitation methods. The headspace/gas chromatography quantitative analysis showed inclusions contents higher than 50%. On the other hand, the product revealed LC50 of 23.01 ppm, close to CSEO LC50 21.5 PPm. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Galvao, J. G.; Silva, V. F.; Ferreira, S. G.; Araujo, A. A. S.; Cavalcanti, S. C. H.; Nunes, R. S.] Univ Fed Sergipe, Dept Pharm, BR-49000100 Sao Cristovao, Sergipe, Brazil.
   [Franca, F. R. M.] Univ Fed Sergipe, Dept Chem Engn, BR-49000100 Sao Cristovao, Sergipe, Brazil.
   [Santos, D. A.; Freitas, L. S.; Alves, P. B.] Univ Fed Sergipe, Dept Chem, BR-49000100 Sao Cristovao, Sergipe, Brazil.
RP Galvao, JG (corresponding author), Univ Fed Sergipe, Dept Pharm, S-N Cidade Univ, BR-49000100 Sao Cristovao, Sergipe, Brazil.
EM julianaggalvao@gmail.com
RI Nunes, Rogeria RSN/R-5248-2018; de Alexandria Santos,
   Darlisson/AAV-8587-2020; Freitas, Lisiane S/J-1661-2015; Santos,
   Darlisson A/E-2970-2016; Cavalcanti, Socrates/AAQ-7004-2020; Alves,
   Pericles/S-8768-2019; Galvao, Juliana Gouveia/AAI-9737-2020
OI Nunes, Rogeria RSN/0000-0001-6681-2042; de Alexandria Santos,
   Darlisson/0000-0001-5817-5792; Freitas, Lisiane S/0000-0002-6720-8338;
   Santos, Darlisson A/0000-0001-5817-5792; Alves,
   Pericles/0000-0002-8955-9614; Galvao, Juliana
   Gouveia/0000-0002-5471-4530
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES/Brazil)CAPES; Fundacao de Amparo a Pesquisa do Estado de
   Sergipe (FAPITEC/SE)
FX The authors acknowledge the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq/Brazil), the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil), and the
   Fundacao de Amparo a Pesquisa do Estado de Sergipe (FAPITEC/SE) for
   supporting funds and CMNano for SEM analysis.
CR Ayala-Zavala JF, 2008, J INCL PHENOM MACRO, V60, P359, DOI 10.1007/s10847-007-9385-1
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Bonaccorsi I, 2011, REV BRAS FARMACOGN, V21, P841, DOI 10.1590/S0102-695X2011005000123
   Boonyarattanakalin KS, 2011, J INCL PHENOM MACRO, V70, P279, DOI 10.1007/s10847-010-9913-2
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Bruneton J., 1993, PHARMACOGNOSIE PLYTO
   Marques HMC, 2010, FLAVOUR FRAG J, V25, P313, DOI 10.1002/ffj.2019
   Ezeonu FC, 2001, BIORESOURCE TECHNOL, V76, P273, DOI 10.1016/S0960-8524(00)00120-6
   Finney D. J., 1971, PROBIT ANAL
   Furtado RF, 2005, NEOTROP ENTOMOL, V34, P843, DOI 10.1590/S1519-566X2005000500018
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   He J, 2009, J INCL PHENOM MACRO, V65, P249, DOI 10.1007/s10847-009-9575-0
   HUANG JF, 1992, APPL SPECTROSC, V46, P606, DOI 10.1366/0003702924124998
   Li N, 2005, J PHARMACEUT BIOMED, V39, P824, DOI 10.1016/j.jpba.2005.05.011
   Liu BG, 2012, FOOD CHEM, V134, P926, DOI 10.1016/j.foodchem.2012.02.207
   Loftsson T., 1997, PHARM TECHNOLOGY EUR, V9, P26
   Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020
   Marreto RN, 2008, THERMOCHIM ACTA, V475, P53, DOI 10.1016/j.tca.2008.06.015
   Martins P, 2011, CHEM ENGINEER TRANS, V24, P463, DOI 10.3303/CET1124078
   Miro A., 2000, CONTROL RELEASE SOC, V1, P1270
   Morales-Saldana J., 2007, REV PERUANA BIOL, V14, P297
   Rodriguez MM, 2002, J MED ENTOMOL, V39, P882, DOI 10.1603/0022-2585-39.6.882
   Romi R, 2003, J AM MOSQUITO CONTR, V19, P419
   Scalia S, 2002, J PHARMACEUT BIOMED, V30, P1181, DOI 10.1016/S0731-7085(02)00433-8
   Scalia S, 2006, INT J PHARMACEUT, V320, P79, DOI 10.1016/j.ijpharm.2006.04.008
   Serafini MR, 2012, J THERM ANAL CALORIM, V109, P951, DOI 10.1007/s10973-011-1736-x
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Songkro S, 2012, J INCL PHENOM MACRO, V72, P339, DOI 10.1007/s10847-011-9985-7
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   Veiga Junior C., 2003, QUUM NOVA, V16, P390
   Venturini CDG, 2008, QUIM NOVA, V31, P360, DOI 10.1590/S0100-40422008000200032
   Wang J, 2011, FOOD CHEM, V127, P1680, DOI 10.1016/j.foodchem.2011.02.036
   Wirth MC, 1999, J AM MOSQUITO CONTR, V15, P315
   Wouessidjewe D., 1994, CAD FARM, V10, P7
NR 34
TC 41
Z9 41
U1 0
U2 34
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0040-6031
EI 1872-762X
J9 THERMOCHIM ACTA
JI Thermochim. Acta
PD MAY 20
PY 2015
VL 608
BP 14
EP 19
DI 10.1016/j.tca.2015.04.001
PG 6
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA CI2QK
UT WOS:000354591900003
DA 2020-12-08
ER

PT J
AU de Santana, MT
   Silva, VB
   de Brito, RG
   dos Santos, PL
   Cavalcanti, SCD
   Barreto, EO
   Ferro, JND
   dos Santos, MRV
   Araujo, AADS
   Quintans, LJ
AF de Santana, Marilia Trindade
   Silva, Viviane Barros
   de Brito, Renan Guedes
   dos Santos, Priscila Laise
   de Holanda Cavalcanti, Socrates Cabral
   Barreto, Emiliano Oliveira
   de Souza Ferro, Jamylle Nunes
   Viana dos Santos, Marcio Roberto
   de Sousa Araujo, Adriano Antunes
   Quintans-Junior, Lucindo Jose
TI Synthesis and Pharmacological Evaluation of Carvacrol Propionate
SO INFLAMMATION
LA English
DT Article
DE terpene; carvacrol propionate; hyperalgesia; inflammation; pain
ID NATURAL-PRODUCTS; MECHANICAL HYPERNOCICEPTION; ANTIINFLAMMATORY
   ACTIVITY; ANTINOCICEPTIVE ACTIVITY; ANIMAL-MODELS; FORMALIN TEST; PAW
   EDEMA; HYPERALGESIA; NERVE; PAIN
AB This study aimed at synthesizing the carvacrol propionate (CP) and evaluating its pharmacological profile. CP was obtained from carvacrol and propionyl chloride through an esterification reaction. Male Swiss mice were treated with CP (25, 50, or 100 mg/kg). We evaluated the analgesic effect, mechanical hyperalgesia, and anti-inflammatory effect. Pre-treatment with CP inhibited (p < 0.01 and 0.001) the formalin-induced nociception in both phases. CP inhibited (p < 0.05, 0.01, and 0.001) the development of mechanical hyperalgesia. CP was able to decrease the leukocyte recruitment (p < 0.001) and the amount of TNF-alpha (p < 0.001), IL-1 beta (p < 0.05), and protein leakage (p < 0.01) into the pleural cavity. In addition, the paw edema was inhibited by CP (p < 0.05, 0.01, and 0.001). The CP attenuates nociception, mechanical hyperalgesia, and inflammation, through an inhibition of cytokines.
C1 [de Santana, Marilia Trindade; de Brito, Renan Guedes; Quintans-Junior, Lucindo Jose] Univ Fed Sergipe, Dept Physiol, Sao Cristovao, Brazil.
   [Silva, Viviane Barros; de Holanda Cavalcanti, Socrates Cabral; Viana dos Santos, Marcio Roberto; de Sousa Araujo, Adriano Antunes] Univ Fed Sergipe, Dept Pharm, Sao Cristovao, Brazil.
   [dos Santos, Priscila Laise] Univ Fed Sergipe, Dept Morphol, Sao Cristovao, Brazil.
   [Barreto, Emiliano Oliveira; de Souza Ferro, Jamylle Nunes] Univ Fed Alagoas, Cell Biol Lab, Maceio, Brazil.
RP Quintans, LJ (corresponding author), Univ Fed Sergipe, Dept Physiol, Av Marechal Rondom S-N, Sao Cristovao, Brazil.
EM lucindojr@gmail.com
RI Barreto, Emiliano/J-2109-2012; Quintans, Lucindo/A-2434-2012; Brito,
   Renan/H-9584-2015; Barreto, Emiliano/T-3671-2019; Cavalcanti,
   Socrates/AAQ-7004-2020
OI Barreto, Emiliano/0000-0002-4956-5075; Quintans,
   Lucindo/0000-0001-5155-938X; Brito, Renan/0000-0001-5214-9681; Barreto,
   Emiliano/0000-0002-4956-5075; Santos, Priscila/0000-0001-5592-1120
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Apoio a Pesquisa e a Inovacao
   Tecnologica do Estado de Sergipe (FAPITEC/SE/Brazil); Financiadora de
   Estudos e Projetos (FINEP/Brazil)Ciencia Tecnologia e Inovacao (FINEP)
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil), Fundacao de
   Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe
   (FAPITEC/SE/Brazil), and Financiadora de Estudos e Projetos
   (FINEP/Brazil). We thank teacher Abilio Borghi for the grammar review on
   the manuscript.
CR ASAKURA W, 1993, PHARMACOL BIOCHEM BE, V46, P111, DOI 10.1016/0091-3057(93)90325-N
   Baker DD, 2007, NAT PROD REP, V24, P1225, DOI 10.1039/b602241n
   Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028
   Bennett G, 1998, PAIN, V77, P315, DOI 10.1016/S0304-3959(98)00114-6
   Capasso A, 1996, PHYTOTHER RES, V10, P309, DOI 10.1002/(SICI)1099-1573(199606)10:4&lt;309::AID-PTR850&gt;3.0.CO;2-J
   Capuano A, 2009, EUR J PHARMACOL, V605, P57, DOI 10.1016/j.ejphar.2008.12.029
   CASTRO JA, 1968, LIFE SCI PT 1 PHYSI, V7, P129, DOI 10.1016/0024-3205(68)90326-3
   Castro S. H., 1979, ADV INFLAMMAT RES, P311
   Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807
   Chen HS, 2008, PAIN, V135, P31, DOI 10.1016/j.pain.2007.04.040
   CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x
   CUNHA FQ, 1991, BRIT J PHARMACOL, V104, P765, DOI 10.1111/j.1476-5381.1991.tb12502.x
   Cunha TM, 2008, EUR J PAIN, V12, P1059, DOI 10.1016/j.ejpain.2008.02.003
   Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654
   Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107
   Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018
   Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102
   Sa RDDE, 2013, MOLECULES, V18, P1227, DOI 10.3390/molecules18011227
   Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076
   de Sousa DP, 2007, Z NATURFORSCH C, V62, P39
   de Sousa DP, 2010, Z NATURFORSCH C, V65, P543
   Dolly, 2003, TETRAHEDRON, V59, P9161, DOI 10.1016/j.tet.2003.09.051
   DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322
   FERREIRA SH, 1993, BRIT J PHARMACOL, V110, P1227, DOI 10.1111/j.1476-5381.1993.tb13946.x
   Foster PA, 2003, FASEB J, V17, P1703, DOI 10.1096/fj.02-1000fje
   Franco CIF, 2005, J ETHNOPHARMACOL, V98, P275, DOI 10.1016/j.jep.2005.01.008
   Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528
   Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016
   Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108
   Goncalves JCR, 2010, EUR J PHARMACOL, V645, P108, DOI 10.1016/j.ejphar.2010.07.027
   Guimaraes AG, 2013, PHYTOTHER RES, V27, P1, DOI 10.1002/ptr.4686
   Guimaraes AG, 2012, N-S ARCH PHARMACOL, V385, P253, DOI 10.1007/s00210-011-0715-x
   Guimaraes AG, 2010, BASIC CLIN PHARMACOL, V107, P949, DOI 10.1111/j.1742-7843.2010.00609.x
   Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004
   HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1
   HUNTER JC, 1994, NEUROSCI LETT, V174, P217, DOI 10.1016/0304-3940(94)90025-6
   KURAISHI Y, 1983, BRAIN RES, V273, P245, DOI 10.1016/0006-8993(83)90849-1
   Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8
   Landa P, 2009, ARCH PHARM RES, V32, P75, DOI 10.1007/s12272-009-1120-6
   Lavich TR, 2006, PAIN, V125, P180, DOI 10.1016/j.pain.2006.08.006
   Le Bars D, 2001, PHARMACOL REV, V53, P597
   LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456
   LEVY L, 1969, LIFE SCI PT 1 PHYSI, V8, P601, DOI 10.1016/0024-3205(69)90021-6
   Lima MD, 2013, EUR J PHARMACOL, V699, P112, DOI 10.1016/j.ejphar.2012.11.040
   Lorenzetti BB, 1996, INFLAMM RES, V45, P308, DOI 10.1007/BF02280997
   Mathela CS, 2010, ACTA POL PHARM, V67, P375
   McMahon SB, 2008, WALL MELZACKS TXB PA, P49
   Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nair V, 2012, INDIAN J MED RES, V135, P240
   Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s
   Nikumbh VP, 2003, J SCI IND RES INDIA, V62, P1086
   Olagnier D, 2007, BIOORG MED CHEM LETT, V17, P6075, DOI 10.1016/j.bmcl.2007.09.056
   Oliveira FD, 2008, BIOL PHARM BULL, V31, P588, DOI 10.1248/bpb.31.588
   Passos CS, 2009, REV BRAS FARMACOGN, V19, P140, DOI 10.1590/S0102-695X2009000100024
   Petho G, 2001, EUR J NEUROSCI, V14, P210, DOI 10.1046/j.0953-816x.2001.01651.x
   Porto TS, 2009, FITOTERAPIA, V80, P432, DOI 10.1016/j.fitote.2009.06.003
   Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650
   Quintans LJ, 2010, J OROFAC PAIN, V24, P305
   Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886
   Sommer C, 1998, EXP NEUROL, V151, P138, DOI 10.1006/exnr.1998.6797
   Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97
   Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001
   Villarreal CF, 2009, LIFE SCI, V85, P822, DOI 10.1016/j.lfs.2009.10.018
   Zouikr I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053384
NR 65
TC 3
Z9 3
U1 1
U2 19
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0360-3997
EI 1573-2576
J9 INFLAMMATION
JI Inflammation
PD OCT
PY 2014
VL 37
IS 5
BP 1575
EP 1587
DI 10.1007/s10753-014-9884-3
PG 13
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA AP9YN
UT WOS:000342438200024
PM 24710701
DA 2020-12-08
ER

PT J
AU Lima, TC
   da Silva, TKM
   Silva, FL
   Barbosa, JM
   Marques, MOM
   Santos, RL
   Cavalcanti, SCD
   de Sousa, DP
AF Lima, Tamires Cardoso
   Mariano da Silva, Tayane Kayne
   Silva, Fabiana Lima
   Barbosa-Filho, Jose Maria
   Mayo Marques, Marcia Ortiz
   Santos, Roseli La Corte
   de Holanda Cavalcanti, Socrates Cabral
   de Sousa, Damiao Pergentino
TI Larvicidal activity of Mentha x villosa Hudson essential oil,
   rotundifolone and derivatives
SO CHEMOSPHERE
LA English
DT Article
DE Larvicidal activity; Essential oil; Aedes aegypti; Terpene; Dengue
ID TRIBOLIUM-CASTANEUM HERBST; SITOPHILUS-ORYZAE L.; AEDES-AEGYPTI;
   INSECTICIDAL PROPERTIES; PIPERITENONE OXIDE; DIPTERA; MONOTERPENOIDS;
   REPELLENT; DENGUE; COLEOPTERA
AB The aim of this study was to evaluate the larvicidal activity of Mentha x villosa essential oil (MVEO) and its major constituent, rotundifolone, against larvae of Aedes aegypti. Additionally, a set of 15 analogues of the rotundifolone were evaluated to identify the molecular characteristics which contribute to the larvicidal effect. The results from the present study showed that the MVEO exhibited outstanding toxic effects against Ae. aegypti larvae (LC50 = 45.0 ppm). Rotundifolone exhibited reasonable larvicidal activity (LC50 = 62.5 ppm). With respect to comparative study of rotundifolone and its analogues, all tested compounds were less potent than rotundifolone, except (-)-limonene. In general, replacement of C-C double bonds by epoxides groups decreases the larvicidal potency. The presence of alpha,beta-unsaturated carbonyls contributes to the larvicidal toxicity. The addition of hydroxyl groups in the chemical structure resulted in less potent compounds. Furthermore, the enantioselectivity seems to play an important role for the larvicidal toxicity. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Lima, Tamires Cardoso; Mariano da Silva, Tayane Kayne; de Holanda Cavalcanti, Socrates Cabral] Univ Fed Sergipe, Dept Pharm, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Silva, Fabiana Lima; Barbosa-Filho, Jose Maria; de Sousa, Damiao Pergentino] Univ Fed Paraiba, Dept Pharmaceut Sci, BR-58051970 Joao Pessoa, Paraiba, Brazil.
   [Mayo Marques, Marcia Ortiz] Inst Agron Estado Sao Paulo, Ctr Genet Mol Biol & Phytochem, BR-13001970 Campinas, SP, Brazil.
   [Santos, Roseli La Corte] Univ Fed Sergipe, Dept Morphol, BR-49100000 Sao Cristovao, Sergipe, Brazil.
RP de Sousa, DP (corresponding author), Univ Fed Paraiba, Dept Pharmaceut Sci, BR-58051970 Joao Pessoa, Paraiba, Brazil.
EM damiao_desousa@yahoo.com.br
RI Cavalcanti, Socrates/AAQ-7004-2020; de Sousa, Damiao
   Pergentino/B-2580-2018; Marques, Marcia O.M./E-1283-2019; Filho, Jose
   Maria Barbosa/B-3951-2010; de Sousa, Damiao Pergentino/AAY-1244-2020;
   Santos, Roseli LC/F-1735-2015
OI de Sousa, Damiao Pergentino/0000-0002-7180-4896; Marques, Marcia
   O.M./0000-0001-8270-4308; Filho, Jose Maria Barbosa/0000-0002-9567-4096;
   Silva, Fabiana/0000-0002-8599-4985
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPITEC; Federal University of Sergipe
FX The authors are thankful to the CAPES, CNPq, FAPITEC, and Federal
   University of Sergipe for financial support.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Abdelgaleil SAM, 2009, J CHEM ECOL, V35, P518, DOI 10.1007/s10886-009-9635-3
   Adams RP, 2001, IDENTIFICATION ESSEN, P456
   Alencastro F.M.M.R., 1965, CONTRIBUICAO BIBLIOG, P354
   Almeida R. N., 1996, Fitoterapia, V67, P334
   Andrade LN, 2011, J MED PLANTS RES, V5, P6995, DOI 10.5897/JMPR11.1074
   Ansari MA, 2000, BIORESOURCE TECHNOL, V71, P267, DOI 10.1016/S0960-8524(99)00079-6
   Arruda Thúlio. A., 2006, Rev. bras. farmacogn., V16, P307, DOI 10.1590/S0102-695X2006000300005
   BUCHI G, 1979, J ORG CHEM, V44, P546
   Cheng SS, 2009, PEST MANAG SCI, V65, P339, DOI 10.1002/ps.1693
   Coelho AAM, 2009, BIOASSAY, V4, P1, DOI DOI 10.14295/BA.v4.0.22
   Porto KRD, 2008, REV SOC BRAS MED TRO, V41, P586, DOI 10.1590/S0037-86822008000600008
   de Sousa DP, 2007, Z NATURFORSCH C, V62, P39
   de Sousa DP, 2008, Z NATURFORSCH C, V63, P808
   dosSantos RB, 1997, TETRAHEDRON LETT, V38, P745, DOI 10.1016/S0040-4039(96)02451-3
   Faria M. L., 2000, TETRAHEDRON-ASYMMETR, V11, P4093
   Finney D. J., 1971, PROBIT ANAL
   Franzios G, 1997, J AGR FOOD CHEM, V45, P2690, DOI 10.1021/jf960685f
   Furniss B.S., 1998, VOGELS TXB PRACTICAL
   Garcia M, 2005, PEST MANAG SCI, V61, P612, DOI 10.1002/ps.1028
   Govindarajan M, 2012, PARASITOL RES, V110, P2023, DOI 10.1007/s00436-011-2731-7
   KATSUHARA J, 1967, J ORG CHEM, V32, P797, DOI 10.1021/jo01278a062
   KIDO F, 1992, J CHEM SOC PERK T 1, P229, DOI 10.1039/p19920000229
   Koliopoulos G, 2010, PARASITOL RES, V107, P327, DOI 10.1007/s00436-010-1865-3
   Kumar P, 2011, IND CROP PROD, V34, P802, DOI 10.1016/j.indcrop.2011.02.019
   Kumar Sarita, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P85, DOI 10.1016/S2221-1691(11)60001-4
   Lee S, 2003, J STORED PROD RES, V39, P77, DOI 10.1016/S0022-474X(02)00020-6
   Leite AM, 2009, REV BRAS FARMACOGN, V19, P842, DOI 10.1590/S0102-695X2009000600008
   Ligon B Lee, 2005, Semin Pediatr Infect Dis, V16, P60, DOI 10.1053/j.spid.2004.09.013
   Lopez O, 2005, GREEN CHEM, V7, P431, DOI 10.1039/b500733j
   MATOS FJA, 1999, J ESSENT OIL RES, V11, P41
   Michaelakis A., 2011, Hellenic Plant Protection Journal, V4, P35
   Michaelakis A, 2009, PARASITOL RES, V105, P769, DOI 10.1007/s00436-009-1452-7
   Mohamed MIE, 2008, APPL ENTOMOL ZOOL, V43, P599, DOI 10.1303/aez.2008.599
   Moreira JA, 2003, TETRAHEDRON-ASYMMETR, V14, P3787, DOI 10.1016/j.tetasy.2003.09.030
   RICE PJ, 1994, J ECON ENTOMOL, V87, P1172, DOI 10.1093/jee/87.5.1172
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Rosen L, 1999, Med Trop (Mars), V59, P495
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Simas NK, 2004, QUIM NOVA, V27, P46, DOI 10.1590/S0100-40422004000100009
   Sousa PJC, 2009, BRAZ J MED BIOL RES, V42, P655, DOI 10.1590/S0100-879X2009000700010
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018
   THOMAS AF, 1989, NAT PROD REP, V6, P291, DOI 10.1039/np9890600291
   Tripathi AK, 2004, J MED ENTOMOL, V41, P691, DOI 10.1603/0022-2585-41.4.691
   Tripathi AK, 2003, J ECON ENTOMOL, V96, P1594, DOI 10.1603/0022-0493-96.5.1594
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
   Wang ZD, 2008, BIOORG MED CHEM LETT, V18, P2854, DOI 10.1016/j.bmcl.2008.03.091
   Zahran HEM, 2011, J ASIA-PAC ENTOMOL, V14, P46, DOI 10.1016/j.aspen.2010.11.013
   Zoubiri S., 2011, J SAUDI CHEM SOC
NR 50
TC 35
Z9 35
U1 0
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD JUN
PY 2014
VL 104
BP 37
EP 43
DI 10.1016/j.chemosphere.2013.10.035
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AE6EX
UT WOS:000334084500006
PM 24275151
DA 2020-12-08
ER

PT J
AU Scotti, L
   Scotti, MT
   Silva, VB
   Santos, SRL
   Cavalcanti, SCH
   Mendonca, FJB
AF Scotti, Luciana
   Scotti, Marcus Tullius
   Silva, Viviane Barros
   Lima Santos, Sandra Regina
   Cavalcanti, Socrates C. H.
   Mendonca Junior, Francisco J. B.
TI Chemometric Studies on Potential Larvicidal Compounds Against Aedes
   Aegypti
SO MEDICINAL CHEMISTRY
LA English
DT Article
DE Aedes aegypti; chemometry; CPCA; descriptors; PLS; VolSurf
ID AIDED DRUG DESIGN; DERIVATIVES; VOLSURF; LARVAE; QSAR; DESCRIPTORS;
   SUITABILITY; TEMEPHOS; EFFICACY; MODELS
AB The mosquito Aedes aegypti (Diptera, Culicidae) is the vector of yellow and dengue fever. In this study, chemometric tools, such as, Principal Component Analysis (PCA), Consensus PCA (CPCA), and Partial Least Squares Regression (PLS), were applied to a set of fifty five active compounds against Ae. aegypti larvae, which includes terpenes, cyclic alcohols, phenolic compounds, and their synthetic derivatives. The calculations were performed using the VolSurf+ program. CPCA analysis suggests that the higher weight blocks of descriptors were SIZE/SHAPE, DRY, and H2O. The PCA was generated with 48 descriptors selected from the previous blocks. The scores plot showed good separation between more and less potent compounds. The first two PCs accounted for over 60% of the data variance. The best model obtained in PLS, after validation leave-one-out, exhibited q(2) = 0.679 and r(2) = 0.714. External prediction model was R-2 = 0.623. The independent variables having a hydrophobic profile were strongly correlated to the biological data. The interaction maps generated with the GRID force field showed that the most active compounds exhibit more interaction with the DRY probe.
C1 [Scotti, Luciana; Mendonca Junior, Francisco J. B.] State Univ Paraiba, Dept Biol Sci, Lab Synth & Drug Delivery, BR-58070450 Joao Pessoa, PB, Brazil.
   [Scotti, Marcus Tullius] Univ Fed Paraiba, Dept Engn & Environm, BR-58297000 Rio Tinto, PB, Brazil.
   [Silva, Viviane Barros; Lima Santos, Sandra Regina; Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Dept Pharm, Med Chem Lab, BR-49100000 Sao Cristovao, Sergipe, Brazil.
RP Scotti, L (corresponding author), State Univ Paraiba, Dept Biol Sci, Lab Synth & Drug Delivery, BR-58070450 Joao Pessoa, PB, Brazil.
EM luciana.scotti@gmail.com
RI Cavalcanti, Socrates/AAQ-7004-2020; Scotti, Luciana/C-7811-2013; JUNIOR,
   FRANCISCO JAIME BEZERRA MENDONCA/J-2926-2015; Scotti, Marcus/G-2981-2012
OI Scotti, Luciana/0000-0003-1866-4107; JUNIOR, FRANCISCO JAIME BEZERRA
   MENDONCA/0000-0003-3588-833X; Scotti, Marcus/0000-0003-4863-8057;
   Mendonca Junior, Francisco Jaime/0000-0002-8840-8486
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); UEPB (Research and Post-Graduation Incentive
   Program/PROPESQ-PRPGP)
FX The authors are grateful to Prof. Gabriele Cruciani from Universita di
   Perugia - Italy for the VolSurf+ license and to CNPq and UEPB (Research
   and Post-Graduation Incentive Program/PROPESQ-PRPGP) for financial
   support.
CR Adeleke M A, 2009, Tanzan J Health Res, V11, P250
   ALLINGER NL, 1977, J AM CHEM SOC, V99, P8127, DOI 10.1021/ja00467a001
   [Anonymous], HYP PROGR REL 8 0 WI
   BALANKUR.M, 1966, B WORLD HEALTH ORGAN, V35, P75
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Beebe K.R., 1998, CHEMOMETRICS PRACTIC, P185
   Ben Arfa A, 2006, LETT APPL MICROBIOL, V43, P149, DOI 10.1111/j.1472-765X.2006.01938.x
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Cantrell CL, 2010, CHEM BIODIVERS, V7, P1681, DOI 10.1002/cbdv.201000031
   Chiu MW, 2007, J BIOMED SCI, V14, P429, DOI 10.1007/s11373-007-9151-9
   Cianchetta G, 2004, J MED CHEM, V47, P3193, DOI 10.1021/jm030986y
   Cohen N.C., 1996, GUIDEBOOK MOL MODELI, P361
   COOLEN HKAC, 1995, J AM CHEM SOC, V117, P11906, DOI 10.1021/ja00153a012
   COREY EJ, 1975, TETRAHEDRON LETT, P2647
   Crivori P, 2000, J MED CHEM, V43, P2204, DOI 10.1021/jm990968+
   Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17, DOI 10.1016/S0166-1280(99)00360-7
   Cruciani G, 2002, J MED CHEM, V45, P2685, DOI 10.1021/jm0011326
   Cruciani G, 2000, EUR J PHARM SCI, V11, pS29, DOI 10.1016/S0928-0987(00)00162-7
   DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024
   Dolly, 2003, TETRAHEDRON, V59, P9161, DOI 10.1016/j.tet.2003.09.051
   Feio MJ, 2012, ECOL INDIC, V15, P236, DOI 10.1016/j.ecolind.2011.09.039
   Figueiredo LTM, 2006, REV SOC BRAS MED TRO, V39, P203, DOI 10.1590/S0037-86822006000200014
   Fontes Junior U. R., 2012, African Journal of Biotechnology, V11, P3169
   Garza-Robledo AA, 2011, J AM MOSQUITO CONTR, V27, P404, DOI 10.2987/11-6133.1
   Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946
   Grodnitzky JA, 2002, J AGR FOOD CHEM, V50, P4576, DOI 10.1021/jf0201475
   Jean-Pierre P, 2011, CANCER-AM CANCER SOC, V117, P854, DOI 10.1002/cncr.25501
   KLEIN E, 1963, TETRAHEDRON, V19, P1091, DOI 10.1016/S0040-4020(01)99364-0
   Kovatcheva A, 2004, J CHEM INF COMP SCI, V44, P582, DOI 10.1021/ci034203t
   Leach A.R., 2001, MOL MODELLING PRINCI, P784
   Luthria DL, 2008, J AGR FOOD CHEM, V56, P9819, DOI 10.1021/jf801606x
   Machado-Machado EA, 2012, APPL GEOGR, V33, P82, DOI 10.1016/j.apgeog.2011.06.011
   McNally RC, 2011, J PROD INNOVAT MANAG, V28, P63, DOI 10.1111/j.1540-5885.2011.00861.x
   Nikumbh VP, 2003, J SCI IND RES INDIA, V62, P1086
   Ooms F, 2000, CURR MED CHEM, V7, P141, DOI 10.2174/0929867003375317
   Oprea TI, 2002, J COMB CHEM, V4, P258, DOI 10.1021/cc010093w
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Scotti L, 2012, MOLECULES, V17, P2298, DOI 10.3390/molecules17032298
   Scotti L, 2010, MOLECULES, V15, P7363, DOI 10.3390/molecules15107363
   Sharaf M.A., 1986, CHEMOMETRICS, P336
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   THOMAS AF, 1989, NAT PROD REP, V6, P291, DOI 10.1039/np9890600291
   Vaughan IP, 2005, J APPL ECOL, V42, P487, DOI 10.1111/j.1365-2664.2005.01038.x
   Vimaladevi S, 2012, BIOLOGIA, V67, P212, DOI 10.2478/s11756-011-0152-9
   Wang ZQ, 2012, PEST MANAG SCI, V68, P1041, DOI 10.1002/ps.3265
   Westerhuis JA, 1998, J CHEMOMETR, V12, P301, DOI 10.1002/(SICI)1099-128X(199809/10)12:5<301::AID-CEM515>3.3.CO;2-J
   Xuan PF, 2012, GLYCOBIOLOGY, V22, P552, DOI 10.1093/glycob/cwr163
   Zamora I, 2003, J MED CHEM, V46, P25, DOI 10.1021/jm011051p
NR 49
TC 20
Z9 20
U1 0
U2 33
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4064
EI 1875-6638
J9 MED CHEM
JI Med. Chem.
PD MAR
PY 2014
VL 10
IS 2
BP 201
EP 210
DI 10.2174/15734064113099990005
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AB6IQ
UT WOS:000331891200008
PM 23676010
DA 2020-12-08
ER

PT J
AU Oliveira, RRB
   Brito, TB
   Nepel, A
   Costa, EV
   Barison, A
   Nunes, RS
   Santos, RLC
   Cavalcanti, SCH
AF Oliveira, Rafael R. B.
   Brito, Thaysnara B.
   Nepel, Angelita
   Costa, Emmanoel V.
   Barison, Andersson
   Nunes, Rogeria S.
   Santos, Roseli L. C.
   Cavalcanti, Socrates C. H.
TI Synthesis, Activity, and QSAR Studies of Tryptamine Derivatives on
   Third-instar Larvae of Aedes Aegypti Linn
SO MEDICINAL CHEMISTRY
LA English
DT Article
DE QSAR; tryptamine derivatives; Aedes aegypti; larvicidal activity;
   dengue; neglected diseases
ID INSECTICIDES; INDOLES; DIPTERA
AB Special attention has been given to the mosquito Aedes aegypti Linn. (Diptera: Culicidae) owing to numerous dengue epidemic outbreaks worldwide. Failure to control vector spreading is accounted for unorganized urban growth and resistance to larvicides and insecticides. Therefore, researchers are currently searching for new and more efficient larvicides and insecticides to aid dengue control measures. Triptamine is known to affect insect behavior, development, and physiology. Expression of this compound in plants has reduced the growth rate of herbivore insects. In view of these facts, it was of our interest to synthesize triptamine amide derivatives as potential larvicides against Ae. aegypti, establishing a Structure-Activity Relationship. Eleven amide derivatives of triptamine were synthesized, characterized, and evaluated for their larvicidal activity against third-instar Ae. aegypti larvae. N-(2-(1H-indol-3-yl) ethyl)-2,2,2-trichloroacetamide exhibited the highest overall larvicidal potency, while N-(2-(1H-Indol-3-yl) ethyl) acetamide displayed the lowest larvicidal potency. A regression equation correlating the larvicidal activity with Log P was obtained. We have found a clear relationship between the larvicidal activity of non-chlorinated compounds and Log P. Analysis of the relationship between Log P and larvicidal activity against Ae. aegypti may be useful in the evaluation of potential larvicidal compounds.
C1 [Oliveira, Rafael R. B.; Brito, Thaysnara B.; Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Med Chem Lab, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
   [Nunes, Rogeria S.] Univ Fed Sergipe, Pharmaceut Technol Lab, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
   [Nepel, Angelita; Barison, Andersson] Univ Fed Parana, Dept Chem, Nucl Magnet Resonance Lab, BR-81531990 Curitiba, Parana, Brazil.
   [Costa, Emmanoel V.] Univ Fed Sergipe, Nat Prod Lab, Dept Chem, BR-49100000 Sao Cristovao, SE, Brazil.
   [Santos, Roseli L. C.] Univ Fed Sergipe, Dept Morphol, Parasitol Lab, BR-49100000 Sao Cristovao, SE, Brazil.
RP Cavalcanti, SCH (corresponding author), Univ Fed Sergipe, Med Chem Lab, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
EM socratescavalcanti@yahoo.com.br
RI Nunes, Rogeria RSN/R-5248-2018; Barison, Andersson/F-7134-2012; Santos,
   Roseli LC/F-1735-2015; Cavalcanti, Socrates/AAQ-7004-2020; Nepel,
   Angelita/J-2796-2016
OI Nunes, Rogeria RSN/0000-0001-6681-2042; Barison,
   Andersson/0000-0001-9381-8239; Nepel, Angelita/0000-0002-7426-0927
FU DECIT/SCTIE/MS; CNPqNational Council for Scientific and Technological
   Development (CNPq); SES-SE; FAPITEC-SE
FX The authors wish to acknowledge DECIT/SCTIE/MS, CNPq, SES-SE, and
   FAPITEC-SE for supporting funds. We extend our acknowledgement to Prof.
   Norberto Peporine Lopes for mass spectra analyses.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Ali A, 2012, J MED ENTOMOL, V49, P1370, DOI 10.1603/ME12026
   Astolfi P, 2006, ORG BIOMOL CHEM, V4, P3282, DOI 10.1039/b607680g
   BECK AL, 1992, J CHEM SOC PERK T 1, P797, DOI 10.1039/p19920000797
   Cantrell CL, 2010, CHEM BIODIVERS, V7, P1681, DOI 10.1002/cbdv.201000031
   Clark TM, 2005, TISSUE CELL, V37, P457, DOI 10.1016/j.tice.2005.08.001
   CRAMER RD, 1988, QUANT STRUCT-ACT REL, V7, P18, DOI 10.1002/qsar.19880070105
   CSABA G, 1993, EXPERIENTIA, V49, P627, DOI 10.1007/BF01923943
   Duong QY, 2006, J ORGANOMET CHEM, V691, P1775, DOI 10.1016/j.jorganchem.2005.12.005
   Farnesi LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030363
   Figueira VBC, 2005, ARKIVOC, P14, DOI 10.3998/ark.5550190.0006.e02
   Finney D. J., 1971, PROBIT ANAL
   Gill RIS, 2003, J CHEM ECOL, V29, P779, DOI 10.1023/A:1022983529555
   Grundmann F, 2012, BEILSTEIN J ORG CHEM, V8, P749, DOI 10.3762/bjoc.8.85
   Han Q, 2002, J BIOL CHEM, V277, P15781, DOI 10.1074/jbc.M201202200
   Hansch C, 2009, EUR J MED CHEM, V44, P260, DOI 10.1016/j.ejmech.2008.02.040
   Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700
   Leclerc V, 1998, BIOORGAN MED CHEM, V6, P1875, DOI 10.1016/S0968-0896(98)00147-3
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Medley JW, 2013, ORG LETT, V15, P3614, DOI 10.1021/ol401465y
   Minkwitz R, 2005, QSAR COMB SCI, V24, P343, DOI 10.1002/qsar.200420050
   Ozmen M., 1999, ENV TOXICOL CHEM
   Pedras MSC, 2012, J AGR FOOD CHEM, V60, P7792, DOI 10.1021/jf302038a
   Sadasivam S., 2003, MOL HOST PLANT RESIS
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Song XQ, 2007, APPL ORGANOMET CHEM, V21, P545, DOI 10.1002/aoc.1241
   Tedford HW, 2013, PESTIC BIOCHEM PHYS, V106, P124, DOI 10.1016/j.pestbp.2013.01.009
   Thomas JC, 1999, PLANT PHYSIOL BIOCH, V37, P665, DOI 10.1016/S0981-9428(00)80096-0
   Vontas J., 2012, PESTIC BIOCH PHYS
   Wang ZQ, 2012, PEST MANAG SCI, V68, P1041, DOI 10.1002/ps.3265
   WHO, 1963, WHO TECHN REP SER, P265
   WHO, 2012, DENG DENG HAEM FEV F
   Yamada K, 2009, HETEROCYCLES, V79, P635, DOI 10.3987/COM-08-S(D)29
NR 34
TC 4
Z9 5
U1 0
U2 18
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4064
EI 1875-6638
J9 MED CHEM
JI Med. Chem.
PY 2014
VL 10
IS 6
BP 580
EP 587
DI 10.2174/1573406409666131202144010
PG 8
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AN5PK
UT WOS:000340643500005
PM 24295020
DA 2020-12-08
ER

PT J
AU Sousa, D
   Lima, T
   Silva, T
   Barbosa, J
   Santos, R
   Cavalcanti, S
AF Sousa, D.
   Lima, T.
   Silva, T.
   Barbosa-Filho, J.
   Santos, R.
   Cavalcanti, S.
TI Larvicidal activity of Mentha 3 villosa Hudson essential oil and
   derivatives
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Sousa, D.; Barbosa-Filho, J.] Univ Fed Paraiba, BR-58059900 Joao Pessoa, Paraiba, Brazil.
   [Lima, T.; Silva, T.; Santos, R.; Cavalcanti, S.] Univ Fed Sergipe, Aracaju, Brazil.
RI Cavalcanti, Socrates/AAQ-7004-2020; Filho, Jose Maria
   Barbosa/B-3951-2010
OI Filho, Jose Maria Barbosa/0000-0002-9567-4096
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD SEP
PY 2013
VL 18
SU 1
SI SI
BP 117
EP 117
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 213BS
UT WOS:000324029000314
DA 2020-12-08
ER

PT J
AU Cruz, EMD
   Costa, LM
   Pinto, JAO
   Santos, DD
   de Araujo, SA
   Arrigoni-Blank, MD
   Bacci, L
   Alves, PB
   Cavalcanti, SCD
   Blank, AF
AF de Oliveira Cruz, Elizangela Mercia
   Costa-Junior, Livio Martins
   Oliveira Pinto, Jessika Andreza
   Santos, Darlisson de Alexandria
   de Araujo, Sandra Alves
   Arrigoni-Blank, Maria de Fatima
   Bacci, Leandro
   Alves, Pericles Barreto
   de Holanda Cavalcanti, Socrates Cabral
   Blank, Arie Fitzgerald
TI Acaricidal activity of Lippia gracilis essential oil and its major
   constituents on the tick Rhipicephalus (Boophilus) microplus
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Lippia gracilis; Volatile oil; Carvacrol; Thymol; Cattle tick
ID IXODES-SCAPULARIS ACARI; COMPONENTS; EFFICACY; IXODIDAE; THYMOL
AB The present study aimed to evaluate the activity of Lippia gracilis Schauer essential oil obtained from different L:gracilis genotypes and their major components, carvacrol and thymol against Rhipicephalus (Boophilus) microplus (cattle tick) larvae and engorged females. The larval test was performed parallel to the adult immersion test for engorged females for four L. gracilis genotypes. Similar tests were further performed for their major compounds carvacrol and thymol. Carvacrol (LC50 of 0.22 and 4.46 mg/mL, to larvae and engorged females, respectively) was more efficient than thymol (LC50 of 3.86 and 5.50 mg/mL, to larvae and engorged females, respectively). The lethal concentrations obtained for the isolated essential oil from genotypes LGRA-201 against larvae (1.31 mg/mL) and LGRA-106 against engorged females (4.66 mg/mL) confirmed the acaricidal activity of L gracilis essential oil and its effectiveness in controlling the southern cattle tick. (c) 2013 Elsevier B.V. All rights reserved.
C1 [de Oliveira Cruz, Elizangela Mercia; Oliveira Pinto, Jessika Andreza; Arrigoni-Blank, Maria de Fatima; Bacci, Leandro; Blank, Arie Fitzgerald] Univ Fed Sergipe, Dept Agron, BR-49100000 Sao Cristovao, SE, Brazil.
   [Costa-Junior, Livio Martins; de Araujo, Sandra Alves] Univ Fed Maranhao, Dept Anim Sci, BR-65500000 Chapadinha, MA, Brazil.
   [Santos, Darlisson de Alexandria; Alves, Pericles Barreto] Univ Fed Sergipe, Dept Chem, BR-49100000 Sao Cristovao, SE, Brazil.
   [de Holanda Cavalcanti, Socrates Cabral] Univ Fed Sergipe, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
RP Blank, AF (corresponding author), Univ Fed Sergipe, Dept Agron, Av Marechal Rondon S-N, BR-49100000 Sao Cristovao, SE, Brazil.
EM arie.blank@gmail.com
RI Blank, Arie F/C-7537-2013; Cavalcanti, Socrates/AAQ-7004-2020; Santos,
   Darlisson A/E-2970-2016; Costa-Junior, Livio M/H-7530-2012; de
   Alexandria Santos, Darlisson/AAV-8587-2020; Alves, Pericles/S-8768-2019;
   Bacci, Leandro/F-4571-2017
OI Blank, Arie F/0000-0003-2888-2239; Santos, Darlisson
   A/0000-0001-5817-5792; Costa-Junior, Livio M/0000-0002-1475-049X; de
   Alexandria Santos, Darlisson/0000-0001-5817-5792; Alves,
   Pericles/0000-0002-8955-9614; Bacci, Leandro/0000-0002-8198-6080
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPITEC/SE; CAPESCAPES
FX The authors wish to acknowledge CNPq, FAPITEC/SE and CAPES for
   supporting funds.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Adams R.P., 2007, IDENTIFICATION ESSEN
   Agnolin C.A., 2010, Rev. bras. plantas med., V12, P482, DOI 10.1590/S1516-05722010000400012
   Anthony JP, 2005, TRENDS PARASITOL, V21, P462, DOI 10.1016/j.pt.2005.08.004
   Castrejon Francisco Muro, 2003, Parasitologia Latinoamericana, V58, P118
   Cavalcanti SCH, 2010, BIORESOURCE TECHNOL, V101, P829, DOI 10.1016/j.biortech.2009.08.053
   Cetin H, 2010, VET PARASITOL, V170, P287, DOI 10.1016/j.vetpar.2010.02.031
   Novelino AMD, 2007, PARASITOL RES, V101, P809, DOI 10.1007/s00436-007-0560-5
   Daemon E, 2009, PARASITOL RES, V105, P495, DOI 10.1007/s00436-009-1426-9
   Dietrich G, 2006, J MED ENTOMOL, V43, P957, DOI 10.1603/0022-2585(2006)43[957:RAOFCF]2.0.CO;2
   DRUMMOND RO, 1973, J ECON ENTOMOL, V66, P130, DOI 10.1093/jee/66.1.130
   FAO, 1984, TICKS TICKB DIS CONT, P621
   Graf JF, 2004, PARASITOLOGY, V129, pS427, DOI 10.1017/S0031182004006079
   Leite RC, 1988, THESIS UFMG BELO HOR, P151
   Madzimure J, 2011, TROP ANIM HEALTH PRO, V43, P481, DOI 10.1007/s11250-010-9720-1
   Martinez-Velazquez M, 2011, PARASITOL RES, V108, P481, DOI 10.1007/s00436-010-2069-6
   Mendes AD, 2011, VET PARASITOL, V183, P136, DOI 10.1016/j.vetpar.2011.07.007
   Panella NA, 2005, J MED ENTOMOL, V42, P352, DOI 10.1603/0022-2585(2005)042[0352:UONCFP]2.0.CO;2
   Panella NA, 1997, J MED ENTOMOL, V34, P340, DOI 10.1093/jmedent/34.3.340
   Pessoa ODL, 2005, FITOTERAPIA, V76, P712, DOI 10.1016/j.fitote.2005.07.004
   Scoralik MG, 2012, PARASITOL RES, V110, P645, DOI 10.1007/s00436-011-2539-5
   STONE B. F., 1962, BULL ENTOMOL RES, V53, P563
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
NR 23
TC 50
Z9 50
U1 2
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD JUL 1
PY 2013
VL 195
IS 1-2
BP 198
EP 202
DI 10.1016/j.vetpar.2012.12.046
PG 5
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA 168VR
UT WOS:000320736500029
PM 23337330
DA 2020-12-08
ER

PT J
AU Almeida, JRGD
   Souza, GR
   Silva, JC
   Saraiva, SRGD
   de Oliveira, RG
   Quintans, JDS
   Barreto, RDS
   Bonjardim, LR
   Cavalcanti, SCD
   Quintans, LJ
AF Guedes da Silva Almeida, Jackson Roberto
   Souza, Grasielly Rocha
   Silva, Juliane Cabral
   Gomes de Lima Saraiva, Sarah Raquel
   de Oliveira Junior, Raimundo Goncalves
   Siqueira Quintans, Jullyana de Souza
   Siqueira Barreto, Rosana de Souza
   Bonjardim, Leonardo Rigoldi
   de Holanda Cavalcanti, Socrates Cabral
   Quintans Junior, Lucindo Jose
TI Borneol, a Bicyclic Monoterpene Alcohol, Reduces Nociceptive Behavior
   and Inflammatory Response in Mice
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Article
ID FORMALIN TEST; MODELS
AB Borneol, a bicyclic monoterpene, has been evaluated for antinociceptive and anti-inflammatory activities. Antinociceptive and anti-inflammatory activities were studied by measuring nociception by acetic acid, formalin, hot plate, and grip strength tests, while inflammation was prompted by carrageenan-induced peritonitis. Therotarod test was used to evaluate motor coordination. Borneol produced a significant (P < 0.01) reduction of the nociceptive behavior at the early and late phases of paw licking and reduced the writhing reflex in mice (formalin and writhing tests, resp.). When the hot plate test was conducted, borneol (in higher dose) produced an inhibition (P < 0.05) of the nociceptive behavior. Such results were unlikely to be provoked by motor abnormality. Additionally, borneol-treated mice reduced the carrageenan-induced leukocytes migration to the peritoneal cavity. Together, our results suggest that borneol possess significant central and peripheral antinociceptive activity; it has also anti-inflammatory activity. In addition, borneol did not impair motor coordination.
C1 [Guedes da Silva Almeida, Jackson Roberto; Souza, Grasielly Rocha; Silva, Juliane Cabral; Gomes de Lima Saraiva, Sarah Raquel; de Oliveira Junior, Raimundo Goncalves] Univ Fed Vale Sao Francisco, Nucleo Estudos & Pesquisas Plantas Med, BR-56304205 Petrolina, PE, Brazil.
   [Siqueira Quintans, Jullyana de Souza; Siqueira Barreto, Rosana de Souza; Bonjardim, Leonardo Rigoldi; Quintans Junior, Lucindo Jose] Univ Fed Sergipe, Lab Farmacol Preclin, BR-49000100 Sao Cristovao, SE, Brazil.
   [de Holanda Cavalcanti, Socrates Cabral] Univ Fed Sergipe, Dept Farm, BR-49000100 Sao Cristovao, SE, Brazil.
RP Almeida, JRGD (corresponding author), Univ Fed Vale Sao Francisco, Nucleo Estudos & Pesquisas Plantas Med, BR-56304205 Petrolina, PE, Brazil.
EM jackson.guedes@univasf.edu.br
RI Quintans, Jullyana/P-5946-2019; Bonjardim, Leonardo R/J-3665-2013; de
   Oliveira Junior, Raimundo Goncalves/J-8633-2014; SILVA, JULIANE
   CABRAL/B-1293-2017; Quintans, Jullyana S.S./A-3917-2012; de
   Oliveira-Junior, Raimundo Goncalves/P-2805-2019; Cavalcanti,
   Socrates/AAQ-7004-2020; Almeida, Jackson/AAE-4933-2019; Almeida, Jackson
   RGS/M-2217-2013; Quintans, Lucindo/A-2434-2012; Barreto,
   Rosana/L-5004-2016
OI Quintans, Jullyana/0000-0001-6507-8982; Bonjardim, Leonardo
   R/0000-0002-0080-7678; de Oliveira Junior, Raimundo
   Goncalves/0000-0002-9458-1744; SILVA, JULIANE
   CABRAL/0000-0003-3098-1885; Quintans, Jullyana S.S./0000-0001-6507-8982;
   de Oliveira-Junior, Raimundo Goncalves/0000-0002-9458-1744; Almeida,
   Jackson/0000-0002-0867-1357; Almeida, Jackson RGS/0000-0002-0867-1357;
   Quintans, Lucindo/0000-0001-5155-938X; Barreto,
   Rosana/0000-0003-2762-4246
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/Brazil)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Apoio a Pesquisa e a Inovacao
   Tecnologica do Estado de Sergipe (FAPITEC-SE/Brazil)
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil) and the Fundacao
   de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe
   (FAPITEC-SE/Brazil).
CR Almeida JRGS, 2011, NAT PROD RES, V25, P1908, DOI 10.1080/14786419.2010.491227
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Bastos LFS, 2007, EUR J PHARMACOL, V576, P171, DOI 10.1016/j.ejphar.2007.07.049
   Bhatia SP, 2008, FOOD CHEM TOXICOL, V46, pS77, DOI 10.1016/j.fct.2008.06.031
   Chen L, 2011, J MED PLANTS RES, V5, P3440
   de Sa P. G. S., 2012, BMC COMPLEM ALTERN M, V12, P1
   EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385
   Granger RE, 2005, BIOCHEM PHARMACOL, V69, P1101, DOI 10.1016/j.bcp.2005.01.002
   Guimaraes AG, 2013, PHYTOTHER RES, V27, P1, DOI 10.1002/ptr.4686
   HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1
   Jasmin L, 2004, CNS NEUROL DISORD-DR, V3, P487, DOI 10.2174/1568007043336716
   KOSTER R, 1959, FED PROC, V18, P412
   Le Bars D, 2001, PHARMACOL REV, V53, P597
   Leite BLS, 2010, PHARM BIOL, V48, P1164, DOI 10.3109/13880200903280000
   Liu R, 2011, NEUROSCIENCE, V176, P408, DOI 10.1016/j.neuroscience.2010.11.029
   Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275
   Meyer O A, 1979, Neurobehav Toxicol, V1, P233
   Quintans LJ, 2010, AFR J BIOTECHNOL, V9, P6566
   REANMONGKOL W, 1994, BIOL PHARM BULL, V17, P1345, DOI 10.1248/bpb.17.1345
   Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x
   Santos MRV, 2011, REV BRAS FARMACOGN, V21, P764, DOI 10.1590/S0102-695X2011005000119
   SAWYNOK J, 1987, PHARMACOL BIOCHEM BE, V26, P463, DOI 10.1016/0091-3057(87)90148-1
   Shen Q, 2011, AAPS PHARMSCITECH, V12, P1044, DOI 10.1208/s12249-011-9672-4
   Silva-Filho J. C., 2011, BASIC CLIN PHARMACOL, V22, P171
   TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T
NR 25
TC 68
Z9 70
U1 0
U2 15
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2013
AR 808460
DI 10.1155/2013/808460
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 132UQ
UT WOS:000318094600001
PM 23710149
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Barbosa, JDF
   Silva, VB
   Alves, PB
   Gumina, G
   Santos, RLC
   Sousa, DP
   Cavalcanti, SCH
AF Barbosa, Juliana D. F.
   Silva, Viviane B.
   Alves, Pericles B.
   Gumina, Giuseppe
   Santos, Roseli L. C.
   Sousa, Damiao P.
   Cavalcanti, Socrates C. H.
TI Structure-activity relationships of eugenol derivatives against Aedes
   aegypti (Diptera: Culicidae) larvae
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE dengue; volatile oil; eugenol derivatives; clove; SAR; Syzygium
   aromaticum
ID CLOVE ESSENTIAL OIL; INSECTICIDAL ACTIVITIES; ANTIOXIDANT PROPERTIES;
   CHEMICAL-COMPOSITION; ANTIFUNGAL ACTIVITY; LARVICIDAL ACTIVITY;
   FRUIT-FLY; CARYOPHYLLATA; DENGUE; LEAF
AB BACKGROUND: Dengue fever is a severe public health problem for several countries. In order to find effective larvicides to aid control programs, the structure-activity relationships of eugenol derivatives against Aedes aegypti (Diptera: Culicidae) larvae were evaluated. Additionally, the composition and larvicidal activity of Syzygium aromaticum essential oil was assessed. RESULTS: Four compounds representing 99.05% of S. aromaticum essential oil have been identified. The essential oil was active against Ae. aegypti larvae (LC50 = 62.3 and 77.0 ppm, field-collected and Rockefeller larvae respectively). The larvicidal activity of eugenol, the major compound of the essential oil, was further evaluated (LC50 = 93.3 and 71.9 ppm, field-collected and Rockefeller larvae respectively). The larvicidal activity and structure-activity relationships of synthetic derivatives of eugenol were also assessed. The larvicidal activity of the derivatives varied between 62.3 and 1614.9 ppm. Oxidation of eugenol allylic bond to a primary alcohol and removal of the phenolic proton resulted in decreased potency. However, oxidation of the same double bond in 1-benzoate-2-methoxy-4-(2-propen-1-yl)-phenol resulted in increased potency. CONCLUSION: Structural characteristics were identified that may contribute to the understanding of the larvicidal activity of phenylpropanoids. The present approach may help future work in the search for larvicidal compounds. Copyright (c) 2012 Society of Chemical Industry
C1 [Barbosa, Juliana D. F.; Silva, Viviane B.; Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Dept Pharm, Med Chem Lab, BR-49100000 Sao Cristovao, SE, Brazil.
   [Alves, Pericles B.] Univ Fed Sergipe, Dept Chem, Nat Prod Lab, BR-49100000 Sao Cristovao, SE, Brazil.
   [Gumina, Giuseppe] Univ South, Sch Pharm, Dept Pharmaceut Sci, Savannah, GA USA.
   [Santos, Roseli L. C.] Univ Fed Sergipe, Dept Morphol, Parasitol Lab, BR-49100000 Sao Cristovao, SE, Brazil.
   [Sousa, Damiao P.] Univ Fed Sergipe, Dept Pharm, Nat Prod & Synthet Chem Lab, BR-49100000 Sao Cristovao, SE, Brazil.
RP Cavalcanti, SCH (corresponding author), Univ Fed Sergipe, Dept Pharm, Med Chem Lab, BR-49100000 Sao Cristovao, SE, Brazil.
EM socratescavalcanti@yahoo.com.br
RI de Sousa, Damiao Pergentino/AAY-1244-2020; de Sousa, Damiao
   Pergentino/B-2580-2018; Cavalcanti, Socrates/AAQ-7004-2020; Santos,
   Roseli LC/F-1735-2015; Alves, Pericles/S-8768-2019
OI de Sousa, Damiao Pergentino/0000-0002-7180-4896; Alves,
   Pericles/0000-0002-8955-9614
FU DECIT/SCTIE/MS; CNPqNational Council for Scientific and Technological
   Development (CNPq); SES/SE; FAPITEC-SE
FX The authors wish to acknowledge DECIT/SCTIE/MS, CNPq, SES/SE and
   FAPITEC-SE for supporting funds.
CR Adams RP, 1995, IDENTIFICATION ESSEN
   Belzile AS, 2000, PESTIC BIOCHEM PHYS, V66, P33, DOI 10.1006/pest.1999.2453
   Ben Arfa A, 2006, LETT APPL MICROBIOL, V43, P149, DOI 10.1111/j.1472-765X.2006.01938.x
   bin Jantan I, 2005, PHARM BIOL, V43, P526, DOI 10.1080/13880200500220771
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Chaieb K, 2007, MYCOSES, V50, P403, DOI 10.1111/j.1439-0507.2007.01391.x
   Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124
   Cheng SS, 2009, PEST MANAG SCI, V65, P339, DOI 10.1002/ps.1693
   Chuang YY, 2008, J ECON ENTOMOL, V101, P352, DOI 10.1603/0022-0493(2008)101[352:EOASUM]2.0.CO;2
   COOLEN HKAC, 1995, J AM CHEM SOC, V117, P11906, DOI 10.1021/ja00153a012
   Enan EE, 2005, ARCH INSECT BIOCHEM, V59, P161, DOI 10.1002/arch.20076
   Fichi G, 2007, EXP PARASITOL, V115, P168, DOI 10.1016/j.exppara.2006.07.005
   Finney D. J., 1971, PROBIT ANAL
   Hemaiswarya S, 2009, PHYTOMEDICINE, V16, P997, DOI 10.1016/j.phymed.2009.04.006
   Jirovetz L, 2006, J AGR FOOD CHEM, V54, P6303, DOI 10.1021/jf060608c
   Laurens A, 1997, PHYTOTHER RES, V11, P145, DOI 10.1002/(SICI)1099-1573(199703)11:2<145::AID-PTR40>3.0.CO;2-#
   Lomonaco D, 2009, GREEN CHEM, V11, P31, DOI 10.1039/b811504d
   Lopez O, 2005, GREEN CHEM, V7, P431, DOI 10.1039/b500733j
   Lucia A, 2009, BIORESOURCE TECHNOL, V100, P6083, DOI 10.1016/j.biortech.2009.02.075
   PEPPER JM, 1971, CAN J CHEMISTRY, V49, P3394, DOI 10.1139/v71-564
   Pinto E, 2009, J MED MICROBIOL, V58, P1454, DOI 10.1099/jmm.0.010538-0
   Sadeghian H, 2008, BIOORGAN MED CHEM, V16, P890, DOI 10.1016/j.bmc.2007.10.016
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Shattuck JC, 2001, ORG LETT, V3, P3021, DOI 10.1021/ol0164482
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Simas NK, 2004, QUIM NOVA, V27, P46, DOI 10.1590/S0100-40422004000100009
   Singhasivanon P, 2009, J CLIN VIROL, V46, pS1, DOI 10.1016/S1386-6532(09)70285-9
   Slamenova D, 2009, MUTAT RES-GEN TOX EN, V677, P46, DOI 10.1016/j.mrgentox.2009.05.016
   Tapia-Conyer R, 2009, J CLIN VIROL, V46, pS3, DOI 10.1016/S1386-6532(09)70286-0
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   VARMA RL, 1985, INDIAN J CHEM B, V24, P302
   WAGNER H, 1979, PLANTA MED, V37, P9, DOI 10.1055/s-0028-1097288
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
   World Health Organization, 2011, IMP DENG
   Yang YC, 2002, J AGR FOOD CHEM, V50, P3765, DOI 10.1021/jf011708f
NR 36
TC 43
Z9 44
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD NOV
PY 2012
VL 68
IS 11
BP 1478
EP 1483
DI 10.1002/ps.3331
PG 6
WC Agronomy; Entomology
SC Agriculture; Entomology
GA 023KP
UT WOS:000310031700008
PM 22674880
DA 2020-12-08
ER

PT J
AU Sardella, TB
   Silva, VB
   Cavalcanti, SCH
   Fernandes, PD
AF Sardella, T. B.
   Silva, V. B.
   Cavalcanti, S. C. H.
   Fernandes, P. D.
TI Evaluation of the cytotoxic effects from carvacrol and two new analogues
SO PLANTA MEDICA
LA English
DT Meeting Abstract
CT International Congress on Natural Products Research on Global Change,
   Natural Products and Human Health/8th Joint Meeting of AFERP, ASP, GA,
   PSE and SIF
CY JUL 28-AUG 01, 2012
CL New York, NY
SP Amer Soc Pharmacognosy (ASP), Soc Med Plant & Nat Prod Res (GA), Italian Soc Phytochem (SIF), Phytochem Soc Europe (PSE), French Speaking Soc Pharmacognosy (AFERP)
C1 [Sardella, T. B.; Fernandes, P. D.] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941 Rio De Janeiro, Brazil.
   [Silva, V. B.; Cavalcanti, S. C. H.] Univ Fed Sergipe, Dept Pharm, Med Chem Lab, Aracaju, Brazil.
RI Fernandes, Patricia Dias/C-4489-2013; Fernandes, Patricia/W-1565-2019;
   Cavalcanti, Socrates/AAQ-7004-2020
OI Fernandes, Patricia Dias/0000-0001-6870-6745; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0032-0943
J9 PLANTA MED
JI Planta Med.
PD AUG
PY 2012
VL 78
IS 11
BP 1073
EP 1073
PG 1
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 982KT
UT WOS:000307042800178
DA 2020-12-08
ER

PT J
AU Guimaraes, AG
   Xavier, MA
   de Santana, MT
   Camargo, EA
   Santos, CA
   Brito, FA
   Barreto, EO
   Cavalcanti, SCH
   Antoniolli, AR
   Oliveira, RCM
   Quintans, LJ
AF Guimaraes, Adriana G.
   Xavier, Maria A.
   de Santana, Marilia T.
   Camargo, Enilton A.
   Santos, Cliomar A.
   Brito, Fabiola A.
   Barreto, Emiliano O.
   Cavalcanti, Socrates C. H.
   Antoniolli, Angelo R.
   Oliveira, Rita C. M.
   Quintans-Junior, Lucindo J.
TI Carvacrol attenuates mechanical hypernociception and inflammatory
   response
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Article
DE Monoterpene; Carvacrol; Mechanical hypernociception; Inflammation;
   TNF-alpha
ID BIOASSAY-GUIDED EVALUATION; MOUSE PAW EDEMA; NITRIC-OXIDE; MICE
   INVOLVEMENT; CARRAGEENAN; (-)-LINALOOL; HYPERALGESIA; THYMOL; SYSTEM;
   PAIN
AB Carvacrol is a phenolic monoterpene present in the essential oil of the family Lamiaceae, as in the genera Origanum and Thymus. We previously reported that carvacrol is effective as an analgesic compound in various nociceptive models, probably by inhibition of peripheral mediators that could be related with its strong antioxidant effect observed in vitro. In this study, the anti-hypernociceptive activity of carvacrol was tested in mice through models of mechanical hypernociception induced by carrageenan, and the involvement of important mediators of its signaling cascade, as tumor necrosis factor-alpha (TNF-alpha), prostaglandin E-2 (PGE(2)), and dopamine, were assessed. We also investigated the anti-inflammatory effect of carvacrol on the model of carrageenan-induced pleurisy and mouse paw edema, and the lipopolysaccharide (LPS)-induced nitrite production in murine macrophages was observed. Systemic pretreatment with carvacrol (50 or 100 mg/kg; i.p.) inhibited the development of mechanical hypernociception and edema induced by carrageenan and TNF-alpha; however, no effect was observed on hypernociception induced by PGE(2) and dopamine. Besides this, carvacrol significantly decreased TNF-alpha levels in pleural lavage and suppressed the recruitment of leukocytes without altering the morphological profile of these cells. Carvacrol (1, 10, and 100 mu g/mL) also significantly reduced (p < 0.001) the LPS-induced nitrite production in vitro and did not produce citotoxicity in the murine peritoneal macrophages in vitro. The spontaneous locomotor activity of mice was not affected by carvacrol. This study adds information about the beneficial effects of carvacrol on mechanical hypernociception and inflammation. It also indicates that this monoterpene might be potentially interesting in the development of novel tools for management and/or treatment of painful conditions, including those related to inflammatory and prooxidant states.
C1 [Quintans-Junior, Lucindo J.] Univ Fed Sergipe UFS, Dept Fisiol, Sao Cristovao, Sergipe, Brazil.
   [Guimaraes, Adriana G.; Xavier, Maria A.; de Santana, Marilia T.; Camargo, Enilton A.; Santos, Cliomar A.; Cavalcanti, Socrates C. H.; Antoniolli, Angelo R.; Quintans-Junior, Lucindo J.] Univ Fed Sergipe LAPEC DFS UFS, Dept Fisiol, Lab Farmacol Preclin, Sao Cristovao, Sergipe, Brazil.
   [Brito, Fabiola A.; Barreto, Emiliano O.] Univ Fed Alagoas UFAL, Lab Biol Celular Nucleo Pesquisa Multidisciplinar, Maceio, Alagoas, Brazil.
   Univ Fed Piaui, Teresina, Piaui, Brazil.
RP Quintans, LJ (corresponding author), Univ Fed Sergipe UFS, Dept Fisiol, Av Marechal Rondom S-N, Sao Cristovao, Sergipe, Brazil.
EM lucindo_jr@yahoo.com.br
RI Barreto, Emiliano/J-2109-2012; Quintans, Lucindo/A-2434-2012; Guimaraes,
   Adriana G/G-6860-2014; Camargo, Enilton A/D-6520-2017; Barreto,
   Emiliano/T-3671-2019; Antoniolli, Angelo/B-5741-2015; de Cassia Meneses
   Oliveira, Rita/AAD-3141-2020; Cavalcanti, Socrates/AAQ-7004-2020
OI Barreto, Emiliano/0000-0002-4956-5075; Quintans,
   Lucindo/0000-0001-5155-938X; Guimaraes, Adriana G/0000-0003-1643-5642;
   Camargo, Enilton A/0000-0003-2745-0768; Barreto,
   Emiliano/0000-0002-4956-5075; 
FU National Council of Technological and Scientific Development (Conselho
   Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPq/Brazil)National Council for Scientific and
   Technological Development (CNPq) [305783/2010-6]; Research Supporting
   Foundation of State of Sergipe (Fundacao de Apoio a Pesquisa e a
   Inovacao Tecnologica do Estado de Sergipe/FAPITEC-SE)
   [019.203.00860/2009-6]
FX We thank Mr. Osvaldo Andrade Santos for the technical support. This work
   was supported by grants from the National Council of Technological and
   Scientific Development (Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico/CNPq/Brazil) (grant number 305783/2010-6) and the Research
   Supporting Foundation of State of Sergipe (Fundacao de Apoio a Pesquisa
   e a Inovacao Tecnologica do Estado de Sergipe/FAPITEC-SE) (grant number
   019.203.00860/2009-6).
CR ASAKURA W, 1993, PHARMACOL BIOCHEM BE, V46, P111, DOI 10.1016/0091-3057(93)90325-N
   Baser KHC, 2008, CURR PHARM DESIGN, V14, P3106, DOI 10.2174/138161208786404227
   Batista PA, 2010, J PAIN, V11, P1222, DOI 10.1016/j.jpain.2010.02.022
   Ben Arfa A, 2006, LETT APPL MICROBIOL, V43, P149, DOI 10.1111/j.1472-765X.2006.01938.x
   Berliocchi L, 2009, INT REV NEUROBIOL, V85, P221, DOI 10.1016/S0074-7742(09)85017-4
   Botelho MA, 2009, PHYTOTHER RES, V23, P1439, DOI 10.1002/ptr.2798
   Melo FHC, 2011, FUND CLIN PHARMACOL, V25, P362, DOI 10.1111/j.1472-8206.2010.00850.x
   Melo FHC, 2010, FUND CLIN PHARMACOL, V24, P437, DOI 10.1111/j.1472-8206.2009.00788.x
   Conti P, 1988, Scand J Rheumatol Suppl, V75, P318
   CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x
   Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018
   Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102
   de Sousa DP, 2006, BIOL PHARM BULL, V29, P811, DOI 10.1248/bpb.29.811
   DRAY A, 1995, BRIT J ANAESTH, V75, P125, DOI 10.1093/bja/75.2.125
   FERREIRA SH, 1979, PROSTAGLANDINS, V18, P179, DOI 10.1016/0090-6980(79)90103-5
   FERREIRA SH, 1978, PROSTAGLANDINS, V16, P31, DOI 10.1016/0090-6980(78)90199-5
   FERREIRA SH, 1993, BRIT J PHARMACOL, V110, P1227, DOI 10.1111/j.1476-5381.1993.tb13946.x
   Ferreira SH, 1990, MIGRAINE SPECTRUM ID, P136
   Feucht CL, 2010, PEDIATR CLIN N AM, V57, P751, DOI 10.1016/j.pcl.2010.02.004
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Guimaraes AG, 2010, BASIC CLIN PHARMACOL, V107, P949, DOI 10.1111/j.1742-7843.2010.00609.x
   Haddad JJ, 2007, EXCLI J, V6, P68
   HENRIQUES MGMO, 1987, BRAZ J MED BIOL RES, V20, P243
   Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200
   Ipek E, 2005, FOOD CHEM, V93, P551, DOI 10.1016/j.foodchem.2004.12.034
   Ipek E, 2003, CYTOTECHNOLOGY, V43, P145, DOI 10.1023/B: CYTO.0000039896.26707.40
   Jukic M, 2007, PHYTOTHER RES, V21, P259, DOI 10.1002/ptr.2063
   Karkabounas S., 2006, Experimental Oncology, V28, P121
   Kasama Tsuyoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P273, DOI 10.2174/1568010054022114
   Koparal AT, 2005, CYTOTECNOLOGY, V43, P149
   Lee SP, 2008, BRIT J PHARMACOL, V153, P1739, DOI 10.1038/bjp.2008.85
   LEVY L, 1969, LIFE SCI PT 1 PHYSI, V8, P601, DOI 10.1016/0024-3205(69)90021-6
   Luo ZD, 2004, METH MOLEC MED, P1
   Lyons CR, 1995, ADV IMMUNOL, V60, P323, DOI 10.1016/S0065-2776(08)60589-1
   Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700
   MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8
   Melo MS, 2010, PHARM BIOL, V48, P411, DOI 10.3109/13880200903150419
   Melo MS, 2011, REV BRAS FARMACOGN, V21, P697, DOI 10.1590/S0102-695X2011005000124
   Miller MJS, 1995, MEDIAT INFLAMM, V4, P387, DOI 10.1155/S0962935195000639
   Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Neves LA, 2008, J ESSENT OIL RES, V20, P157
   Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009
   Passos CS, 2009, REV BRAS FARMACOGN, V19, P140, DOI 10.1590/S0102-695X2009000100024
   Peana AT, 2004, EUR J PHARMACOL, V497, P279, DOI 10.1016/j.ejphar.2004.06.006
   Peana AT, 2002, PHYTOMEDICINE, V9, P721, DOI 10.1078/094471102321621322
   de Sousa DP, 2006, NEUROSCI LETT, V401, P231, DOI 10.1016/j.neulet.2006.03.030
   Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40
   Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650
   Quintans LJ, 2010, AFR J BIOTECHNOL, V9, P6566
   Quintao NLM, 2010, PLANTA MED, V76, P1411, DOI 10.1055/s-0029-1240891
   Sachs D, 2009, BRIT J PHARMACOL, V156, P826, DOI 10.1111/j.1476-5381.2008.00093.x
   Sosa S, 2005, PHYTOMEDICINE, V12, P271, DOI 10.1016/j.phymed.2004.02.007
   Tao F, 2004, NEUROSCIENCE, V128, P421, DOI 10.1016/j.neuroscience.2004.06.038
   Villarreal CF, 2009, LIFE SCI, V85, P822, DOI 10.1016/j.lfs.2009.10.018
   WAGNER H, 1986, PLANTA MED, P184, DOI 10.1055/s-2007-969117
   Woolf CJ, 1997, BRIT J PHARMACOL, V121, P417, DOI 10.1038/sj.bjp.0701148
   Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692
   Yang Eun-Jin, 2009, Interdiscip Toxicol, V2, P245, DOI 10.2478/v10102-009-0022-2
   Yanishlieva NV, 1999, FOOD CHEM, V64, P59, DOI 10.1016/S0308-8146(98)00086-7
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
NR 61
TC 89
Z9 93
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD MAR
PY 2012
VL 385
IS 3
BP 253
EP 263
DI 10.1007/s00210-011-0715-x
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 895UJ
UT WOS:000300521800003
PM 22139435
DA 2020-12-08
ER

PT J
AU Lima, GM
   Quintans, LJ
   Thomazzi, SM
   Almeida, EMSA
   Melo, MS
   Serafini, MR
   Cavalcanti, SCH
   Gelain, DP
   Santos, JPA
   Blank, AF
   Alves, PB
   Neta, PMO
   Lima, JT
   Rocha, RF
   Moreira, JCF
   Araujo, AAS
AF Lima, Gabrielle M.
   Quintans-Junior, Lucindo J.
   Thomazzi, Sara M.
   Almeida, Emyle M. S. A.
   Melo, Monica S.
   Serafini, Mairim R.
   Cavalcanti, Socrates C. H.
   Gelain, Daniel P.
   Santos, Joao Paulo A.
   Blank, Arie F.
   Alves, Pericles B.
   Oliveira Neta, Paulina M.
   Lima, Julianeli T.
   Rocha, Ricardo F.
   Moreira, Jose Claudio F.
   Araujo, Adriano A. S.
TI Phytochemical screening, antinociceptive and anti-inflammatory
   activities of Chrysopogon zizanioides essential oil
SO REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
LA English
DT Article
DE anti-inflammatory effect; antinociceptive effect; Chrysopogon
   zizanioides; essential oil; phytochemical screening; vetiver
ID HAITIAN VETIVER OIL; LEAF ESSENTIAL OIL; FORMALIN TEST; L. NASH;
   CONSTITUENTS; CARRAGEENIN; EXTRACTS; MICE; PLANTS; EDEMA
AB Chrysopogon zizanioides (L.) Roberty, Poaceae, is a plant widely used in northeast Brazil in folk medicine for the treatment of various pathological conditions, including inflammatory pain. The present study evaluated the antinociceptive and anti-inflammatory effects of C. zizanioides essential oil (EO) in rodents. EO was further characterized by GC/MS. The major components of EO were identified as khusimol (19.57%), E-isovalencenol (13.24%), alpha-vetivone (5.25%), beta-vetivone (4.87%) and hydroxy-valencene (4.64%). Following intraperitoneal injection (i.p.), EO at 50 and 100 mg/kg significantly reduced the number of writhes (51.9 and 64.9%, respectively) and the number of paw licks during phase 2 (56.7 and 86.2%, respectively) of a formalin model when compared to control group animals. However, EO-treated mice were ineffective at all doses in hot-plate and rota-rod tests. The EO inhibited the carrageenan-induced leukocyte migration to the peritoneal cavity in a dose-dependent manner (34.7, 35.4, and 62.5% at doses of 25, 50 and 100 mg/kg, respectively). In the paw edema test, the EO (100 mg/kg) inhibited all three phases of the edema equally well, suggesting that the EO has a non-selective inhibitory effect on the release or actions of these mediators. Our results suggest possible antinociceptive and anti-inflammatory effects of the EO.
C1 [Araujo, Adriano A. S.] Univ Fed Sergipe, Dept Fisiol, Curso Farm, BR-49100000 Sao Cristovao, SE, Brazil.
   [Blank, Arie F.] Univ Fed Sergipe, Dept Agron, BR-49100000 Sao Cristovao, SE, Brazil.
   [Alves, Pericles B.; Oliveira Neta, Paulina M.] Univ Fed Sergipe, Dept Quim, BR-49100000 Sao Cristovao, SE, Brazil.
   [Lima, Julianeli T.] Univ Fed Vale Sao Francisco, Dept Ciencias Farmaceut, Sao Francisco, Brazil.
   [Gelain, Daniel P.; Santos, Joao Paulo A.; Rocha, Ricardo F.; Moreira, Jose Claudio F.; Araujo, Adriano A. S.] Univ Fed Rio Grande do Sul, Dept Bioquim, BR-90046900 Porto Alegre, RS, Brazil.
RP Araujo, AAS (corresponding author), Univ Fed Sergipe, Dept Fisiol, Curso Farm, Av Marechal Rondon Sn, BR-49100000 Sao Cristovao, SE, Brazil.
EM adriano.antunes@pq.cnpq.br
RI Serafini, Mairim R Russo/B-6003-2015; Rocha, Ricardo/C-3267-2013;
   Quintans, Lucindo/A-2434-2012; Almeida dos Santos, Joao
   Paulo/P-6741-2014; Gelain, Daniel Pens/I-5144-2013; Serafini, Mairim
   Russo/X-3034-2019; Thomazzi, Sara M/M-3297-2013; Cavalcanti,
   Socrates/AAQ-7004-2020; Alves, Pericles/S-8768-2019; Santos, Joao Paulo
   Almeida dos/U-3333-2019
OI Serafini, Mairim R Russo/0000-0003-4223-3470; Quintans,
   Lucindo/0000-0001-5155-938X; Gelain, Daniel Pens/0000-0001-5254-0509;
   Serafini, Mairim Russo/0000-0003-4223-3470; Thomazzi, Sara
   M/0000-0003-0348-0401; Alves, Pericles/0000-0002-8955-9614; Santos, Joao
   Paulo Almeida dos/0000-0001-5440-6821
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/Brazil)National Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sergipe
FX We thank Mr Rangel R. Bonfim for the technical support. This work was
   supported by grants from Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico/Brazil) and the Fundacao de Amparo a Pesquisa do Estado de
   Sergipe.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Adams RP, 2008, BIOCHEM SYST ECOL, V36, P177, DOI 10.1016/j.bse.2007.10.004
   Adams RP, 1998, MOL ECOL, V7, P813, DOI 10.1046/j.1365-294x.1998.00394.x
   Almeida RN, 2001, PHYTOMEDICINE, V8, P310, DOI 10.1078/0944-7113-00050
   Bastos LFS, 2007, EUR J PHARMACOL, V576, P171, DOI 10.1016/j.ejphar.2007.07.049
   BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462
   Carter Gregory T, 2002, Curr Opin Investig Drugs, V3, P454
   DIROSA M, 1968, EUR J PHARMACOL, V4, P340, DOI 10.1016/0014-2999(68)90103-9
   DRAPER HH, 1990, METHOD ENZYMOL, V186, P421
   EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385
   Elisabetsky E., 1995, Fitoterapia, V66, P407
   Fischer LG, 2008, BIOL PHARM BULL, V31, P235, DOI 10.1248/bpb.31.235
   Gomes PB, 2005, BIOL PHARM BULL, V28, P42, DOI 10.1248/bpb.28.42
   Gulluce M, 2003, J AGR FOOD CHEM, V51, P3958, DOI 10.1021/jf0340308
   Hammer KA, 1999, J APPL MICROBIOL, V86, P985, DOI 10.1046/j.1365-2672.1999.00780.x
   HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5
   HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1
   Kim HJ, 2005, J AGR FOOD CHEM, V53, P7691, DOI 10.1021/jf050833e
   KOSTER R, 1959, FED PROC, V18, P412
   Lima GM, 2010, THESIS U FEDERAL SER, P80
   Maistrello L, 2001, J ECON ENTOMOL, V94, P1532, DOI 10.1603/0022-0493-94.6.1532
   Martinez J, 2004, J AGR FOOD CHEM, V52, P6578, DOI 10.1021/jf049182x
   Massardo DR, 2006, BIOCHEM SYST ECOL, V34, P376, DOI 10.1016/j.bse.2005.10.016
   NIGAM IC, 1968, J PHARM SCI, V57, P1029, DOI 10.1002/jps.2600570626
   Oliveira JS, 2009, B LATINOAM CARIBE PL, V8, P195
   PAYA M, 1992, BIOCHEM PHARMACOL, V44, P205, DOI 10.1016/0006-2952(92)90002-Z
   Quintans LJ, 2008, PHYTOMEDICINE, V15, P619, DOI 10.1016/j.phymed.2007.09.018
   Goncalves JCR, 2008, BIOL PHARM BULL, V31, P1017, DOI 10.1248/bpb.31.1017
   REANMONGKOL W, 1994, BIOL PHARM BULL, V17, P1345, DOI 10.1248/bpb.17.1345
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   Veldkamp J. F., 1999, Austrobaileya, V5, P503
   VINEGAR R, 1969, J PHARMACOL EXP THER, V166, P96
   WEI ET, 1986, J PHARMACOL EXP THER, V238, P783
   Weyerstahl P, 2000, FLAVOUR FRAG J, V15, P153, DOI 10.1002/1099-1026(200005/06)15:3&lt;153::AID-FFJ885&gt;3.0.CO;2-5
   Weyerstahl P, 2000, FLAVOUR FRAG J, V15, P395, DOI 10.1002/1099-1026(200011/12)15:6&lt;395::AID-FFJ930&gt;3.0.CO;2-9
   WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544
NR 36
TC 5
Z9 5
U1 0
U2 17
PU SOC BRASILEIRA FARMACOGNOSIA
PI CURITIBA-PR
PA C/O PROF CID AIMBIRE DE MORAES SANTOS, UFPR-LAB FARM, RUA PREF LOTHARIO
   MEISSNER, 632-JD BOTANICO, CURITIBA-PR, 80210-170, BRAZIL
SN 0102-695X
J9 REV BRAS FARMACOGN
JI Rev. Bras. Farmacogn.-Braz. J. Pharmacogn.
PD MAR-APR
PY 2012
VL 22
IS 2
BP 443
EP 450
DI 10.1590/S0102-695X2012005000002
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 884XM
UT WOS:000299742200027
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Silva-Filho, JC
   Oliveira, NNPM
   Arcanjo, DDR
   Quintans, LJ
   Cavalcanti, SCH
   Santos, MRV
   Oliveira, RDCM
   Oliveira, AP
AF Silva-Filho, Jose Couras
   Oliveira, Nelma Neylanne P. M.
   Arcanjo, Daniel D. R.
   Quintans-Junior, Lucindo J.
   Cavalcanti, Socrates C. H.
   Santos, Marcio Roberto V.
   Oliveira, Rita de Cassia M.
   Oliveira, Aldeidia P.
TI Investigation of Mechanisms Involved in (-)-Borneol-Induced Vasorelaxant
   Response on Rat Thoracic Aorta
SO BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
LA English
DT Article
ID SMOOTH-MUSCLE; ESSENTIAL OIL; ANTIMICROBIAL ACTIVITY;
   CHEMICAL-COMPOSITION; CHANNEL; RELAXATION; POTASSIUM; BORNEOL; CA2+;
   ANTIOXIDANT
AB The monoterpene (-)-borneol is present in essential oils of several medicinal plants. The aim of this study was to evaluate (-)-borneol effects on rat thoracic aorta artery rings. The cumulative addition of (-)-borneol (10(-9)-3 x 10(-4) M) on a phenylephrine-induced pre-contraction (10(-6) M) promoted a vasorelaxant effect in a concentration-dependent manner and independent of vascular endothelium. A similar effect was obtained on KCl-induced pre-contractions (80 mM). (-)-Borneol (10(-5)-3 x 10(-4) M) inhibited contractions induced by cumulative addition of CaCl2 (10(-6)-3 x 10(-2) M) in depolarizing medium without Ca2+ in a concentration-dependent manner. On S-(-) Bay K 8644-induced pre-contractions (10(-7) M), (-)-borneol did not induce significant changes compared with KCl-induced pre-contractions. In a Ca2+-free medium, (-)-borneol (10(-5), 10(-4) or 10(-3) M) interfered in calcium mobilization from phenylephrine (10(-6) M)-or caffeine (20 mM)-sensitive intracellular stores. The involvement of K+ channels was evaluated by tetraethylammonium (3 mM), 4-aminopyridine (1 mM) and glibenclamide (10(-5) M) pre-treatment, and (-)-borneol-induced vasorelaxation was markedly attenuated. Thus, this vasorelaxant effect can probably be attributed to calcium influx blockade through voltage-operated calcium channels (CavL), calcium mobilization from intracellular stores and potassium channels activation.
C1 [Silva-Filho, Jose Couras; Oliveira, Nelma Neylanne P. M.; Arcanjo, Daniel D. R.; Oliveira, Rita de Cassia M.; Oliveira, Aldeidia P.] Univ Fed Piaui, Med Plants Res Ctr, BR-64049550 Teresina, PI, Brazil.
   [Quintans-Junior, Lucindo J.; Cavalcanti, Socrates C. H.; Santos, Marcio Roberto V.] Univ Fed Sergipe, Dept Physiol, Sao Cristovao, SE, Brazil.
RP Oliveira, RDCM (corresponding author), Univ Fed Piaui, Med Plants Res Ctr, SG 15, BR-64049550 Teresina, PI, Brazil.
EM menesesoliveira@gmail.com
RI Arcanjo, Daniel Dias Rufino/D-8851-2012; SANTOS, MARCIO/U-2200-2019;
   Cavalcanti, Socrates/AAQ-7004-2020; de Cassia Meneses Oliveira,
   Rita/AAD-3141-2020; Quintans, Lucindo/A-2434-2012
OI Arcanjo, Daniel Dias Rufino/0000-0001-7021-2744; Quintans,
   Lucindo/0000-0001-5155-938X; Oliveira, Aldeidia/0000-0003-3286-4295
FU UFPI (Federal University of Piaui, Brazil); CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior, Brazil)CAPES; FAPEPI
   (Fundacao de Amparo a Pesquisa do Estado do Piaui, Brazil); CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq)
FX This work was supported by UFPI (Federal University of Piaui, Brazil),
   CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior,
   Brazil), FAPEPI (Fundacao de Amparo a Pesquisa do Estado do Piaui,
   Brazil) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico). Additionally, there are no conflicts of interest
   associated with this study.
CR Adaramoye OA, 2009, J ETHNOPHARMACOL, V124, P457, DOI 10.1016/j.jep.2009.05.021
   Ajay M, 2006, CLIN EXP PHARMACOL P, V33, P345, DOI 10.1111/j.1440-1681.2006.04373.x
   ALTURA BM, 1970, AM J PHYSIOL, V219, P1698
   ASANO M, 1987, J PHARMACOL EXP THER, V243, P646
   Barrus MT, 1996, J AUTON PHARMACOL, V16, P161
   Bastos JFA, 2010, BASIC CLIN PHARMACOL, V106, P331, DOI 10.1111/j.1742-7843.2009.00492.x
   Berg T, 2002, EUR J PHARMACOL, V452, P325, DOI 10.1016/S0014-2999(02)02306-3
   Brochet DXP, 2006, PLUFGERS ARCH, V535, P243
   Cai Z, 2008, J DRUG TARGET, V16, P178, DOI [10.1080/10611860701794395, 10.1080/10611860701794395 ]
   Candan F, 2003, J ETHNOPHARMACOL, V87, P215, DOI 10.1016/S0378-8741(03)00149-1
   Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5
   Chan WK, 2000, CARDIOVASC RES, V46, P180, DOI 10.1016/S0008-6363(99)00423-X
   Chen GP, 2009, LIFE SCI, V84, P81, DOI 10.1016/j.lfs.2008.11.003
   Cribbs LL, 2006, CELL CALCIUM, V40, P221, DOI 10.1016/j.ceca.2006.04.026
   Dai JP, 2009, J ORAL PATHOL MED, V38, P276, DOI 10.1111/j.1600-0714.2008.00738.x
   EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0
   Granger RE, 2005, BIOCHEM PHARMACOL, V69, P1101, DOI 10.1016/j.bcp.2005.01.002
   Guan WQ, 2006, NAT PROD RES, V20, P992, DOI 10.1080/14786410600921599
   Guedes DN, 2004, BRAZ J MED BIOL RES, V37, P1881, DOI 10.1590/S0100-879X2004001200014
   Horvathova E, 2009, FOOD CHEM TOXICOL, V47, P1318, DOI 10.1016/j.fct.2009.03.002
   Hu L.M., 2006, J TOXICOL, V20, P275
   Ibrahim B, 1998, BIOELECTROCH BIOENER, V45, P131, DOI 10.1016/S0302-4598(97)00105-0
   Iida S, 2001, EUR J PHARMACOL, V411, P155, DOI 10.1016/S0014-2999(00)00892-X
   Jackson WF, 2000, HYPERTENSION, V35, P173, DOI 10.1161/01.HYP.35.1.173
   Jackson WF, 2005, MICROCIRCULATION, V12, P113, DOI 10.1080/10739680590896072
   Juhas S, 2008, FOLIA BIOL-PRAGUE, V54, P1
   Knobloch K., 1989, Journal of Essential Oil Research, V1, P119
   Kordali S, 2005, J AGR FOOD CHEM, V53, P9452, DOI 10.1021/jf0516538
   Kumar M.S., 2010, INT J PHARM BIOL ARC, V1, P271
   Lahlou S, 2001, PLANTA MED, V67, P638, DOI 10.1055/s-2001-17352
   Li YH, 2008, AM J CHINESE MED, V36, P719, DOI 10.1142/S0192415X08006181
   McGeown JG, 2004, CELL CALCIUM, V35, P613, DOI 10.1016/j.ceca.2004.01.016
   Peixoto-Neves D, 2010, FUND CLIN PHARMACOL, V24, P341, DOI 10.1111/j.1472-8206.2009.00768.x
   de Oliveira AP, 2006, VASC PHARMACOL, V44, P338, DOI 10.1016/j.vph.2006.01.009
   Ravid Uzi, 1996, Flavour and Fragrance Journal, V11, P191, DOI 10.1002/(SICI)1099-1026(199605)11:3&lt;191::AID-FFJ568&gt;3.0.CO;2-M
   Ribeiro Luciano A. A., 2007, Rev. bras. farmacogn., V17, P197, DOI 10.1590/S0102-695X2007000200011
   Rocha ML, 2009, VASC PHARMACOL, V50, P98, DOI 10.1016/j.vph.2008.11.004
   Sakata K, 1991, BRIT J PHARMACOL, V102, P147
   Sei Y, 2001, CELL CALCIUM, V29, P149, DOI 10.1054/ceca.2000.0175
   Sobey CG, 2001, ARTERIOSCL THROM VAS, V21, P28, DOI 10.1161/01.ATV.21.1.28
   Standen NB, 1998, ACTA PHYSIOL SCAND, V164, P549
   SVOBODA KP, 1999, SPECIALITY CHEM 21 C, P1
   Tabanca N, 2001, J AGR FOOD CHEM, V49, P4300, DOI 10.1021/jf0105034
   Tabanca N, 2006, J AGR FOOD CHEM, V54, P6593, DOI 10.1021/jf0608773
   Wang G, 2006, MED SCI MONITOR, V12, P1
   Xiao-Fei J, 2008, WORLD SCI TECHNOL, V10, P27
   Zwenger S., 2008, Biotechnology and Molecular Biology Reviews, V3, P001
NR 47
TC 18
Z9 18
U1 3
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-7835
EI 1742-7843
J9 BASIC CLIN PHARMACOL
JI Basic Clin. Pharmacol. Toxicol.
PD FEB
PY 2012
VL 110
IS 2
BP 171
EP 177
DI 10.1111/j.1742-7843.2011.00784.x
PG 7
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 907RD
UT WOS:000301434200009
PM 21883938
OA Bronze
DA 2020-12-08
ER

PT J
AU Silva, DM
   Costa, EV
   Nogueira, PCD
   Moraes, VRD
   Cavalcanti, SCD
   Salvador, MJ
   Ribeiro, LHG
   Gadelha, FR
   Barison, A
   Ferreira, AG
AF Silva, Dayanne Meneses
   Costa, Emmanoel Vilaca
   de Lima Nogueira, Paulo Cesar
   de Souza Moraes, Valeria Regina
   de Holanda Cavalcanti, Socrates Cabral
   Salvador, Marcos Jose
   Gonzaga Ribeiro, Luis Henrique
   Gadelha, Fernanda Ramos
   Barison, Andersson
   Ferreira, Antonio Gilberto
TI ent-KAURANE DITERPENOIDS AND OTHER CONSTITUENTS FROM THE STEM OF Xylopia
   laevigata (Annonaceae)
SO QUIMICA NOVA
LA English
DT Article
DE Xylopia laevigata; ent-kaurane-diterpenes; larvicidal and antifungal
   properties
ID ACID; ANTIOXIDANT; OILS
AB Phytochemical investigation of the hexane extract from the stem of Xylopia laevigata led to the isolation of the ent-kaurane diterpenoids, ent-kaur-16-en-19-oic acid, 4-epi-kaurenic acid, ent-16 beta-hydroxy-17-acetoxy-kauran-19-al,ent-3 beta-hydroxy-kaur-16-en-19-oic acid, and ent-16 beta,17-dihydroxy-kauran-19-oic acid, as well as spathulenol and a mixture of beta-sitosterol, stigmasterol and campesterol. The identification of the compounds was performed on the basis of spectrometric methods including GC-MS, IR, and 1D and 2D NMR. Potent larvicidal activity against Aedes aegypti larvae with LC50 of 62.7 mu g mL(-1) was found for ent-3 beta-hydroxykaur-16-en-19-oic acid. This compound also showed significant antifungal activity against Candida glabrata and Candida dubliniensis with MIC values of 62.5 mg mL(-1).
C1 [Silva, Dayanne Meneses; Costa, Emmanoel Vilaca; de Lima Nogueira, Paulo Cesar; de Souza Moraes, Valeria Regina] Univ Fed Sergipe, Dept Quim, BR-49100000 Sao Cristovao, SE, Brazil.
   [de Holanda Cavalcanti, Socrates Cabral] Univ Fed Sergipe, Dept Farm, BR-49100000 Sao Cristovao, SE, Brazil.
   [Salvador, Marcos Jose] Univ Estadual Campinas, Inst Biol, Dept Biol Vegetal, Curso Farm, BR-13083970 Campinas, SP, Brazil.
   [Gonzaga Ribeiro, Luis Henrique; Gadelha, Fernanda Ramos] Univ Estadual Campinas, Inst Biol, Dept Bioquim, BR-13083970 Campinas, SP, Brazil.
   [Barison, Andersson] Univ Fed Parana, Dept Quim, BR-81531990 Curitiba, Parana, Brazil.
   [Ferreira, Antonio Gilberto] Univ Fed Sao Carlos, Dept Quim, BR-13565905 Sao Carlos, SP, Brazil.
RP Silva, DM (corresponding author), Univ Fed Sergipe, Dept Quim, Av Mal Rondon S-N, BR-49100000 Sao Cristovao, SE, Brazil.
EM emmanoelvc@gmail.com
RI Barison, Andersson/F-7134-2012; de Lima Nogueira, Paulo
   Cesar/R-2346-2019; Cavalcanti, Socrates/AAQ-7004-2020; Salvador,
   Marcos/V-3129-2019; Ferreira, Antonio Gilberto/D-8254-2013; Moraes,
   Valeria/AAH-3449-2020
OI Barison, Andersson/0000-0001-9381-8239; de Lima Nogueira, Paulo
   Cesar/0000-0003-0832-1047; Salvador, Marcos/0000-0002-3839-5445;
   Ferreira, Antonio Gilberto/0000-0003-2314-216X; Regina de Souza Moraes,
   Valeria/0000-0003-3463-4960; Costa, Emmanoel/0000-0002-0153-822X
FU FAPITEC/SE [07/2009, 10/2009]; CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP)
FX The authors are grateful to FAPITEC/SE (Editais No 07/2009 and 10/2009),
   CNPq, CAPES and FAPESP for financial support, and Prof. Dr. A. P. do N.
   Prata of the DBI/UFS for the botanical identification.
CR ALVES TMA, 1995, PLANTA MED, V61, P85, DOI 10.1055/s-2006-958011
   Barrero AF, 1999, PHYTOCHEMISTRY, V50, P1133, DOI 10.1016/S0031-9422(98)00699-2
   CASTELLANI O, 1967, J PROTOZOOL, V14, P447, DOI 10.1111/j.1550-7408.1967.tb02024.x
   Castello-Branco MVS, 2011, REV BRAS FARMACOGN, V21, P1035, DOI 10.1590/S0102-695X2011005000135
   Chen CY, 1997, J CHIN CHEM SOC-TAIP, V44, P313, DOI 10.1002/jccs.199700047
   Correa M. P., 1984, J AGR FOOD CHEM
   Costa EV, 2011, J BRAZIL CHEM SOC, V22, P1111, DOI 10.1590/S0103-50532011000600016
   Costa EV, 2011, NAT PROD COMMUN, V6, P907
   da Silva MS, 2009, QUIM NOVA, V32, P1566, DOI 10.1590/S0100-40422009000600040
   FINNEY DJ, 1948, BIOMETRIKA, V35, P191, DOI 10.1093/biomet/35.1-2.191
   Izumi E, 2011, NAT PROD REP, V28, P809, DOI 10.1039/c0np00069h
   LEBOEUF M, 1982, PHYTOCHEMISTRY, V21, P2783, DOI 10.1016/0031-9422(80)85046-1
   Li C, 2009, J NAT PROD, V72, P1949, DOI 10.1021/np900572g
   Lopez R, 2009, PARASITE IMMUNOL, V31, P623, DOI 10.1111/j.1365-3024.2009.01134.x
   Lunnon M.W., 1977, J CHEM SOC P1, V20, P2308
   Maas P., 2001, RODRIGUESIA, V52, P61
   Maas PJM, 2011, NORD J BOT, V29, P257, DOI 10.1111/j.1756-1051.2011.01092.x
   MAAS PJM, 2007, RODRIGUESIA, V58, P617
   Maia JGS, 2005, FLAVOUR FRAG J, V20, P474, DOI 10.1002/ffj.1499
   Moreira IC, 2003, J BRAZIL CHEM SOC, V14, P828, DOI 10.1590/S0103-50532003000500020
   Nguemtchouin MMG, 2010, CROP PROT, V29, P985, DOI 10.1016/j.cropro.2010.06.007
   Nishiyama Y, 2010, J NAT MED-TOKYO, V64, P9, DOI 10.1007/s11418-009-0356-2
   Silva Ana Elisa Pereira, 2008, Acta Amaz., V38, P733, DOI 10.1590/S0044-59672008000400017
   Pontes Aline Fernandes, 2004, Acta Bot. Bras., V18, P281, DOI 10.1590/S0102-33062004000200008
   Pontes Wendel José Teles, 2007, Quím. Nova, V30, P838, DOI 10.1590/S0100-40422007000400015
   Puvanendran S, 2008, PHARM BIOL, V46, P352, DOI 10.1080/13880200801887989
   Ragasa CY, 2003, CHEM PHARM BULL, V51, P1208, DOI 10.1248/cpb.51.1208
   Rezende MC, 2000, J ETHNOPHARMACOL, V72, P459, DOI 10.1016/S0378-8741(00)00239-7
   Salvador MJ, 2002, PHYTOMEDICINE, V9, P566, DOI 10.1078/09447110260573227
   Slimestad R, 1995, PLANTA MED, V61, P562, DOI 10.1055/s-2006-959374
   TAKAHASHI JA, 1995, PHYTOCHEMISTRY, V40, P607, DOI 10.1016/0031-9422(95)00264-8
   Takahashi JA, 2001, QUIM NOVA, V24, P616, DOI 10.1590/S0100-40422001000500008
   Velandia JR, 1998, QUIM NOVA, V21, P397, DOI 10.1590/S0100-40421998000400004
   Vieira HS, 2002, J BRAZIL CHEM SOC, V13, P151, DOI 10.1590/S0103-50532002000200004
   Wu YC, 1996, J NAT PROD, V59, P635, DOI 10.1021/np960416j
NR 35
TC 22
Z9 23
U1 0
U2 28
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0100-4042
EI 1678-7064
J9 QUIM NOVA
JI Quim. Nova
PY 2012
VL 35
IS 8
BP 1570
EP U111
DI 10.1590/S0100-40422012000800015
PG 18
WC Chemistry, Multidisciplinary
SC Chemistry
GA 001JZ
UT WOS:000308458100015
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Bonjardim, LR
   Cunha, ES
   Guimaraes, AG
   Santana, MF
   Oliveira, MGB
   Serafini, MR
   Araujo, AAS
   Antoniolli, AR
   Cavalcanti, SCH
   Santos, MRV
   Quintans, LJ
AF Bonjardim, Leonardo R.
   Cunha, Edisleide S.
   Guimaraes, Adriana G.
   Santana, Michele F.
   Oliveira, Makson G. B.
   Serafini, Mairim R.
   Araujo, Adriano A. S.
   Antoniolli, Angelo R.
   Cavalcanti, Socrates C. H.
   Santos, Marcio R. V.
   Quintans-Junior, Lucindo J.
TI Evaluation of the Anti-Inflammatory and Antinociceptive Properties of
   p-Cymene in Mice
SO ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES
LA English
DT Article
DE Monoterpene; p-Cymene; Pain; Inflammation
ID FORMALIN TEST; CITRONELLAL; MIGRATION
AB We attempted to identify the antinociceptive and anti-inflammatory actions of the monoterpene p-cymene. Firstly, behavioural screening was carried out to verify the influence of p-cymene [25, 50, and 100 mg/kg intraperitoneal (i.p.)] on the central nervous system (CNS) activity. The antinociceptive activity of p-cymene was evaluated by the acetic acid-induced writhing response, formalin, and hot-plate test, respectively. The leukocyte migration induced by injection of carrageenan was used to assess the anti-inflammatory activity. p-Cymenc showed depressant activity on CNS after 4 h of treatment and also a possible action on the autonomous nervous system (ANS), mainly at the dose of 100 mg/kg (i.p.). It was found that p-cymene (50 and 100 mg/kg, i.p.) significantly (p < 0.05) reduced the writhing responses induced by acetic acid. p-Cymene also decreased the licking time in the first and second phase, respectively, of the formalin test. The results of the hot-plate test showed that all doses of p-cymene increased significantly the latency time of the response to the thermal stimulus in both licking and jumping parameters. In addition, there was a significantly (p < 0.05) decreased leukocyte migration at all doses of p-cymene. The experimental data demonstrate that p-cymcne possesses antinociceptive and anti-inflammatory activities.
C1 [Bonjardim, Leonardo R.; Cunha, Edisleide S.; Guimaraes, Adriana G.; Santana, Michele F.; Oliveira, Makson G. B.; Serafini, Mairim R.; Araujo, Adriano A. S.; Antoniolli, Angelo R.; Cavalcanti, Socrates C. H.; Santos, Marcio R. V.; Quintans-Junior, Lucindo J.] Univ Fed Sergipe DFS UFS, Dept Physiol, Aracaju, SE, Brazil.
RP Bonjardim, LR (corresponding author), Univ Fed Sergipe DFS UFS, Dept Physiol, Aracaju, SE, Brazil.
EM lbonjardim@yahoo.com.br
RI Cavalcanti, Socrates/AAQ-7004-2020; Serafini, Mairim Russo/X-3034-2019;
   Quintans, Lucindo/A-2434-2012; Bonjardim, Leonardo R/J-3665-2013;
   Guimaraes, Adriana G/G-6860-2014; Antoniolli, Angelo/B-5741-2015;
   SANTOS, MARCIO/U-2200-2019
OI Serafini, Mairim Russo/0000-0003-4223-3470; Quintans,
   Lucindo/0000-0001-5155-938X; Bonjardim, Leonardo R/0000-0002-0080-7678;
   Guimaraes, Adriana G/0000-0003-1643-5642; FRAGA DE SANTANA,
   MICHELE/0000-0002-5557-260X
FU Fundacao de Amparo a Pesquisa do Estado de Sergipe (FAPITECSE); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of
   BrazilNational Council for Scientific and Technological Development
   (CNPq)
FX We would like to thank the Fundacao de Amparo a Pesquisa do Estado de
   Sergipe (FAPITECSE) and Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq) of Brazil for financial support.
CR Almeida R., 1999, REV BRASILEIRA FARMA, V80, P72, DOI DOI 10.1590/S0102-695X2006000300015]
   Almeida RN, 2001, PHYTOMEDICINE, V8, P310, DOI 10.1078/0944-7113-00050
   Arruda VA, 2003, TOXICON, V41, P99, DOI 10.1016/S0041-0101(02)00238-6
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Bastos LFS, 2007, EUR J PHARMACOL, V576, P171, DOI 10.1016/j.ejphar.2007.07.049
   BROADBEAR JH, 1994, PSYCHOPHARMACOLOGY, V115, P311, DOI 10.1007/BF02245071
   DAPINO P, 1994, RESPIRATION, V61, P336
   de Queiroz AC, 2010, J ETHNOPHARMACOL, V128, P377, DOI 10.1016/j.jep.2010.01.041
   Dewick PM, 2009, MED NATURAL PRODUCTS
   dos Santos DA, 2010, J ETHNOPHARMACOL, V127, P543, DOI 10.1016/j.jep.2009.09.061
   EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385
   Guimaraes AG, 2010, BASIC CLIN PHARMACOL, V107, P949, DOI 10.1111/j.1742-7843.2010.00609.x
   Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200
   HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1
   Khan H, 2010, J ETHNOPHARMACOL, V127, P521, DOI 10.1016/j.jep.2009.10.003
   KOSTER R, 1959, FED PROC, V18, P412
   Le Bars D, 2001, PHARMACOL REV, V53, P597
   Loram LC, 2007, J PAIN, V8, P127, DOI 10.1016/j.jpain.2006.06.010
   Martin-Luengo MA, 2008, APPL CATAL B-ENVIRON, V81, P218, DOI 10.1016/j.apcatb.2007.12.003
   Melo MS, 2010, PHARM BIOL, V48, P411, DOI 10.3109/13880200903150419
   Philis JG, 2005, SPECTROCHIM ACTA A, V61, P1239, DOI 10.1016/j.saa.2004.06.046
   Quintans LJ, 2011, REV BRAS FARMACOGN, V21, P497, DOI 10.1590/S0102-695X2011005000065
   Quintans LJ, 2010, J OROFAC PAIN, V24, P305
   Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x
   Santana MF, 2011, REV BRAS FARMACOGN, V21, P1138, DOI 10.1590/S0102-695X2011005000156
   Thomazzi SM, 2010, J ETHNOPHARMACOL, V127, P451, DOI 10.1016/j.jep.2009.10.014
   TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T
   Verma PR, 2005, J ETHNOPHARMACOL, V102, P298, DOI 10.1016/j.jep.2005.05.039
   WALDE A, 1983, XENOBIOTICA, V13, P503, DOI 10.3109/00498258309052290
NR 29
TC 33
Z9 34
U1 0
U2 7
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0939-5075
EI 1865-7125
J9 Z NATURFORSCH C
JI Z.Naturforsch.(C)
PD JAN-FEB
PY 2012
VL 67
IS 1-2
BP 15
EP 21
DI 10.5560/ZNC.2012.67c0015
PG 7
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 926PJ
UT WOS:000302843000003
PM 22486037
DA 2020-12-08
ER

PT J
AU Santana, MF
   Quintans, LJ
   Cavalcanti, SCH
   Oliveira, MGB
   Guimaraes, AG
   Cunha, ES
   Melo, MS
   Santos, MRV
   Araujo, AAS
   Bonjardim, LR
AF Santana, Michele F.
   Quintans-Junior, Lucindo J.
   Cavalcanti, Socrates C. H.
   Oliveira, Makson G. B.
   Guimaraes, Adriana G.
   Cunha, Edisleide S.
   Melo, Monica S.
   Santos, Marcio R. V.
   Araujo, Adriano A. S.
   Bonjardim, Leonardo R.
TI p-Cymene reduces orofacial nociceptive response in mice
SO REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
LA English
DT Article
DE p-cymene; antinociception; orofacial nociception; formalin; capsaicin;
   glutamate
ID FORMALIN TEST; ANTINOCICEPTIVE ACTIVITY; GLUTAMATE; PAIN; INJECTION;
   CAPSAICIN; ACTIVATION; RECEPTORS; RESIN; RAT
AB This study investigated the possible antinociceptive effect of p-cymene in different tests of orofacial nociception. The animals (mice) were pretreated (i.p.) with p-cymene (25, 50, 100 mg/kg), morphine (5 mg/kg), or vehicle (0.2% Tween 80+saline), and were then subsequently administered, subcutaneously into their upper lip: formalin, capsaicin, and glutamate. The nociceptive behavior response was characterized by the time in s that the mice remained rubbing the orofacial region, for a period of 40 min in the formalin test (first phase, 0-6 min; and second phase, 21-40 min), and for 42 and 15 min in the capsaicin and glutamate tests, respectively. To verify the possible opioid involvement in the antinociceptive effects, naloxone (i.p.) was administered into the mice 15 min prior to the pretreatment with p-cymene (100 mg/kg). Finally, whether or not the p-cymene evoked any change in motor performance in the Rota-rod test was evaluated. The results showed that the treatment with p-cymene, at all doses, reduced (p<0.001) the nociceptive behavior in all nociception tests. The antinociceptive effect of p-cymene was antagonized by naloxone (1.5 mg/kg). Additionally, mice treated with p-cymene did not show any change in motor performance. In conclusion, p-cymene attenuated orofacial nociception, suggesting an involvement of the opioid system in this effect. Thus, p-cymene might represent an important biomolecule for management and/or treatment of orofacial pain.
C1 [Santana, Michele F.; Quintans-Junior, Lucindo J.; Cavalcanti, Socrates C. H.; Oliveira, Makson G. B.; Guimaraes, Adriana G.; Cunha, Edisleide S.; Melo, Monica S.; Santos, Marcio R. V.; Araujo, Adriano A. S.; Bonjardim, Leonardo R.] Univ Fed Sergipe, Dept Fisiol, BR-49100000 Sao Cristovao, SE, Brazil.
RP Bonjardim, LR (corresponding author), Univ Fed Sergipe, Dept Fisiol, BR-49100000 Sao Cristovao, SE, Brazil.
EM lbonjardim@ufs.br
RI SANTOS, MARCIO/U-2200-2019; Guimaraes, Adriana G/G-6860-2014; Bonjardim,
   Leonardo R/J-3665-2013; Cavalcanti, Socrates/AAQ-7004-2020; Quintans,
   Lucindo/A-2434-2012
OI Guimaraes, Adriana G/0000-0003-1643-5642; Bonjardim, Leonardo
   R/0000-0002-0080-7678; Quintans, Lucindo/0000-0001-5155-938X; FRAGA DE
   SANTANA, MICHELE/0000-0002-5557-260X
FU Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de
   Sergipe [019.203.00860/2009-6]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, BrazilNational Council for Scientific and
   Technological Development (CNPq)
FX This work was supported by the Fundacao de Apoio a Pesquisa e a Inovacao
   Tecnologica do Estado de Sergipe [grant number 019.203.00860/2009-6] and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil.
   The authors thank Richard Berger for editing the English of the
   manuscript.
CR Barros VD, 2009, J OROFAC PAIN, V23, P28
   Batista PA, 2008, NEUROSCI LETT, V440, P299, DOI 10.1016/j.neulet.2008.05.092
   Beirith A, 2002, BRAIN RES, V924, P219, DOI 10.1016/S0006-8993(01)03240-1
   Bispo MD, 2001, J ETHNOPHARMACOL, V76, P81, DOI 10.1016/S0378-8741(01)00172-6
   CADET R, 1993, NEUROSCI LETT, V156, P43, DOI 10.1016/0304-3940(93)90435-N
   Cairns BE, 1998, J NEUROSCI, V18, P8056
   Cairns BE, 2002, NEUROSCIENCE, V109, P389, DOI 10.1016/S0306-4522(01)00489-4
   Cairns BE, 2001, J NEUROPHYSIOL, V86, P782
   Cairns BE, 2001, J NEUROPHYSIOL, V85, P2446
   Coggeshall RE, 1997, BRAIN RES REV, V24, P28, DOI 10.1016/S0165-0173(97)00010-6
   de Almeida RN, 2004, PHARMACOL BIOCHEM BE, V77, P361, DOI 10.1016/j.pbb.2003.11.004
   Dionne R A, 2001, J Dent Educ, V65, P1393
   Ferreira J, 1999, NEUROPHARMACOLOGY, V38, P835, DOI 10.1016/S0028-3908(99)00006-4
   Galeotti N, 2002, NEUROSCI LETT, V322, P145, DOI 10.1016/S0304-3940(01)02527-7
   Henry JL, 1999, J NEUROSCI, V19, P6588
   HU JW, 2005, ORAL BIOSCI MED, V4, P241
   HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5
   Keast JR, 2000, J COMP NEUROL, V424, P577
   Lam DK, 2009, BRAIN RES, V1253, P48, DOI 10.1016/j.brainres.2008.11.056
   Lam David K, 2005, Pain Res Manag, V10, P145
   Lam DK, 2009, BRAIN RES, V1251, P130, DOI 10.1016/j.brainres.2008.11.029
   LIPTON JA, 1993, J AM DENT ASSOC, V124, P115, DOI 10.14219/jada.archive.1993.0200
   Luccarini P, 2006, J PAIN, V7, P908, DOI 10.1016/j.jpain.2006.04.010
   Melo MS, 2010, PHARM BIOL, V48, P411, DOI 10.3109/13880200903150419
   Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609
   Oliveira FA, 2005, LIFE SCI, V77, P2942, DOI 10.1016/j.lfs.2005.05.031
   Otuki MF, 2001, LIFE SCI, V69, P2225, DOI 10.1016/S0024-3205(01)01310-8
   Peana AT, 2006, LIFE SCI, V78, P719, DOI 10.1016/j.lfs.2005.05.065
   Pelissier T, 2002, PAIN, V96, P81, DOI 10.1016/S0304-3959(01)00432-8
   de Sousa DP, 2006, NEUROSCI LETT, V401, P231, DOI 10.1016/j.neulet.2006.03.030
   Quintans LJ, 2010, J OROFAC PAIN, V24, P305
   Ramezani M, 2004, J ETHNOPHARMACOL, V91, P167, DOI 10.1016/j.jep.2003.12.016
   Goncalves JCR, 2008, BIOL PHARM BULL, V31, P1017, DOI 10.1248/bpb.31.1017
   SAKURADA T, 1992, NEUROPHARMACOLOGY, V31, P1279, DOI 10.1016/0028-3908(92)90057-V
   SESSLE BJ, 1987, J DENT RES, V66, P962, DOI 10.1177/00220345870660052201
   SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4
   Siani AC, 1999, J ETHNOPHARMACOL, V66, P57, DOI 10.1016/S0378-8741(98)00148-2
   TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T
   Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245
   Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692
   Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
NR 42
TC 31
Z9 33
U1 0
U2 4
PU SOC BRASILEIRA FARMACOGNOSIA
PI CURITIBA-PR
PA C/O PROF CID AIMBIRE DE MORAES SANTOS, UFPR-LAB FARM, RUA PREF LOTHARIO
   MEISSNER, 632-JD BOTANICO, CURITIBA-PR, 80210-170, BRAZIL
SN 0102-695X
J9 REV BRAS FARMACOGN
JI Rev. Bras. Farmacogn.-Braz. J. Pharmacogn.
PD NOV-DEC
PY 2011
VL 21
IS 6
BP 1138
EP 1143
DI 10.1590/S0102-695X2011005000156
PG 6
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 850RZ
UT WOS:000297216900026
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Sousa, D
   Vieira, Y
   Uliana, M
   Santos, S
   Brocksom, T
   Cavalcanti, S
AF Sousa, D.
   Vieira, Y.
   Uliana, M.
   Santos, S.
   Brocksom, T.
   Cavalcanti, S.
TI Larvicidal activity of oximes
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Sousa, D.; Santos, S.; Cavalcanti, S.] Univ Fed Sergipe, Sao Paulo, Brazil.
   [Vieira, Y.; Uliana, M.; Brocksom, T.] Univ Fed Sao Carlos, BR-13560 Sao Carlos, SP, Brazil.
RI Cavalcanti, Socrates/AAQ-7004-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD OCT
PY 2011
VL 16
SU 1
SI SI
BP 237
EP 237
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 828RC
UT WOS:000295519100711
DA 2020-12-08
ER

PT J
AU Santos, SRL
   Melo, MA
   Cardoso, AV
   Santos, RLC
   de Sousa, DP
   Cavalcanti, SCH
AF Santos, Sandra R. L.
   Melo, Manuela A.
   Cardoso, Andrea Valenca
   Santos, Roseli L. C.
   de Sousa, Damiao P.
   Cavalcanti, Socrates C. H.
TI Structure-activity relationships of larvicidal monoterpenes and
   derivatives against Aedes aegypti Linn
SO CHEMOSPHERE
LA English
DT Article
DE Structure-activity relationships; Monoterpene; Larvicidal activity;
   Aedesaegypti; Essential oil; Limonene
ID DIPTERA-CULICIDAE; ESSENTIAL OILS; LARVAE; INSECTICIDES; TERPENES;
   LIMONENE; BRAZIL
AB In the search for larvicidal compounds against Aedes aegypti L (Diptera: Culicidae), a collection of monoterpenes were selected and evaluated. R- and S-limonene exhibited the highest larvicidal potency (LC(50) = 27 and 30 ppm, respectively), followed by gamma-terpinene (LC(50) = 56 ppm) and RS-carvone (LC(50) = 118 ppm). Structural characteristics which may contribute to the understanding of the larvicidal activity of monoterpenes were empirically identified. The presence of heteroatoms in the basic hydrocarbon structure decreases larvicidal potency. Conjugated and exo double bonds appear to increase larvicidal potency. Replacement of double bonds by more reactive epoxides decreases the larvicidal potency. The presence of hydroxyls in the cyclic structure resulted in decreased potency, probably due to increased polarity indicanting that lipophilicity seems to play an important role in increasing the larvicidal potency in this set of compounds. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Santos, Sandra R. L.; Melo, Manuela A.; Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Dept Pharm, Med Chem Lab, Sao Cristovao, Sergipe, Brazil.
   [Cardoso, Andrea Valenca; Santos, Roseli L. C.] Univ Fed Sergipe, Dept Morphol, Parasitol Lab, Sao Cristovao, Sergipe, Brazil.
   [de Sousa, Damiao P.] Univ Fed Sergipe, Dept Pharm, Nat Prod & Synthet Chem Lab, Sao Cristovao, Sergipe, Brazil.
RP Cavalcanti, SCH (corresponding author), Univ Fed Sergipe, Dept Pharm, Med Chem Lab, Av Marechal Rondon S-N, Sao Cristovao, Sergipe, Brazil.
EM socratescavalcanti@yahoo.com.br
RI Santos, Roseli LC/F-1735-2015; de Sousa, Damiao Pergentino/B-2580-2018;
   de Sousa, Damiao Pergentino/AAY-1244-2020; Cavalcanti,
   Socrates/AAQ-7004-2020
OI de Sousa, Damiao Pergentino/0000-0002-7180-4896; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [550 116/2010-9]; Fundacao de Apoio a Pesquisa e Inovacao
   Tecnologica do Estado de Sergipe (FAPITEC/SE)
FX The authors are deeply grateful to the technical assistance of Mr.
   Osvaldo Andrade Santos. This work was supported by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Grant nuber 550
   116/2010-9) and Fundacao de Apoio a Pesquisa e Inovacao Tecnologica do
   Estado de Sergipe (FAPITEC/SE).
CR Belzile AS, 2000, PESTIC BIOCHEM PHYS, V66, P33, DOI 10.1006/pest.1999.2453
   Bhanti M, 2007, CHEMOSPHERE, V69, P63, DOI 10.1016/j.chemosphere.2007.04.071
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Cantrell CL, 2010, CHEM BIODIVERS, V7, P1681, DOI 10.1002/cbdv.201000031
   COCKER W, 1995, J CHEM SOC PERK T 1, P1153, DOI 10.1039/p19950001153
   COREY EJ, 1975, TETRAHEDRON LETT, V16, P2647
   Doria GAA, 2010, PHARM BIOL, V48, P615, DOI 10.3109/13880200903222952
   Erasto P, 2008, NAT PROD COMMUN, V3, P1193
   Finney D. J., 1971, PROBIT ANAL
   KLEIN E, 1963, TETRAHEDRON, V19, P1091, DOI 10.1016/S0040-4020(01)99364-0
   Laurens A, 1997, PHYTOTHER RES, V11, P145, DOI 10.1002/(SICI)1099-1573(199703)11:2<145::AID-PTR40>3.0.CO;2-#
   Lim PFC, 2009, J ESSENT OIL RES, V21, P423, DOI 10.1080/10412905.2009.9700208
   Lomonaco D, 2009, GREEN CHEM, V11, P31, DOI 10.1039/b811504d
   Lopez O, 2005, GREEN CHEM, V7, P431, DOI 10.1039/b500733j
   Perumalsamy H, 2009, J MED ENTOMOL, V46, P1420, DOI 10.1603/033.046.0624
   Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005
   Radwan M. A., 2008, International Journal of Tropical Insect Science, V28, P61, DOI 10.1017/S1742758408962366
   ROD RL, 1997, USPTO PATENT FULL TE, P11
   Samarasekera R, 2008, PEST MANAG SCI, V64, P290, DOI 10.1002/ps.1516
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   THOMAS AF, 1989, NAT PROD REP, V6, P291, DOI 10.1039/np9890600291
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
   *WHO, 2009, DENG DENG HAEM FEV
   YANG W, 2008, SHIJIE NONGYAO WORLD, V30, P33
NR 26
TC 66
Z9 69
U1 0
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
J9 CHEMOSPHERE
JI Chemosphere
PD JUN
PY 2011
VL 84
IS 1
BP 150
EP 153
DI 10.1016/j.chemosphere.2011.02.018
PG 4
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 787ZY
UT WOS:000292416400021
PM 21376365
DA 2020-12-08
ER

PT J
AU Costa, EV
   Dutra, LM
   de Jesus, HCR
   Nogueira, PCD
   Moraes, VRD
   Salvador, MJ
   Cavalcanti, SCD
   dos Santos, RL
   Prata, APD
AF Costa, Emmanoel Vilaca
   Dutra, Livia Macedo
   Ramos de Jesus, Hugo Cesar
   de Lima Nogueira, Paulo Cesar
   de Souza Moraes, Valeria Regina
   Salvador, Marcos Jose
   de Holanda Cavalcanti, Socrates Cabral
   dos Santos, Roseli La Corte
   do Nacimento Prata, Ana Paula
TI Chemical Composition and Antioxidant, Antimicrobial, and Larvicidal
   Activities of the Essential Oils of Annona salzmannii and A. pickelii
   (Annonaceae)
SO NATURAL PRODUCT COMMUNICATIONS
LA English
DT Article
DE Annona salzmannii; Annona pickelii; essential oil composition;
   antioxidant; antimicrobial and larvicidal activity
ID CONSTITUENTS; ACETOGENINS; ALKALOIDS; ROOTS
AB The essential oils from the leaves of Annona salzmannii and A. pickelii (Annonaceae) growing in Sergipe, northeastern region of Brazil, were obtained by hydrodistillation using a Clevenger-type apparatus, and analyzed by GC/MS and GC/FID. Thirty-four compounds were identified in the essential oil of A. salzmannii and twenty-seven in that of A. pickelii; sesquiterpenes predominated in both essential oils. Bicyclogermacrene (20.3%), (E)-caryophyllene (19.9%), delta-cadinene (15.3%), alpha-copaene (10.0%), and allo-aromadendrene (5.7%) were the main components of A. salzmannii, and bicyclogermacrene (45.4%), (E)-caryophyllene (14.6%), and a-copaene (10.6%) of A. pickelii. The essential oils showed significant antioxidant capacity in the ORAC(FL) and DPPH assays. The antimicrobial activity of these essential oils was also evaluated against bacteria and fungi, as well as the larvicidal activity against Aedes aegvpti larvae.
C1 [Costa, Emmanoel Vilaca; Dutra, Livia Macedo; Ramos de Jesus, Hugo Cesar; de Lima Nogueira, Paulo Cesar; de Souza Moraes, Valeria Regina] Univ Fed Sergipe, Dept Quim, Lab Pesquisa Quim Organ Sergipe LABORGANICS, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Salvador, Marcos Jose] Univ Estadual Campinas, Dept Biol Vegetal, Curso Farm, BR-13083970 Campinas, SP, Brazil.
   [de Holanda Cavalcanti, Socrates Cabral] Univ Fed Sergipe, Dept Farm, Quim Farmaceut Lab, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [dos Santos, Roseli La Corte] Univ Fed Sergipe, Dept Morfol, Parasitol Lab, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [do Nacimento Prata, Ana Paula] Univ Fed Sergipe, Dept Biol, Lab Sistemat Vegetal, BR-49100000 Sao Cristovao, Sergipe, Brazil.
RP Costa, EV (corresponding author), Univ Fed Sergipe, Dept Quim, Lab Pesquisa Quim Organ Sergipe LABORGANICS, BR-49100000 Sao Cristovao, Sergipe, Brazil.
EM emmanoelvilaca@yahoo.com.br
RI de Lima Nogueira, Paulo Cesar/R-2346-2019; DE JESUS, HUGO/G-2438-2012;
   Cavalcanti, Socrates/AAQ-7004-2020; Prata, Ana Paula do
   Nascimento/H-8937-2012; Salvador, Marcos/V-3129-2019; Santos, Roseli
   LC/F-1735-2015; Dutra, Livia Macedo/P-4406-2018; Moraes,
   Valeria/AAH-3449-2020
OI de Lima Nogueira, Paulo Cesar/0000-0003-0832-1047; DE JESUS,
   HUGO/0000-0001-8223-094X; Salvador, Marcos/0000-0002-3839-5445; Dutra,
   Livia Macedo/0000-0002-9963-1093; 
FU FAPITEC/SE [07/2009, 10/2009]; CNPqNational Council for Scientific and
   Technological Development (CNPq); CAPESCAPES; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP)
FX The authors are grateful to FAPITEC/SE (Editais No 07/2009 and 10/2009),
   CNPq, CAPES, and FAPESP for financial support.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Boyom FF, 2003, PHYTOCHEMISTRY, V64, P1269, DOI 10.1016/j.phytochem.2003.08.004
   Cavin A, 1998, J NAT PROD, V61, P1497, DOI 10.1021/np980203p
   Chatrou LW, 2009, MOL PHYLOGENET EVOL, V53, P726, DOI 10.1016/j.ympev.2009.07.024
   Correa M. P., 1984, DICIONARIO PLANTAS U
   Costa EV, 2008, PHYTOCHEMISTRY, V69, P1895, DOI 10.1016/j.phytochem.2008.03.005
   Costa EV, 2010, J NAT PROD, V73, P1180, DOI 10.1021/np100013r
   Costa EV, 2009, QUIM NOVA, V32, P78, DOI 10.1590/S0100-40422009000100015
   Doria GAA, 2010, PHARM BIOL, V48, P615, DOI 10.3109/13880200903222952
   Feitosa EMA, 2009, J BRAZIL CHEM SOC, V20, P375, DOI 10.1590/S0103-50532009000200024
   FINNEY DJ, 1948, BIOMETRIKA, V35, P191, DOI 10.1093/biomet/35.1-2.191
   Maas P., 2001, RODRIGUESIA, V52, P61
   Mesquita L.M., 1988, BIOCH SYST ECOL, V16, P379
   Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o
   PAULO MD, 1992, J ETHNOPHARMACOL, V36, P39
   Pinheiro MLB, 2009, J BRAZIL CHEM SOC, V20, P1095, DOI 10.1590/S0103-50532009000600015
   Queiroz EF, 2003, J NAT PROD, V66, P755, DOI 10.1021/np020543h
   Queiroz EF, 1999, J NAT PROD, V62, P710, DOI 10.1021/np980482g
   Rainer H., 2006, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V108, P191
   Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537
   RUPPRECHT JK, 1990, J NAT PROD, V53, P237, DOI 10.1021/np50068a001
   Salvador MJ, 2006, Z NATURFORSCH C, V61, P19
   Salvador MJ, 2002, PHYTOMEDICINE, V9, P566, DOI 10.1078/09447110260573227
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   SIQUEIRA CAT, 2011, BRAZILIAN J PHARM, V21, P33
   Stevigny C., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P173, DOI 10.2174/1568011053174864
   Takamatsu S, 2003, J NAT PROD, V66, P605, DOI 10.1021/np0204038
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
NR 28
TC 38
Z9 38
U1 0
U2 17
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1934-578X
EI 1555-9475
J9 NAT PROD COMMUN
JI Nat. Prod. Commun.
PD JUN
PY 2011
VL 6
IS 6
BP 907
EP 912
PG 6
WC Chemistry, Medicinal; Food Science & Technology
SC Pharmacology & Pharmacy; Food Science & Technology
GA 780EW
UT WOS:000291838300036
PM 21815437
DA 2020-12-08
ER

PT J
AU Guilhon, CC
   Raymundo, LJRP
   Alviano, DS
   Blank, AF
   Arrigoni-Blank, MF
   Matheus, ME
   Cavalcanti, SCH
   Alviano, CS
   Fernandes, PD
AF Guilhon, Carolina C.
   Raymundo, Larissa J. R. P.
   Alviano, Daniela S.
   Blank, Arie F.
   Arrigoni-Blank, Maria F.
   Matheus, Maria Eline
   Cavalcanti, Socrates C. H.
   Alviano, Celuta S.
   Fernandes, Patricia D.
TI Characterisation of the anti-inflammatory and antinociceptive activities
   and the mechanism of the action of Lippia gracilis essential oil
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Lippia gracilis Schauer; Verbenaceae; Essential oil; Antinociceptive
   activity; Anti-inflammatory activity
ID NITRIC-OXIDE SYNTHASE; FORMALIN TEST; ACTIVATION; INTERLEUKIN-6;
   INVOLVEMENT; EXPRESSION; STRATEGIES; NITRATE; ALPHA; GAMMA
AB Ethnopharmacological relevance: The species Lippia gracilis Schauer, known in Brazil as "Alecrim-dachapada", is popularly used in folk medicine to treat cough, bronchitis, nasal congestion, and headache.
   Materials and methods: Lippia gracilis essential oil (EO; 10, 30, and 100 mg/kg, p.o.) and the reference drugs morphine (5 mg/kg, p.o.) and acetylsalicylic acid (ASA; 200 mg/kg, p.o.) were evaluated using models for analgesia (acetic acid-induced contortion, formalin-induced licking, and hot plate) or inflammation (formalin-induced licking response and subcutaneous air pouch model). To elucidate the antinociceptive mechanism of action, animals were pre-treated with naloxone (opioid receptor antagonist; 1 mg/kg, i.p.), atropine (cholinergic antagonist; 1 mg/kg, i.p.) or L-nitro arginine methyl ester (L-NAME; 3 mg/kg, i.p.) 30 min prior to oral administration of EO.
   Results: EO significantly inhibited the number of writhings in acetic acid-induced contortions and the time that the animal spent licking the formalin-injected paw (second phase). All doses of EO increased the baseline and the area under the curve in the hot plate model. The administration of naloxone did not reverse the antinociceptive effect of EO in the acetic acid-induced contortion and formalin-induced licking models. L-NAME and atropine significantly reversed the effect of EO in the models of contortion, formalin, and hot plate. EO also inhibited the inflammatory process induced by subcutaneous carrageenan injection, reducing cell migration, exudate volume, extravased protein, and inflammatory mediators (nitric oxide, prostaglandin E2, TNF-alpha, and IFN-gamma) produced in the pouch.
   Conclusions: Our results indicate that the essential oil from Lippia gracilis produces an antinociceptive effect that could be potentially mediated by cholinergic receptors and the nitric oxide pathway. Our data also suggest that the anti-inflammatory activity caused by EO exposure occurs through inhibition of nitric oxide and PGE2 production. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Fernandes, Patricia D.] Univ Fed Rio de Janeiro, ICB, Lab Farmacol Inflamacao & Oxido Nitr, Programa Desenvolvimento Farmacos, BR-21941902 Rio De Janeiro, Brazil.
   [Alviano, Daniela S.; Alviano, Celuta S.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941902 Rio De Janeiro, Brazil.
   [Blank, Arie F.; Arrigoni-Blank, Maria F.] Univ Fed Sergipe, Dept Engn Agron, Sao Cristovao, Brazil.
   [Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Dept Farm, Lab Quim Med, Sao Cristovao, Brazil.
RP Fernandes, PD (corresponding author), Univ Fed Rio de Janeiro, ICB, Lab Farmacol Inflamacao & Oxido Nitr, Programa Desenvolvimento Farmacos, Av Carlos Chagas Filho 373,Predio CCS,Bloco J,Sal, BR-21941902 Rio De Janeiro, Brazil.
EM patfern@farmaco.ufrj.br
RI Alviano, Celuta/V-3878-2019; Alviano, Daniela/U-1556-2019; Cavalcanti,
   Socrates/AAQ-7004-2020; Fernandes, Patricia/W-1565-2019; Blank, Arie
   F/C-7537-2013; Fernandes, Patricia Dias/C-4489-2013
OI Alviano, Celuta/0000-0002-0806-6712; Blank, Arie F/0000-0003-2888-2239;
   Fernandes, Patricia Dias/0000-0001-6870-6745
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); FAPITEC-SE
FX We would like to thank Ms. Camilla Bayer for technical assistance. This
   work was supported by grants obtained from the CNPq (fellowship to LJRPR
   and CCG and grant support), FAPERJ, and FAPITEC-SE.
CR Adams V, 2002, CARDIOVASC RES, V54, P95, DOI 10.1016/S0008-6363(02)00228-6
   Aguiar J. S., 2005, Revista Brasileira de Plantas Medicinais, V8, P79
   Albuquerque FS, 2008, BRAZ J BIOL, V68, P837, DOI 10.1590/S1519-69842008000400020
   Brito GAC, 2006, EUR J NEUROSCI, V24, P1175, DOI 10.1111/j.1460-9568.2006.04991.x
   COLLIER HOJ, 1968, BRIT J PHARMACOL, V32, P295, DOI 10.1111/j.1476-5381.1968.tb00973.x
   DERAEDT R, 1980, EUR J PHARMACOL, V61, P17, DOI 10.1016/0014-2999(80)90377-5
   Eigler A, 1997, IMMUNOL TODAY, V18, P487, DOI 10.1016/S0167-5699(97)01118-3
   Gomes NM, 2007, J ETHNOPHARMACOL, V109, P486, DOI 10.1016/j.jep.2006.08.018
   Granados-Soto V, 1997, EUR J PHARMACOL, V340, P177, DOI 10.1016/S0014-2999(97)01399-X
   Guimaraes AG, 2010, BASIC CLIN PHARMACOL, V107, P949, DOI 10.1111/j.1742-7843.2010.00609.x
   Guslandi M, 1998, EUR J CLIN INVEST, V28, P904
   HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621
   HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1
   Ikeda Y, 2001, LIFE SCI, V69, P2911, DOI 10.1016/S0024-3205(01)01374-1
   Jones PG, 2007, NEUROPHARMACOLOGY, V53, P197, DOI 10.1016/j.neuropharm.2007.04.002
   Katsukawa M, 2010, BBA-MOL CELL BIOL L, V1801, P1214, DOI 10.1016/j.bbalip.2010.07.004
   Levy D, 2004, J NEUROPHYSIOL, V92, P766, DOI 10.1152/jn.00058.2004
   LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480
   MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003
   Martinez V, 1999, PAIN, V81, P179, DOI 10.1016/S0304-3959(99)00008-1
   Matheus ME, 2005, J ETHNOPHARMACOL, V102, P377, DOI 10.1016/j.jep.2005.06.033
   MATOS FJA, 1996, J ESSENT OIL RES, V8, P695, DOI DOI 10.1080/10412905.1996.9701047
   Mendes SS, 2010, J ETHNOPHARMACOL, V129, P391, DOI 10.1016/j.jep.2010.04.005
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   Pang LH, 1997, BIOCHEM PHARMACOL, V53, P773, DOI 10.1016/S0006-2952(96)00817-9
   Park HH, 2008, ARCH PHARM RES, V31, P1303, DOI 10.1007/s12272-001-2110-5
   Pascual ME, 2001, J ETHNOPHARMACOL, V76, P201, DOI 10.1016/S0378-8741(01)00234-3
   Pinheiro MMG, 2010, J ETHNOPHARMACOL, V127, P407, DOI 10.1016/j.jep.2009.10.025
   PRADELLES P, 1985, ANAL CHEM, V57, P1170, DOI 10.1021/ac00284a003
   Prado WA, 2002, EUR J PHARMACOL, V441, P57, DOI 10.1016/S0014-2999(02)01413-9
   Raymundo LJRP, 2011, J ETHNOPHARMACOL, V134, P725, DOI 10.1016/j.jep.2011.01.027
   Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069
   Romano M, 1997, MEDIAT INFLAMM, V6, P32, DOI 10.1080/09629359791901
   ROSLAND JH, 1990, PAIN, V42, P235, DOI 10.1016/0304-3959(90)91167-H
   Sachs D, 2004, P NATL ACAD SCI USA, V101, P3680, DOI 10.1073/pnas.0308382101
   SAHLEY TL, 1979, PSYCHOPHARMACOLOGY, V65, P279, DOI 10.1007/BF00492216
   SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T
   VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253
   XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779
   Xu JL, 2000, J MICROBIOL METH, V41, P23, DOI 10.1016/S0167-7012(00)00141-X
   YUI Y, 1991, J BIOL CHEM, V266, P12544
NR 43
TC 34
Z9 37
U1 0
U2 15
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD MAY 17
PY 2011
VL 135
IS 2
BP 406
EP 413
DI 10.1016/j.jep.2011.03.032
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 778PG
UT WOS:000291716000025
PM 21420477
DA 2020-12-08
ER

PT J
AU Steffler, LM
   Marteis, LS
   Dolabella, SS
   Cavalcanti, SCD
   dos Santos, RL
AF Steffler, Lizandra Makowski
   Marteis, Leticia Silva
   Dolabella, Silvio Santana
   de Holanda Cavalcanti, Socrates Cabral
   dos Santos, Roseli La Corte
TI Risk of dengue occurrence based on the capture of gravid Aedes aegypti
   females using MosquiTRAP
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Aedes aegypti; MosquiTRAP; infestation; vector control; Sergipe
ID SAO-PAULO; BRAZIL; ADULT; TRAPS; CULICIDAE; MIRASSOL; DIPTERA; STATE;
   EGG; L.
AB We assessed the risk classification of dengue fever based on the capture of Aedes aegypti adults using MosquiTRAP, a type of sticky trap, in comparison with traditional larval infestation indices. A total of 27 MosquiTRAPs were installed, with one trap per block, and were inspected weekly between November 2008-February 2009. Infestation baseline data were obtained from a survey conducted prior to trap installation. The index generated by MosquiTRAP and house index (HI) classified the area "in alert situation". The set for risk of dengue occurrence proposed by the use of MosquiTRAP classify areas in the same way of the traditional HI.
C1 [Steffler, Lizandra Makowski; Marteis, Leticia Silva; Dolabella, Silvio Santana; de Holanda Cavalcanti, Socrates Cabral; dos Santos, Roseli La Corte] Univ Fed Sergipe, Ctr Ciencias Biol & Saude, Sao Cristovao, SE, Brazil.
RP dos Santos, RL (corresponding author), Univ Fed Sergipe, Ctr Ciencias Biol & Saude, Sao Cristovao, SE, Brazil.
EM rlacorte@ufs.br
RI Cavalcanti, Socrates/AAQ-7004-2020; Dolabella, Silvio/X-4351-2019;
   Santos, Roseli LC/F-1735-2015
OI Santana Dolabella, Silvio/0000-0001-5576-3214
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [410542/2006-7]; UFS
FX Financial support: CNPq (410542/2006-7), UFS (to LMS)
CR Barrera R, 2000, Rev Panam Salud Publica, V8, P225, DOI 10.1590/S1020-49892000000900001
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   Favaro EA, 2008, J VECTOR ECOL, V33, P8, DOI 10.3376/1081-1710(2008)33[8:AOEIOA]2.0.CO;2
   Favaro EA, 2006, J VECTOR ECOL, V31, P285, DOI 10.3376/1081-1710(2006)31[285:PSOASA]2.0.CO;2
   FOCKS DA, 2003, TDRIDEDEN031 WHO
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Lourenco-de-Oliveira R, 2008, J AM MOSQUITO CONTR, V24, P387, DOI 10.2987/5585.1
   Maciel-de-Freitas R, 2008, MEM I OSWALDO CRUZ, V103, P602, DOI 10.1590/S0074-02762008000600016
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI [10.1590/S0034-89102005000300016, 10.1590/s0034-89102005000300016]
   *MS, 2010, DOENC A Z DENG TAB
   MS-Ministerio da Saude, 2009, DIR NAC PREV CONTR E
   TunLin W, 1995, AM J TROP MED HYG, V53, P595, DOI 10.4269/ajtmh.1995.53.595
NR 15
TC 8
Z9 9
U1 1
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2011
VL 106
IS 3
BP 365
EP 367
DI 10.1590/S0074-02762011000300018
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 773PM
UT WOS:000291319200018
PM 21655827
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Raymundo, LJRP
   Guilhon, CC
   Alviano, DS
   Matheus, ME
   Antoniolli, AR
   Cavalcanti, SCH
   Alves, PB
   Alviano, CS
   Fernandes, PD
AF Raymundo, Larissa J. R. P.
   Guilhon, Carolina C.
   Alviano, Daniela S.
   Matheus, Maria Eline
   Antoniolli, Angelo R.
   Cavalcanti, Socrates C. H.
   Alves, Pericles B.
   Alviano, Celuta S.
   Fernandes, Patricia D.
TI Characterisation of the anti-inflammatory and antinociceptive activities
   of the Hyptis pectinata (L.) Poit essential oil
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Hyptis pectinata Poit; Lamiaceae; Inflammation; Pain; Essential oil
ID COPAIFERA-MULTIJUGA HAYNE; FORMALIN TEST; NITRIC-OXIDE;
   CHEMICAL-COMPOSITION; COPAIBA OILS; EXTRACTS; LEAVES; PAIN; MICE;
   PROSTAGLANDINS
AB Aim of the study: Hyptis pectinata Poit (Lamiaceae) is grown in the northeastern regions of Brazil and is popularly known as "sambacaita" or "canudinho". It is extensively used in folk medicine to treat inflammatory conditions, bacterial infections, pain, and cancer.
   Materials and methods: Hyptis pectinata essential oil (EO, 10, 30, and 100 mg/kg, p.o.) and the reference drugs morphine (5 mg/kg, p.o.) and acetylsalicylic acid (ASA, 200 mg/kg, p.o.) were evaluated using models for analgesia (acetic acid-induced contortions and hot plate) or inflammation (formalin-induced licking response and the subcutaneous air-pouch model). To elucidate the EO's mechanism of action, animals were pre-treated with the opioid receptor antagonist naloxone (1 mg/kg, i.p.), the cholinergic antagonist atropine (1 mg/kg, i.p.), or I.-nitro arginine methyl ester (L-NAME, 3 mg/kg, i.p.) 30 min prior to the oral administration of the EO.
   Results: The EO significantly inhibited the number of writhings and the time the animals spent licking their formalin-injected paws (second phase). The EO, at doses of 30 and 100 mg/kg, increased baseline measurements and area under the curve measurements in the hot plate model, respectively. The administration of naloxone reversed the antinociceptive effect of the EO in the hot plate model. t-NAME significantly reversed the effects of the EO in the contortions and hot plate models. Atropine completely reversed the antinociceptive activity of the EO in all models. Additionally, the EO inhibited the inflammatory process induced by subcutaneous carrageenan injection by reducing cell migration, exudate volume, protein concentration, and inflammatory mediators (nitric oxide, prostaglandin E2, IL-6, and TNF-alpha) produced in the pouch.
   Conclusions: Our results indicate that the Hyptis pectinata essential oil exhibits antinociceptive effects, likely mediated by opioid and cholinergic receptors, and anti-inflammatory activity through the inhibition of nitric oxide and PGE2 production. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Fernandes, Patricia D.] Univ Fed Rio de Janeiro, ICB, Programa Desenvolvimento Farmacos, Lab Farmacol Inflamacao & Oxido Nitr, BR-21941902 Rio De Janeiro, Brazil.
   [Alviano, Daniela S.; Alviano, Celuta S.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941902 Rio De Janeiro, Brazil.
   [Antoniolli, Angelo R.] Univ Fed Sergipe, Dept Fisiol, Farmacol Lab, Sao Cristovao, Sergipe, Brazil.
   [Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Dept Fisiol, Quim Farmaceut Lab, Sao Cristovao, Sergipe, Brazil.
   [Alves, Pericles B.] Univ Fed Sergipe, Dept Quim, Lab Prod Nat, Sao Cristovao, Sergipe, Brazil.
RP Fernandes, PD (corresponding author), Univ Fed Rio de Janeiro, ICB, Programa Desenvolvimento Farmacos, Lab Farmacol Inflamacao & Oxido Nitr, Av Carlos Chagas Filho 373,Predio CCS,Bloco J Sal, BR-21941902 Rio De Janeiro, Brazil.
EM patfern@farmaco.ufrj.br
RI Fernandes, Patricia Dias/C-4489-2013; Fernandes, Patricia/W-1565-2019;
   Cavalcanti, Socrates/AAQ-7004-2020; Antoniolli, Angelo/B-5741-2015;
   Alves, Pericles/S-8768-2019; Alviano, Celuta/V-3878-2019; Alviano,
   Daniela/U-1556-2019
OI Fernandes, Patricia Dias/0000-0001-6870-6745; Alves,
   Pericles/0000-0002-8955-9614; Alviano, Celuta/0000-0002-0806-6712; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); FAPITEC-SE
FX We would like to thank Ms Camilla Bayer for the technical assistance.
   This work was supported by grants from CNPq (fellowship to LJRPR, CCG,
   and grant support), FAPERJ, and FAPITEC-SE.
CR Aceto MD, 1997, EUR J PHARMACOL, V338, P215, DOI 10.1016/S0014-2999(97)81924-3
   Arrigoni-Blank MF, 2008, PHYTOMEDICINE, V15, P334, DOI 10.1016/j.phymed.2007.09.009
   Azevedo NR, 2002, BIOCHEM SYST ECOL, V30, P205, DOI 10.1016/S0305-1978(01)00075-8
   Bispo MD, 2001, J ETHNOPHARMACOL, V76, P81, DOI 10.1016/S0378-8741(01)00172-6
   COLLIER HOJ, 1968, BRIT J PHARMACOL, V32, P295, DOI 10.1111/j.1476-5381.1968.tb00973.x
   Correa M. P., 1984, DICIONARIO PLANTAS U
   CROTEAU R, 1977, HORTSCIENCE, V12, P563
   DERAEDT R, 1980, EUR J PHARMACOL, V61, P17, DOI 10.1016/0014-2999(80)90377-5
   Fernandes ES, 2007, EUR J PHARMACOL, V569, P228, DOI 10.1016/j.ejphar.2007.04.059
   Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105
   Gomes ND, 2010, J ETHNOPHARMACOL, V128, P177, DOI 10.1016/j.jep.2010.01.005
   Gomes NM, 2007, J ETHNOPHARMACOL, V109, P486, DOI 10.1016/j.jep.2006.08.018
   Guslandi M, 1998, EUR J CLIN INVEST, V28, P904
   HERZ A, 1973, EXPERIENTIA, V29, P64, DOI 10.1007/BF01913254
   HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1
   Ikeda Y, 2001, LIFE SCI, V69, P2911, DOI 10.1016/S0024-3205(01)01374-1
   Joly A. B., 1998, BOT INTRO TAXONOMIA
   Jones PG, 2007, NEUROPHARMACOLOGY, V53, P197, DOI 10.1016/j.neuropharm.2007.04.002
   Khan MMA, 1999, CAN J PLANT SCI, V79, P587, DOI 10.4141/P98-090
   Lisboa ACCD, 2006, FITOTERAPIA, V77, P439, DOI 10.1016/j.fitote.2006.06.001
   LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480
   MALAN K, 1988, PLANTA MED, P531, DOI 10.1055/s-2006-962540
   MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003
   Martinez M, 1989, PLANTAS MED MEXICO, P508
   Matheus ME, 2005, J ETHNOPHARMACOL, V102, P377, DOI 10.1016/j.jep.2005.06.033
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   Nascimento PFC, 2008, ORAL DIS, V14, P485, DOI 10.1111/j.1601-0825.2007.01405.x
   de Melo JO, 2006, BIOL PHARM BULL, V29, P2241
   Pang LH, 1997, BIOCHEM PHARMACOL, V53, P773, DOI 10.1016/S0006-2952(96)00817-9
   Pinheiro MMG, 2010, J ETHNOPHARMACOL, V127, P407, DOI 10.1016/j.jep.2009.10.025
   Pol O, 2007, CURR MED CHEM, V14, P1945
   PRADELLES P, 1985, ANAL CHEM, V57, P1170, DOI 10.1021/ac00284a003
   PUTIEVSKY E, 1986, J NAT PROD, V49, P326, DOI 10.1021/np50044a023
   Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069
   ROJAS A, 1992, J ETHNOPHARMACOL, V35, P275, DOI 10.1016/0378-8741(92)90025-M
   ROSLAND JH, 1990, PAIN, V42, P235, DOI 10.1016/0304-3959(90)91167-H
   SAHLEY TL, 1979, PSYCHOPHARMACOLOGY, V65, P279, DOI 10.1007/BF00492216
   Santos-Gomes PC, 2001, J AGR FOOD CHEM, V49, P2908, DOI 10.1021/jf001102b
   SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4
   TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T
   Veiga VF, 2007, J ETHNOPHARMACOL, V112, P248, DOI 10.1016/j.jep.2007.03.005
   Wallace JL, 1999, BRIT J PHARMACOL, V126, P1200, DOI 10.1038/sj.bjp.0702420
   Xu JL, 2000, J MICROBIOL METH, V41, P23, DOI 10.1016/S0167-7012(00)00141-X
NR 43
TC 55
Z9 58
U1 0
U2 24
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD APR 12
PY 2011
VL 134
IS 3
BP 725
EP 732
DI 10.1016/j.jep.2011.01.027
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 754OZ
UT WOS:000289866500019
PM 21277967
DA 2020-12-08
ER

PT J
AU Quintans, LJ
   Guimaraes, AG
   Oliveira, MGB
   Barreto, RS
   Cavalcanti, SCH
   Araujo, AAS
   Santos, MRV
   Quintans, JSS
   Bonjardim, LR
AF Quintans Junior, Lucindo Jose
   Guimaraes, Adriana Gibara
   Oliveira, Makson G. B.
   Barreto, Rosana Siqueira
   Cavalcanti, Socrates C. H.
   Araujo, Adriano A. S.
   Santos, Marcio R. V.
   Quintans, Jullyana S. S.
   Bonjardim, Leonardo R.
TI Antinociceptive activity of carvacrol in formalin-, capsaicin- and
   glutamate-induced orofacial nociception in rodents
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting 2011
CY APR 09-13, 2011
CL Washington, DC
SP Amer Assoc Anatomists (AAA), Amer Physiolog Soc (APS), Amer Soc Biochem & Mol Biol (ASBMB), Amer Soc Investigat Pathol (ASIP), Amer Soc Nutrit (ASN), Amer Soc Pharmacol & Expt Therapeut (ASPET)
C1 [Quintans Junior, Lucindo Jose; Guimaraes, Adriana Gibara; Oliveira, Makson G. B.; Barreto, Rosana Siqueira; Cavalcanti, Socrates C. H.; Araujo, Adriano A. S.; Santos, Marcio R. V.; Quintans, Jullyana S. S.; Bonjardim, Leonardo R.] Univ Fed Sergipe, Cristovao, SE, Brazil.
RI SANTOS, MARCIO/U-2200-2019; Quintans, Lucindo/A-2434-2012; Cavalcanti,
   Socrates/AAQ-7004-2020; Bonjardim, Leonardo R/J-3665-2013; Barreto,
   Rosana S S/L-5004-2016; Guimaraes, Adriana G/G-6860-2014; Quintans,
   Jullyana S.S./A-3917-2012
OI Quintans, Lucindo/0000-0001-5155-938X; Bonjardim, Leonardo
   R/0000-0002-0080-7678; Barreto, Rosana S S/0000-0003-2762-4246;
   Guimaraes, Adriana G/0000-0003-1643-5642; Quintans, Jullyana
   S.S./0000-0001-6507-8982
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2011
VL 25
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 032IE
UT WOS:000310708403482
DA 2020-12-08
ER

PT J
AU Guimaraes, AG
   Oliveira, GF
   Melo, MS
   Cavalcanti, SCH
   Antoniolli, AR
   Bonjardim, LR
   Silva, FA
   Santos, JPA
   Rocha, RF
   Moreira, JCF
   Araujo, AAS
   Gelain, DP
   Quintans, LJ
AF Guimaraes, Adriana G.
   Oliveira, Geovana F.
   Melo, Monica S.
   Cavalcanti, Socrates C. H.
   Antoniolli, Angelo R.
   Bonjardim, Leonardo R.
   Silva, Francilene A.
   Santos, Joao Paulo A.
   Rocha, Ricardo F.
   Moreira, Jose Claudio F.
   Araujo, Adriano A. S.
   Gelain, Daniel P.
   Quintans-Junior, Lucindo J.
TI Bioassay-guided Evaluation of Antioxidant and Antinociceptive Activities
   of Carvacrol
SO BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
LA English
DT Article
ID NITRIC-OXIDE; PROSTAGLANDIN BIOSYNTHESIS; GLUTAMATERGIC RECEPTORS;
   ANTICONVULSANT ACTIVITY; FORMALIN TEST; ACETIC ACID; MICE; INFLAMMATION;
   INVOLVEMENT; NOCICEPTION
AB We examined the antioxidant properties in vitro and the antinociceptive effect of carvacrol (CARV) in several models of pain in mice. CARV presented a strong antioxidant potential according to the TRAP/TAR evaluation; it also presented scavenger activity against nitric oxide and prevented lipid peroxidation in vitro. In mice, when evaluated against acetic acid-induced abdominal writhing, CARV (25, 50 and 100 mg/kg, i.p.) reduced (p < 0.001) the number of writhing compared to the control group, without opioid participation. In the formalin test, CARV also significantly inhibited both the early (neurogenic pain) and the late (inflammatory pain) phases of formalin-induced licking, with inhibition percentage values of 56.8% (100 mg/kg) for the neurogenic phase and 41.2% (25 mg/kg), 73.8% (50 mg/kg) and 99.7% (100 mg/kg) for the inflammatory phase. CARV also produced a significant inhibition of the pain caused by capsaicin (63.1, 67.1 and 95.8%, p < 0.001) and glutamate (46.4, 61.4 and 97.9%, p < 0.01). When assessed in a thermal model of pain, CARV (100 mg/kg, i.p.) caused a significant increase (p < 0.05) in the latency response on the hot-plate test. Such results were unlikely to be provoked by motor abnormality. Together, these results indicate that the properties of CARV should be more thoroughly examined in order to achieve newer tools for management and/or treatment of painful conditions, including those related to pro-oxidant states.
C1 [Guimaraes, Adriana G.; Oliveira, Geovana F.; Melo, Monica S.; Cavalcanti, Socrates C. H.; Antoniolli, Angelo R.; Bonjardim, Leonardo R.; Silva, Francilene A.; Santos, Joao Paulo A.; Araujo, Adriano A. S.; Gelain, Daniel P.; Quintans-Junior, Lucindo J.] Fed Univ Sergipe DFS UFS, Dept Physiol, Sao Cristovao, SE, Brazil.
   [Rocha, Ricardo F.; Moreira, Jose Claudio F.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil.
RP Quintans, LJ (corresponding author), Univ Fed Sergipe, Dept Physiol, Ave Marechal Rondom, Sao Cristovao, Sergipe, Brazil.
EM lucindo_jr@yahoo.com.br
RI Cavalcanti, Socrates/AAQ-7004-2020; Antoniolli, Angelo/B-5741-2015;
   Bonjardim, Leonardo R/J-3665-2013; Santos, Joao Paulo Almeida
   dos/U-3333-2019; Rocha, Ricardo/C-3267-2013; Gelain, Daniel
   Pens/I-5144-2013; Quintans, Lucindo/A-2434-2012; Almeida dos Santos,
   Joao Paulo/P-6741-2014; Guimaraes, Adriana G/G-6860-2014; da Silva,
   Francilene Amaral/ABC-3682-2020
OI Bonjardim, Leonardo R/0000-0002-0080-7678; Santos, Joao Paulo Almeida
   dos/0000-0001-5440-6821; Gelain, Daniel Pens/0000-0001-5254-0509;
   Quintans, Lucindo/0000-0001-5155-938X; Guimaraes, Adriana
   G/0000-0003-1643-5642; da Silva, Francilene Amaral/0000-0001-6729-2843
FU National Council of Technological and Scientific Development (Conselho
   Nacional de Desenvolvimento Cientifico e
   Tecnologico/CNPq/Brazil)National Council for Scientific and
   Technological Development (CNPq) [470290/2008-0]; Research Supporting
   Foundation of State of Sergipe (Fundacao de Apoio a Pesquisa e a
   Inovacao Tecnologica do Estado de Sergipe/FAPITEC-SE)
   [019.203.00860/2009-6]
FX We thank Mr. Osvaldo Andrade Santos for the technical support. This work
   was supported by grants from the National Council of Technological and
   Scientific Development (Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico/CNPq/Brazil) [grant number 470290/2008-0] and the Research
   Supporting Foundation of State of Sergipe (Fundacao de Apoio a Pesquisa
   e a Inovacao Tecnologica do Estado de Sergipe/FAPITEC-SE) [grant number
   019.203.00860/2009-6].
CR Akada Y, 2006, J PHARMACOL SCI, V102, P205, DOI 10.1254/jphs.FP0060621
   Almeida RN, 2001, PHYTOMEDICINE, V8, P310, DOI 10.1078/0944-7113-00050
   Amresh G, 2007, J ETHNOPHARMACOL, V111, P531, DOI 10.1016/j.jep.2006.12.026
   Baser KHC, 2008, CURR PHARM DESIGN, V14, P3106, DOI 10.2174/138161208786404227
   Batista PA, 2008, NEUROSCI LETT, V440, P299, DOI 10.1016/j.neulet.2008.05.092
   Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2
   Beirith A, 2002, BRAIN RES, V924, P219, DOI 10.1016/S0006-8993(01)03240-1
   Bodhinathan K, 2010, J NEUROSCI, V30, P1914, DOI 10.1523/JNEUROSCI.5485-09.2010
   BROADBEAR JH, 1994, PSYCHOPHARMACOLOGY, V115, P311, DOI 10.1007/BF02245071
   da Silva EG, 2007, BIOL PHARM BULL, V30, P1488, DOI 10.1248/bpb.30.1488
   Dapkevicius A, 2002, J NAT PROD, V65, P892, DOI 10.1021/np010636j
   de Sousa DP, 2007, Z NATURFORSCH C, V62, P39
   de Sousa DP, 2007, PHARM BIOL, V45, P69, DOI 10.1080/13880200601028388
   de Sousa DP, 2006, BIOL PHARM BULL, V29, P811, DOI 10.1248/bpb.29.811
   de Sousa DP, 2006, MOLECULES, V11, P148, DOI 10.3390/11020148
   DUARTE IDG, 1988, BRAZ J MED BIOL RES, V21, P341
   DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322
   Elisabetsky E., 1995, Fitoterapia, V66, P407
   ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
   Silva MIG, 2007, PHARMACOL BIOCHEM BE, V88, P141, DOI 10.1016/j.pbb.2007.07.015
   Granger DL, 1996, METHOD ENZYMOL, V268, P142
   Halliwell B, 2007, FREE RADICALS BIOL M
   HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1
   JACOB JJ, 1974, PSYCHOPHARMACOLOGIA, V37, P217, DOI 10.1007/BF00421535
   JACOB JJC, 1978, BRIT J PHARMACOL, V64, P91, DOI 10.1111/j.1476-5381.1978.tb08645.x
   Kirimer N., 1995, Chemistry of Natural Compounds, V31, P37, DOI 10.1007/BF01167568
   KOSTER R, 1959, FED PROC, V18, P412
   Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459
   Le Bars D, 2001, PHARMACOL REV, V53, P597
   Lima RK, 2007, FITOS, V3, P14
   Lyons CR, 1995, ADV IMMUNOL, V60, P323, DOI 10.1016/S0065-2776(08)60589-1
   Ma F, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-31
   MARCINKIEWICZ J, 1995, EUR J IMMUNOL, V25, P947, DOI 10.1002/eji.1830250414
   Melo MS, 2010, PHARM BIOL, V48, P411, DOI 10.3109/13880200903150419
   Mollace V, 2005, PHARMACOL REV, V57, P217, DOI 10.1124/pr.57.2.1
   Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609
   Omote K, 2001, BRAIN RES, V912, P171, DOI 10.1016/S0006-8993(01)02733-0
   de Sousa DP, 2006, NEUROSCI LETT, V401, P231, DOI 10.1016/j.neulet.2006.03.030
   Quintans LJ, 2008, REV BRAS FARMACOGN, V18, P798, DOI 10.1590/S0102-695X2008000500026
   Quintans LJ, 2008, PHYTOMEDICINE, V15, P619, DOI 10.1016/j.phymed.2007.09.018
   Goncalves JCR, 2008, BIOL PHARM BULL, V31, P1017, DOI 10.1248/bpb.31.1017
   REANMONGKOL W, 1994, BIOL PHARM BULL, V17, P1345, DOI 10.1248/bpb.17.1345
   Ribas CM, 2008, BASIC CLIN PHARMACOL, V103, P43, DOI 10.1111/j.1742-7843.2008.00245.x
   Roberto D, 2010, BASIC CLIN PHARMACOL, V106, P38, DOI 10.1111/j.1742-7843.2009.00467.x
   Sakurada T, 2003, PHARMACOL BIOCHEM BE, V75, P115, DOI 10.1016/S0091-3057(03)00066-2
   SAKURADA T, 1992, NEUROPHARMACOLOGY, V31, P1279, DOI 10.1016/0028-3908(92)90057-V
   Salvemini D, 2006, BIOCHEM SOC T, V34, P965, DOI 10.1042/BST0340965
   Salvemini D, 1996, J CLIN INVEST, V97, P2562, DOI 10.1172/JCI118704
   SAUTEBIN L, 1995, BRIT J PHARMACOL, V114, P323, DOI 10.1111/j.1476-5381.1995.tb13230.x
   Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010
   Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543
   TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T
   Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245
   WAGNER H, 1986, PLANTA MED, P184, DOI 10.1055/s-2007-969117
   Waning J, 2007, CELL CALCIUM, V42, P17, DOI 10.1016/j.ceca.2006.11.005
   Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692
   YAKSH TL, 1976, SCIENCE, V192, P1357, DOI 10.1126/science.1273597
NR 57
TC 119
Z9 122
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-7835
EI 1742-7843
J9 BASIC CLIN PHARMACOL
JI Basic Clin. Pharmacol. Toxicol.
PD DEC
PY 2010
VL 107
IS 6
BP 949
EP 957
DI 10.1111/j.1742-7843.2010.00609.x
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 682AZ
UT WOS:000284370400005
PM 20849525
DA 2020-12-08
ER

PT J
AU Santos, SRL
   Silva, VB
   Melo, MA
   Barbosa, JDF
   Santos, RLC
   de Sousa, DP
   Cavalcanti, SCH
AF Santos, Sandra R. L.
   Silva, Viviane B.
   Melo, Manuela A.
   Barbosa, Juliana D. F.
   Santos, Roseli L. C.
   de Sousa, Damiao P.
   Cavalcanti, Socrates C. H.
TI Toxic Effects on and Structure-Toxicity Relationships of
   Phenylpropanoids, Terpenes, and Related Compounds in Aedes aegypti
   Larvae
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Bicyclic derivatives; Dengue; Essential oils; Larvicidal activity;
   p-cymene; Phenol derivatives
ID LARVICIDAL ACTIVITY; ESSENTIAL OILS; COMPONENTS; RESISTANCE; DIPTERA;
   FEVER
AB In the search for toxic compounds against Aedes aegypti L. (Diptera: Culicidae) larvae, a collection of commercially available aromatic and aliphatic diversely substituted compounds were selected and evaluated. p-Cymene exhibited the highest larvicidal potency LC50 = 51 ppm, whereas 1,8-cineole exhibited the lowest activity value LC50 = 1419 ppm. To aid future work on the search for larvicidal compounds, the structure-toxicity relationships of this collection have been evaluated. The presence of lipophilic groups results in an overall increase in potency. In general, the presence of hydroxyl groups resulted in less potent compounds. However, methylation of such hydroxyls led to an overall increase in potency. The most potent compounds showed comparably good larvicidal activity in A. aegypti larvae as other terpenes, which we assume to be the result of the increased lipophilicity.
C1 [Santos, Sandra R. L.; Silva, Viviane B.; Melo, Manuela A.; Barbosa, Juliana D. F.; de Sousa, Damiao P.; Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Med Chem Lab, Dept Pharm, Sao Cristovao, Brazil.
   [Santos, Roseli L. C.] Univ Fed Sergipe, Dept Morphol, Parasitol Lab, Sao Cristovao, Brazil.
RP Cavalcanti, SCH (corresponding author), Univ Fed Sergipe, Lab Quim Farmacuet, Dept Farm, Av Marechal Rondon S-N, BR-49100000 Rosa Elze, Sao Cristovao, Brazil.
EM socrates@ufs.br
RI de Sousa, Damiao Pergentino/AAY-1244-2020; Cavalcanti,
   Socrates/AAQ-7004-2020; de Sousa, Damiao Pergentino/B-2580-2018; Santos,
   Roseli LC/F-1735-2015
OI de Sousa, Damiao Pergentino/0000-0002-7180-4896; 
FU DECIT/SCTIE/MS; CNPqNational Council for Scientific and Technological
   Development (CNPq); SES/SE; FAPITEC-SE
FX The authors wish to acknowledge DECIT/SCTIE/MS, CNPq, SES/SE, and
   FAPITEC-SE for supporting funds.
CR Albuquerque MRJR, 2004, J AGR FOOD CHEM, V52, P6708, DOI 10.1021/jf0352881
   Belzile AS, 2000, PESTIC BIOCHEM PHYS, V66, P33, DOI 10.1006/pest.1999.2453
   Beserra EB, 2007, NEOTROP ENTOMOL, V36, P303, DOI 10.1590/S1519-566X2007000200019
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   CEPLEANU F, 1993, HELV CHIM ACTA, V76, P1379, DOI 10.1002/hlca.19930760324
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   de Sousa DP, 2007, Z NATURFORSCH C, V62, P39
   De Sousa DP, 2007, CHIRALITY, V19, P264, DOI 10.1002/chir.20379
   Dewick P.M., 2001, MED NATURAL PRODUCTS
   do Amaral JF, 2007, BIOL PHARM BULL, V30, P1217, DOI 10.1248/bpb.30.1217
   FINNEY DJ, 1948, BIOMETRIKA, V35, P191, DOI 10.1093/biomet/35.1-2.191
   Kim NJ, 2008, PEST MANAG SCI, V64, P857, DOI 10.1002/ps.1557
   Laurens A, 1997, PHYTOTHER RES, V11, P145, DOI 10.1002/(SICI)1099-1573(199703)11:2<145::AID-PTR40>3.0.CO;2-#
   Lomonaco D, 2009, GREEN CHEM, V11, P31, DOI 10.1039/b811504d
   Lopez O, 2005, GREEN CHEM, V7, P431, DOI 10.1039/b500733j
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Medronho RD, 2008, CAD SAUDE PUBLICA, V24, P949
   Morais SM, 2006, J AM MOSQUITO CONTR, V22, P161, DOI 10.2987/8756-971X(2006)22[161:LAOEOF]2.0.CO;2
   Seccacini E, 2008, J AM MOSQUITO CONTR, V24, P398, DOI 10.2987/5697.1
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Simas NK, 2004, QUIM NOVA, V27, P46, DOI 10.1590/S0100-40422004000100009
   THANGAM TS, 1991, BOT MAR, V34, P433, DOI 10.1515/botm.1991.34.5.433
   Trayers FJ, 2008, MIL MED, V173, P1188, DOI 10.7205/MILMED.173.12.1188
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
NR 26
TC 40
Z9 42
U1 1
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD DEC
PY 2010
VL 10
IS 10
BP 1049
EP 1054
DI 10.1089/vbz.2009.0158
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 689TL
UT WOS:000284952100014
PM 20455777
DA 2020-12-08
ER

PT J
AU Quintans, LJ
   Guimaraes, AG
   Araujo, BES
   Oliveira, GF
   Santana, MT
   Moreira, FV
   Santos, MRV
   Cavalcanti, SCH
   De Lucca, W
   Botelho, MA
   Ribeiro, LAA
   Nobrega, FFF
   Almeida, RN
AF Quintans-Junior, Lucindo J.
   Guimaraes, Adriana G.
   Araujo, Bruno E. S.
   Oliveira, Geovana F.
   Santana, Marilia T.
   Moreira, Flavia V.
   Santos, Marcio R. V.
   Cavalcanti, Socrates C. H.
   De Lucca Junior, Waldecir
   Botelho, Marco A.
   Ribeiro, Luciano A. A.
   Nobrega, Franklin F. F.
   Almeida, Reinaldo N.
TI Carvacrol, (-)- borneol and citral reduce convulsant activity in rodents
SO AFRICAN JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Carvacrol; (-)-borneol; citral; anticonvulsant activity
ID ANTICONVULSANT PROPERTIES; N-SALICYLOYLTRYPTAMINE; ANTIOXIDANT; PLANTS
AB Carvacrol, a monoterpenic phenol present in essential oils of the Labiatae family, has been used through the ages as a source of flavor in food and for medicinal purposes. Borneol is a monoterpene found in several species of Artemisia and Dipterocarpaceae, used for anxiety, pain and anesthesia in traditional Chinese. Citral, a mixture of two geometrical isomers (neral and geranial), is one of the most important compounds in some citrus oils and has central nervous system (CNS) properties. The anticonvulsant effect of carvacrol (CARV), (-)-borneol (BOR) and citral (CIT) was investigated in two animal models of epilepsy. Mice were pretreated with CARV, BOR or CIT (50, 100, and 200 mg/kg, i.p.) 30 min before pentylenetetrazole (PTZ) or maximal electroshock (MES) tests, the two most important animal epilepsy tests. The latency for development of convulsions and protection percentage was recorded. In order to investigate the involvement of GABAergic system, flumazenil was utilized. These monoterpenes, CARV in a higher, but not in a lower dose (p < 0.001), BOR and CIT in all doses (p < 0.05 or p < 0.001), were capable of promoting an increase of latency for the development of convulsions induced by PTZ. Additionally, these compounds were efficient in preventing the tonic convulsions (p < 0.05) induced by MES. However, the GABAergic neurotransmitter system might be involved, at least in BOR effects. Henceforth, our results suggest that CARV, BOR and CIT possess anticonvulsant activity effect against PTZ-induced convulsions and MES.
C1 [Quintans-Junior, Lucindo J.; Guimaraes, Adriana G.; Araujo, Bruno E. S.; Oliveira, Geovana F.; Santana, Marilia T.; Moreira, Flavia V.; Santos, Marcio R. V.; Cavalcanti, Socrates C. H.] Univ Fed Sergipe DFS UFS, Dept Fisiol, Aracaju, SE, Brazil.
   [De Lucca Junior, Waldecir] Univ Fed Sergipe DFS UFS, Dept Morfol, Aracaju, SE, Brazil.
   [Botelho, Marco A.] Inst Fed Educ Ciencia & Tecnol Ceara, Dept Pesquisa, Lab Biotecnol, Caninde, CE, Brazil.
   [Ribeiro, Luciano A. A.] Univ Fed Vale Sao Francisco CFARM UNIVASF, Colegiado Ciencias Farmaceut, Petrolina, PE, Brazil.
   [Nobrega, Franklin F. F.; Almeida, Reinaldo N.] Univ Fed Paraiba LTF UFPB, Lab Tecnol Farmaceut, Joao Pessoa, Paraiba, Brazil.
RP Quintans, LJ (corresponding author), Univ Fed Sergipe DFS UFS, Dept Fisiol, Aracaju, SE, Brazil.
EM lucindo_jr@yahoo.com.br
RI Quintans, Lucindo/A-2434-2012; Ribeiro, Luciano A. A./H-4630-2018;
   Guimaraes, Adriana G/G-6860-2014; SANTOS, MARCIO/U-2200-2019;
   Cavalcanti, Socrates/AAQ-7004-2020; Botelho, Marco A/D-9806-2013
OI Quintans, Lucindo/0000-0001-5155-938X; Ribeiro, Luciano A.
   A./0000-0003-3140-1678; Guimaraes, Adriana G/0000-0003-1643-5642;
   Botelho, Marco A/0000-0001-5269-9966
FU Research Supporting Foundation of the State of Sergipe (Fundacao de
   Apoio a Pesquisa e a Inovacao Tecnologica do Estado de
   Sergipe/FAPITEC-SE [019.203. 00860/2009-6]
FX We thank Mr Osvaldo A. Santos for the technical support. This work was
   supported by grants from the Research Supporting Foundation of the State
   of Sergipe (Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do
   Estado de Sergipe/FAPITEC-SE) grant number 019.203. 00860/2009-6. We
   also thank teacher Abilio Borghi for the English review of the
   manuscript.
CR AESCHBACH R, 1994, FOOD CHEM TOXICOL, V32, P31, DOI 10.1016/0278-6915(84)90033-4
   Almeida R.N., 2008, NEUROSCI LETT, V443, P51, DOI DOI 10.1016/J.NEULET.2008.07.037
   Araujo DAM, 2003, BRIT J PHARMACOL, V140, P1331, DOI 10.1038/sj.bjp.0705471
   Aydin S, 1996, PHYTOTHER RES, V10, P342, DOI 10.1002/(SICI)1099-1573(199606)10:4&lt;342::AID-PTR832&gt;3.0.CO;2-W
   Carlini EA, 2003, PHARMACOL BIOCHEM BE, V75, P501, DOI 10.1016/S0091-3057(03)00112-6
   de Menezes IAC, 2010, J PHARM PHARMACOL, V62, P215, DOI 10.1211/jpp.62.02.0009
   de Sousa DP, 2007, Z NATURFORSCH C, V62, P39
   de Sousa DP, 2007, Z NATURFORSCH C, V62, P563
   de Sousa DP, 2007, PHARM BIOL, V45, P69, DOI 10.1080/13880200601028388
   FILE SE, 1986, PSYCHOPHARMACOLOGY, V88, P1, DOI 10.1007/BF00310505
   Silva MIG, 2009, FITOTERAPIA, V80, P506, DOI 10.1016/j.fitote.2009.06.011
   Granger RE, 2005, BIOCHEM PHARMACOL, V69, P1101, DOI 10.1016/j.bcp.2005.01.002
   GURGEL DT, 2002, PHYTOMEDICINE, V9, P709
   Haruna AK, 2000, PHYTOTHER RES, V14, P57, DOI 10.1002/(SICI)1099-1573(200002)14:1&lt;57::AID-PTR538&gt;3.0.CO;2-V
   Hattori A, 2000, Yakushigaku Zasshi, V35, P49
   Horvathova E, 2009, FOOD CHEM TOXICOL, V47, P1318, DOI 10.1016/j.fct.2009.03.002
   Johnston GAR, 2005, CURR PHARM DESIGN, V11, P1867, DOI 10.2174/1381612054021024
   KIMURA K, 1983, AGR BIOL CHEM TOKYO, V47, P1661, DOI 10.1080/00021369.1983.10865838
   Kirimer N., 1995, Chemistry of Natural Compounds, V31, P37, DOI 10.1007/BF01167568
   Loscher W, 2006, EPILEPSY RES, V69, P183, DOI 10.1016/j.eplepsyres.2006.03.014
   Loscher W, 1998, EUR J PHARMACOL, V342, P1, DOI 10.1016/S0014-2999(97)01514-8
   McCagh J, 2009, EPILEPSY RES, V86, P1, DOI 10.1016/j.eplepsyres.2009.04.007
   Melo MS, 2010, PHARM BIOL, V48, P411, DOI 10.3109/13880200903150419
   Nsour WM, 2000, SEIZURE-EUR J EPILEP, V9, P96, DOI 10.1053/seiz.1999.0378
   Oliveira FA, 2001, PHARMACOL BIOCHEM BE, V68, P199, DOI 10.1016/S0091-3057(00)00484-6
   de Sousa DP, 2006, NEUROSCI LETT, V401, P231, DOI 10.1016/j.neulet.2006.03.030
   QUINTANS LJ, 2010, J OROFACIAL IN PRESS, V24
   Quintans LJ, 2008, REV BRAS FARMACOGN, V18, P798, DOI 10.1590/S0102-695X2008000500026
   Quintans LJ, 2008, PHYTOMEDICINE, V15, P619, DOI 10.1016/j.phymed.2007.09.018
   Schachter SC, 2009, NEUROTHERAPEUTICS, V6, P415, DOI 10.1016/j.nurt.2008.12.004
   Smith M, 2007, NEUROTHERAPEUTICS, V4, P12, DOI 10.1016/j.nurt.2006.11.009
   *SPC, 2005, PHARM PEOPL REP CHIN, P98
   TORTORIELLO J, 1993, PLANTA MED, V59, P398, DOI 10.1055/s-2006-959717
   VIDA JA, 1995, PRINCIPLES MED CHEM, P182
   Wang G, 2006, MED SCI MONITOR, V12, pSR1
   White H S, 1998, Adv Neurol, V76, P29
   *WHO, 2001, 165 WHO
   XIAOFEI J, 2008, WORLD SCI TECHNOL, V10, P27
NR 38
TC 33
Z9 33
U1 1
U2 11
PU ACADEMIC JOURNALS
PI VICTORIA ISLAND
PA P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA
SN 1684-5315
J9 AFR J BIOTECHNOL
JI Afr. J. Biotechnol.
PD SEP 27
PY 2010
VL 9
IS 39
BP 6566
EP 6572
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 655US
UT WOS:000282278000018
DA 2020-12-08
ER

PT J
AU De Sousa, DP
   Vieira, YW
   Uliana, MP
   Melo, MA
   Brocksom, TJ
   Cavalcanti, SCH
AF De Sousa, Damiao P.
   Vieira, Ygor W.
   Uliana, Marciana P.
   Melo, Manuela A.
   Brocksom, Timothy J.
   Cavalcanti, Socrates C. H.
TI Larvicidal activity of para-Benzoquinones
SO PARASITOLOGY RESEARCH
LA English
DT Article
ID AEDES-AEGYPTI; HYDROGEN-PEROXIDE; OXIDATION; QUINONES; PHENOLS;
   NAPHTHOQUINONES; DERIVATIVES; EXTRACTS
AB Plant products may be alternative sources of mosquito larval control agents, since they constitute a rich source of bioactive compounds that are biodegradable into nontoxic products. It has been reported that quinones and derivatives present toxic activity against mosquito larvae Aedes aegypti. Therefore, these facts led us to investigate the larvicidal potential of six structurally related para-benzoquinones against A. aegypti L. (Culicidae) larvae, the vector of dengue fever. All the para-benzoquinones were found to have larvicidal effect. The unsubstituted para-benzoquinone was the compound that exhibited the lowest potency, while 2-isopropyl-para-benzoquinone was the most bioactive. In general, the presence of alkyl groups results in more potent compounds. In addition, the number, position, and size of these groups modulate the potency of the compounds. The experimental results showed that by appropriate structural modification of para-benzoquinones, it may be possible to develop novel insecticidal compounds with potential use to control A. aegypti population.
C1 [De Sousa, Damiao P.] Univ Fed Sergipe, Lab Quim Prod Nat & Sinteticos Bioactivos LAPROBI, BR-49100000 Cristovao, Sergipe, Brazil.
   [Melo, Manuela A.; Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Quim Farmaceut Lab, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Vieira, Ygor W.; Uliana, Marciana P.; Brocksom, Timothy J.] Univ Fed Sao Carlos, Lab Quim Bioorgan, Dept Quim, BR-13565905 Sao Carlos, SP, Brazil.
RP De Sousa, DP (corresponding author), Univ Fed Sergipe, Lab Quim Prod Nat & Sinteticos Bioactivos LAPROBI, BR-49100000 Cristovao, Sergipe, Brazil.
EM damiao_desousa@yahoo.com.br
RI Cavalcanti, Socrates/AAQ-7004-2020; de Sousa, Damiao
   Pergentino/B-2580-2018; de Sousa, Damiao Pergentino/AAY-1244-2020
OI de Sousa, Damiao Pergentino/0000-0002-7180-4896; 
FU National Council of Technological and Scientific DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
FX The authors are grateful to the National Council of Technological and
   Scientific Development for providing financial support.
CR *ACR ORG, 2007, FISHER SCI, V282, P1927
   ADAM W, 1994, J ORG CHEM, V59, P8281, DOI 10.1021/jo00105a058
   BARTON DHR, 1988, TETRAHEDRON, V44, P6397, DOI 10.1016/S0040-4020(01)89827-6
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Cheng SS, 2008, BIORESOURCE TECHNOL, V99, P3617, DOI 10.1016/j.biortech.2007.07.038
   Cohen PA, 1996, EXPERIENTIA, V52, P180, DOI 10.1007/BF01923366
   Dewick PM, 2001, MED NATURAL PRODUCTS, P158
   DOCKAL ER, 1985, SYNTHETIC COMMUN, V15, P1033, DOI 10.1080/00397918508076837
   FINNEY DJ, 1948, BIOMETRIKA, V35, P191, DOI 10.1093/biomet/35.1-2.191
   Hannedouche S, 2002, FITOTERAPIA, V73, P520, DOI 10.1016/S0367-326X(02)00163-6
   Hussein ZAM, 2001, PHARM BIOL, V39, P213
   Ioset JR, 2000, PHYTOCHEMISTRY, V53, P613, DOI 10.1016/S0031-9422(99)00604-4
   Kiprono CP, 2004, B CHEM SOC ETHIOPIA, V18, P45
   Laurent Dominique, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P901
   Midiwo J. O., 1995, Insect Science and its Application, V16, P163
   PINTO AV, 1987, T ROY SOC TROP MED H, V81, P609, DOI 10.1016/0035-9203(87)90427-5
   Ribeiro KAL, 2009, ACTA TROP, V111, P44, DOI 10.1016/j.actatropica.2009.02.008
   Rodrigues AMS, 2005, FITOTERAPIA, V76, P755, DOI 10.1016/j.fitote.2005.08.015
   Saladino R, 2002, TETRAHEDRON, V58, P8493, DOI 10.1016/S0040-4020(02)01025-6
   Sanchez-Valdez Emilio, 2009, Proc West Pharmacol Soc, V52, P14
   Seccacini E, 2008, J AM MOSQUITO CONTR, V24, P398, DOI 10.2987/5697.1
   THANGAM TS, 1991, BOT MAR, V34, P433, DOI 10.1515/botm.1991.34.5.433
   Uliana MP, 2008, J BRAZIL CHEM SOC, V19, P1484, DOI 10.1590/S0103-50532008000800007
   *WHO, 2009, HOM INT GEN DENG DEN
NR 24
TC 12
Z9 12
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
J9 PARASITOL RES
JI Parasitol. Res.
PD AUG
PY 2010
VL 107
IS 3
BP 741
EP 745
DI 10.1007/s00436-010-1942-7
PG 5
WC Parasitology
SC Parasitology
GA 634ER
UT WOS:000280562900033
PM 20549237
DA 2020-12-08
ER

PT J
AU Doria, GAA
   Silva, WJ
   Carvalho, GA
   Alves, PB
   Cavalcanti, SCH
AF Doria, Grace A. A.
   Silva, Wellington J.
   Carvalho, Gilcia A.
   Alves, Pericles B.
   Cavalcanti, Socrates C. H.
TI A study of the larvicidal activity of two Croton species from
   northeastern Brazil against Aedes aegypti
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE Aedes aegypti; beta-caryophyllene; Croton species; bicyclogermacrene;
   essential oil; larvicidal activity
ID RIO-DE-JANEIRO; ESSENTIAL OILS; RESISTANCE; CULICIDAE; TEMEPHOS; DIPTERA
AB The essential oils of Croton heliotropiifolius Kunth (Euphorbiaceae) and Croton pulegiodorus Baill. were selected for larvicidal evaluation against Aedes aegypti L. (Diptera: Culicidae) and studied qualitatively and quantitatively by GC and GC-MS. Sixty-one compounds representing 92.03% (C. heliotropiifolius) and 85.68% (C. pulegiodorus) of the essential oils, respectively, have been identified. The major components of C. heliotropiifolius essential oil were identified as beta-caryophyllene (35.82%), bicyclogermacrene (19.98%), and germacrene-D (11.85%). The major components in C. pulegiodorus essential oil were identified as beta-caryophyllene (20.96%), bicyclogermacrene (16.89%), germacrene-D (10.55%), tau-cadinol (4.56%), and beta-copaen-4-alpha-ol (4.35%). The essential oil of C. pulegiodorus (LC50 159 ppm) was more effective against Ae. aegypti than that of C. heliotropiifolius (LC50 544 ppm). In order to verify whether the major compound of both essential oils is the active principle responsible for the larvicidal activity, beta-caryophyllene was purchased and its larvicidal potential was further evaluated. However, beta-caryophyllene (LC50 1038 ppm) showed weak larvicidal potency. Results of larvicidal evaluation suggest the existence of a synergistic effect of minor components in the essential oils.
C1 [Cavalcanti, Socrates C. H.] Univ Fed Sergipe, CCBS, DFS, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
   [Alves, Pericles B.] Univ Fed Sergipe, Dept Chem, BR-49100000 Sao Cristovao, SE, Brazil.
   [Carvalho, Gilcia A.] Univ Fed Rural Pernambuco, Parasite Dis Lab, Vet Dept, Recife, PE, Brazil.
RP Cavalcanti, SCH (corresponding author), Univ Fed Sergipe, CCBS, DFS, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
EM socrates@ufs.br
RI Cavalcanti, Socrates/AAQ-7004-2020; Alves, Pericles/S-8768-2019
OI Alves, Pericles/0000-0002-8955-9614; Doria, Grace/0000-0002-2454-6775
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPITEC-SE
FX The authors wish to acknowledge CNPq and FAPITEC-SE for funding support.
CR Adams RP, 1995, IDENTIFICATION ESSEN, P469
   Lima Maria Goretti Araújo de, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P211, DOI 10.1590/S0036-46652006000400007
   Baccelli C, 2007, J NAT PROD, V70, P910, DOI 10.1021/np0603976
   Beserra EB, 2007, NEOTROP ENTOMOL, V36, P303, DOI 10.1590/S1519-566X2007000200019
   Bighetti EJB, 2004, CAN J PHYSIOL PHARM, V82, P387, DOI [10.1139/y04-040, 10.1139/Y04-040]
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Brown MD, 2000, J ECON ENTOMOL, V93, P667, DOI 10.1603/0022-0493-93.3.667
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Consoli R., 1994, PRINCIPAIS MOSQUITOS, P228, DOI DOI 10.7476/9788575412909
   FINNEY DJ, 1948, BIOMETRIKA, V35, P191, DOI 10.1093/biomet/35.1-2.191
   Forattini OP, 1998, REV SAUDE PUBL, V32, P497, DOI 10.1590/S0034-89101998000600001
   Govindarajan R, 2008, J PHARM PHARMACOL, V60, P371, DOI 10.1211/jpp.60.3.0013
   Kalinga A K, 2007, Tanzan Health Res Bull, V9, P19
   Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003
   Kusumawathie PHD, 2008, T ROY SOC TROP MED H, V102, P705, DOI 10.1016/j.trstmh.2008.03.013
   LIMA LR, 2008, NORD J BOT, V25, P206
   Morais SM, 2006, J AM MOSQUITO CONTR, V22, P161, DOI 10.2987/8756-971X(2006)22[161:LAOEOF]2.0.CO;2
   Rain AN, 2007, TROP BIOMED, V24, P29
   Rao VS, 2007, J ETHNOPHARMACOL, V113, P357, DOI 10.1016/j.jep.2007.06.009
   Reyes-Trejo B, 2008, J PHARM PHARMACOL, V60, P931, DOI 10.1211/jpp.60.7.0016
   Salatino A, 2007, J BRAZIL CHEM SOC, V18, P11, DOI 10.1590/S0103-50532007000100002
   Santos HS, 2007, NAT PROD COMMUN, V2, P1233
   Seccacini E, 2008, J AM MOSQUITO CONTR, V24, P608, DOI 10.2987/5738.1
   Serrao ML, 2001, MEM I OSWALDO CRUZ, V96, P593, DOI 10.1590/S0074-02762001000500001
   THANGAM TS, 1991, BOT MAR, V34, P433, DOI 10.1515/botm.1991.34.5.433
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
NR 26
TC 26
Z9 29
U1 1
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD JUN 10
PY 2010
VL 48
IS 6
BP 615
EP 620
DI 10.3109/13880200903222952
PG 6
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA 620LW
UT WOS:000279502400003
PM 20645733
DA 2020-12-08
ER

PT B
AU Oliveira, LS
   Santos, VC
   Silva, L
   Matos, L
   Cavalcanti, S
AF Oliveira, L. S.
   Santos, V. C.
   Silva, L.
   Matos, L.
   Cavalcanti, S.
BE Mondaini, RP
TI CLUSTERING DATA IN CHEMOSYSTEMATICS USING A GRAPH-THEORETIC APPROACH: AN
   APPLICATION OF MINIMUM SPANNING TREE WITH PENALTY CONCEPT
SO BIOMAT 2009
LA English
DT Proceedings Paper
CT 9th International Symposium on Mathematical and Computational Biology -
   BIOMAT 2009
CY AUG 01-06, 2009
CL Univ Brasilia, Brasilia, BRAZIL
SP Univ S Paulo, Sch Med
HO Univ Brasilia
ID PLAGIOCHILA
AB Chemosystematics is the classification of plants according to their chemical composition. This paper describes a clustering algorithm, based on minimal spanning trees, that uses the penalty concept to determine the dissimilarity among objects. The algorithm is applied to a dataset of compounds from the essential oil of plants acquired for classification purpose. The results achieved are compared with the ones that consider the proposed algorithm without the penalty concept and the ones that consider a preprocessing of the original data using the principal component analysis method.
C1 [Oliveira, L. S.; Santos, V. C.; Silva, L.; Matos, L.; Cavalcanti, S.] Univ Fed Sergipe, Dept Comp, BR-49100000 Sao Cristovao, SE, Brazil.
RP Oliveira, LS (corresponding author), Univ Fed Sergipe, Dept Comp, Av Marechal Rondon, BR-49100000 Sao Cristovao, SE, Brazil.
EM liliane.stnt@gmail.com; valeriacssp@gmail.com; leila@ufs.br;
   lnmatos@ufs.br; sacrates@ufs.br
RI Cavalcanti, Socrates/AAQ-7004-2020
CR Dosea M, 2008, CHEMOMETR INTELL LAB, V94, P1, DOI 10.1016/j.chemolab.2008.05.007
   FAIRBROTHERS DE, 1977, ANN MO BOT GARD, V64, P147, DOI 10.2307/2395329
   Figueiredo AC, 2005, FLAVOUR FRAG J, V20, P703, DOI 10.1002/ffj.1627
   GIBBS RD, 1999, CHEMOTAXONOMY FLOWER
   Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504
   Kramer R., 1998, CHEMOMETRIC TECHNIQU
   Magalhaes NSS, 1999, EUR J MED CHEM, V34, P83, DOI 10.1016/S0223-5234(99)80043-9
   RAFII ZA, 1991, BIOCHEM SYST ECOL, V19, P249, DOI 10.1016/0305-1978(91)90009-O
   Rycroft DS, 2003, J HATTORI BOT LAB, P331
   Sampaio-Santos MI, 2001, J BRAZIL CHEM SOC, V12, P144
   SEDGEWICK R, 2002, ALGORITHMS 5
   Valant-Vetschera KM, 2001, BIOCHEM SYST ECOL, V29, P149, DOI 10.1016/S0305-1978(00)00033-8
   Waterman PG, 1998, PHYTOCHEMISTRY, V49, P1175
   Yujian L., 2007, PATTERN RECOGN, V40, P1425
   Zidorn C, 2001, BIOCHEM SYST ECOL, V29, P827, DOI 10.1016/S0305-1978(01)00019-9
NR 15
TC 0
Z9 0
U1 0
U2 1
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 978-981-4304-89-4
PY 2010
BP 277
EP 288
DI 10.1142/9789814304900_0019
PG 12
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA BUW21
UT WOS:000290496200019
DA 2020-12-08
ER

PT J
AU Cavalcanti, SCH
   Niculau, ED
   Blank, AF
   Camara, CAG
   Araujo, IN
   Alves, PB
AF Cavalcanti, S. C. H.
   Niculau, E. dos S.
   Blank, A. F.
   Camara, C. A. G.
   Araujo, I. N.
   Alves, P. B.
TI Composition and acaricidal activity of Lippia sidoides essential oil
   against two-spotted spider mite (Tetranychus urticae Koch)
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Lippia sidoides; Essential oil; Acaricidal; Tetranychidae; Spider mite
ID MILBEMYCIN A(4) DERIVATIVES; BEMISIA-TABACI GENN; LARVICIDE; THYMOL
AB The essential oils from accessions of Lippia sidoides Cham. (Verbenaceae) were characterized by GC and GC/MS and investigated for their acaricidal activity against the two-spotted spider mite (Tetranychus urticae Koch). Twenty-nine compounds were identified with potential acaricidal activity. Glass receptacles were Used as test chambers. For each dose and exposure time combination. three replicates were used. Each replicate consisted of 30 adult females of T urticae, 10 mites in each leaf disk of Canavalia ensiformis placed in a Petri dish. Increasing amounts of oil or terpene were applied on a blotting paper strip, fixed on the inner surface of the glass recipient cover, corresponding to 2, 4, 6, 8, and 10 mu L/L of air, respectively. Exposure periods were 24, 48, and 72 h. Data obtained in these experiments were submitted to probit analysis. The essential oil of L. sidoides. thymol and carvacrol exhibited potent acaricidal activity against T urticae. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Niculau, E. dos S.; Alves, P. B.] Univ Fed Sergipe, Dept Quim, BR-49100000 Sao Cristovao, SE, Brazil.
   [Cavalcanti, S. C. H.] Univ Fed Sergipe, Dept Fisiol, BR-49100000 Sao Cristovao, SE, Brazil.
   [Blank, A. F.] Univ Fed Sergipe, Dept Engn Agron, BR-49100000 Sao Cristovao, SE, Brazil.
   [Camara, C. A. G.; Araujo, I. N.] Univ Fed Rural Pernambuco, Dept Quim, BR-52171900 Recife, PE, Brazil.
RP Alves, PB (corresponding author), Univ Fed Sergipe, Dept Quim, Av Marechal Rondon S-N, BR-49100000 Sao Cristovao, SE, Brazil.
EM pericles@ufs.br
RI Blank, Arie F/C-7537-2013; Alves, Pericles/S-8768-2019; Niculau,
   Edenilson dos Santos/B-1380-2013; Cavalcanti, Socrates/AAQ-7004-2020
OI Blank, Arie F/0000-0003-2888-2239; Alves, Pericles/0000-0002-8955-9614;
   Niculau, Edenilson dos Santos/0000-0003-0326-5795; 
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [620212/2006/3]; PIBIC/CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPITEC
FX The authors wish to acknowledge CNPq (ID: 620212/2006/3), PIBIC/CNPq and
   FAPITEC for supporting funds.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Aslan I, 2004, IND CROP PROD, V19, P167, DOI 10.1016/j.indcrop.2003.09.003
   Botelho MA, 2007, BRAZ J MED BIOL RES, V40, P349, DOI 10.1590/S0100-879X2007000300010
   Calmasur O, 2006, IND CROP PROD, V23, P140, DOI 10.1016/j.indcrop.2005.05.003
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Chantraine JM, 1998, PHYTOTHER RES, V12, P350, DOI 10.1002/(SICI)1099-1573(199808)12:5&lt;350::AID-PTR311&gt;3.0.CO;2-7
   ElGengaihi SE, 1996, ANZ SCHADLINGSKD PFL, V69, P157, DOI 10.1007/BF01906806
   FINNEY DJ, 1948, BIOMETRIKA, V35, P191, DOI 10.1093/biomet/35.1-2.191
   Jeppson L.R., 1975, MITES INJURIOUS EC P
   Kabir KE, 2003, J APPL ENTOMOL, V127, P112, DOI 10.1046/j.1439-0418.2003.00716.x
   Pontes WJT, 2007, J ESSENT OIL RES, V19, P379, DOI 10.1080/10412905.2007.9699310
   Pope C, 2005, ENVIRON TOXICOL PHAR, V19, P433, DOI 10.1016/j.etap.2004.12.048
   Shi GL, 2006, J ECON ENTOMOL, V99, P858, DOI 10.1603/0022-0493-99.3.858
   Silva OS, 2004, J AM MOSQUITO CONTR, V20, P456
   Teles Pontes WJ, 2007, QUIM NOVA, V30, P838
   Tsukamoto Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1650, DOI 10.1271/bbb.61.1650
   Tsukamoto Y, 1997, BIOSCI BIOTECH BIOCH, V61, P806, DOI 10.1271/bbb.61.806
   Ullrich A, 2002, FEBS LETT, V529, P346, DOI 10.1016/S0014-5793(02)03425-7
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   Villanueva RT, 2006, J ECON ENTOMOL, V99, P843, DOI 10.1603/0022-0493-99.3.843
NR 20
TC 85
Z9 96
U1 3
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD JAN
PY 2010
VL 101
IS 2
BP 829
EP 832
DI 10.1016/j.biortech.2009.08.053
PG 4
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 511LE
UT WOS:000271165700055
PM 19758799
DA 2020-12-08
ER

PT J
AU Brito, MB
   Barin, GB
   Araujo, AAS
   de Sousa, DP
   Cavalcanti, SCH
   Lira, AAM
   Nunes, RS
AF Brito, M. B.
   Barin, Gabriela B.
   Araujo, A. A. S.
   de Sousa, D. P.
   Cavalcanti, S. C. H.
   Lira, Ana Amelia M.
   Nunes, Rogeria S.
TI The action modes of Lippia sidoides (Cham) essential oil as penetration
   enhancers on snake skin
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article; Proceedings Paper
CT 14th International Congress on Thermal Analysis and Calorimetry
CY SEP 14-18, 2008
CL Sao Pedro, BRAZIL
SP CAPES, CNPq, FAPESP, PETROBRAS
DE DSC; essential oil; FTIR; Lippia sidoides; penetration enhancers
ID VITRO PERCUTANEOUS-ABSORPTION; TRANSDERMAL DELIVERY; PROPYLENE-GLYCOL;
   PERMEATION; VEHICLES; LIPIDS
AB The aim of this work was to study the effect of Lippia sidoides essential oil (LSEO) on stratum corneum lipids and the permeation of salicylic acid. DSC and FTIR spectroscopy were applied. LSEO 1% (v/v) significantly enhanced salicylic acid flux through snake skin. According to the DSC curves changes in the transition temperature of the lipids were observed indicating that LSEO can interact with stratum corneum. The IR spectrum of skin treated with LSEO showed a decrease in the peak intensity for CH2 stretchings (2920-2850 cm(-1)) however the peak positions did not alter suggesting the extraction of the lipids.
C1 [Brito, M. B.; Araujo, A. A. S.; de Sousa, D. P.; Cavalcanti, S. C. H.; Lira, Ana Amelia M.; Nunes, Rogeria S.] Univ Fed Sergipe, Dept Fisiol, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Barin, Gabriela B.] Univ Fed Sergipe, Lab Sintese & Aplicacao Materiais, BR-49100000 Sao Cristovao, Sergipe, Brazil.
RP Araujo, AAS (corresponding author), Univ Fed Sergipe, Dept Fisiol, Av Marechal Rondon S-N,Cidade Univ, BR-49100000 Sao Cristovao, Sergipe, Brazil.
EM adriasa2001@yahoo.com.br
RI Borin Barin, Gabriela/K-5549-2015; Barin, Gabriela Borin/AAD-6645-2019;
   de Sousa, Damiao Pergentino/AAY-1244-2020; Lira, Ana/Y-8196-2019;
   Cavalcanti, Socrates/AAQ-7004-2020; 张, 张鑫月/AAP-1001-2020; Nunes, Rogeria
   RSN/R-5248-2018
OI Borin Barin, Gabriela/0000-0002-1069-6182; Barin, Gabriela
   Borin/0000-0002-1069-6182; Lira, Ana/0000-0003-3451-9049; Nunes, Rogeria
   RSN/0000-0001-6681-2042
CR Almirall M, 1996, ARZNEIMITTEL-FORSCH, V46, P676
   *ASTM, 1993, ANN BOOK ASTM STAND, V14, P1582
   BARRY BW, 1991, J CONTROL RELEASE, V15, P237, DOI 10.1016/0168-3659(91)90115-T
   BARRY BW, 1983, DRUG PHARM SCI, V18, P480
   BENDAS B, 1995, INT J PHARM, V116, P19, DOI 10.1016/0378-5173(94)00267-9
   Bhasi K, 2004, J THERM ANAL CALORIM, V75, P269, DOI 10.1023/B:JTAN.0000017348.24541.fa
   El-Kattan AF, 2001, INT J PHARM, V215, P229, DOI 10.1016/S0378-5173(00)00699-2
   Gao S, 1998, J CONTROL RELEASE, V51, P193, DOI 10.1016/S0168-3659(97)00168-5
   Kang L, 2006, J THERM ANAL CALORIM, V83, P27, DOI 10.1007/s10973-005-7050-8
   LEOPOLD CS, 1995, J PHARM PHARMACOL, V47, P276, DOI 10.1111/j.2042-7158.1995.tb05795.x
   Levang AK, 1999, INT J PHARMACEUT, V181, P255, DOI 10.1016/S0378-5173(99)00055-1
   Lewis Ruthven N. A. H., 1996, P159
   MACAMBIRA LMA, 1986, ACTA AMAZON, V18, P449
   Narishetty STK, 2005, J CONTROL RELEASE, V102, P59, DOI 10.1016/j.jconrel.2004.09.016
   Nokhodchi A, 2007, INT J PHARMACEUT, V335, P97, DOI 10.1016/j.ijpharm.2006.10.041
   NUNES RS, 2005, REV BRAS FARM, V86, P80
   Oh HJ, 2001, INT J PHARM, V212, P63, DOI 10.1016/S0378-5173(00)00598-6
   Schiller R, 2004, J THERM ANAL CALORIM, V77, P497, DOI 10.1023/B:JTAN.0000038989.28709.7f
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Tanojo H, 1999, J THERM ANAL CALORIM, V57, P313, DOI 10.1023/A:1010137807610
   Vaddi HK, 2002, J CONTROL RELEASE, V81, P121, DOI 10.1016/S0168-3659(02)00057-3
   WESTER RC, 1992, CLIN PHARMACOKINET, V23, P253, DOI 10.2165/00003088-199223040-00002
   WILLIAMS AC, 1989, INT J PHARM, V57, pR7, DOI 10.1016/0378-5173(89)90310-4
   Yamane MA, 1995, J PHARM PHARMACOL, V47, P978, DOI 10.1111/j.2042-7158.1995.tb03282.x
   Zhang LC, 2006, BIOL PHARM BULL, V29, P1217, DOI 10.1248/bpb.29.1217
NR 25
TC 6
Z9 7
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1588-2926
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD JUL
PY 2009
VL 97
IS 1
BP 323
EP 327
DI 10.1007/s10973-008-9669-8
PG 5
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 507GT
UT WOS:000270840800053
DA 2020-12-08
ER

PT J
AU Bomfim, RR
   Araujo, AAS
   Cuadros-Orellana, S
   Melo, MGD
   Quintans, LJ
   Cavalcanti, SCH
AF Bomfim, Rangel R.
   Araujo, Adriano A. S.
   Cuadros-Orellana, Sara
   Melo, Marcelia G. D.
   Quintans-Junior, Lucindo J.
   Cavalcanti, Socrates C. H.
TI Larvicidal Activity of Cladonia substellata Extract and Usnic Acid
   against Aedes aegypti and Artemia salina
SO LATIN AMERICAN JOURNAL OF PHARMACY
LA English
DT Article
DE Aedes aegypti; Artemia salina; Cladonia substellata; Larvicidal
   activity; Usnic acid
ID IN-VITRO; LICHENS; METABOLITES; RATS
AB The chloroform extract of Cladonia substellata Vainio was assayed against larvae of Aedes aegypti, the mosquito vector of Dengue fever and Artemia salina. The extract was tested at concentrations ranging from I to 15 ppm in an aqueous medium for 24 h. LC50 and LC90 were evaluated. Since the chloroform extract proved to be lethal for third to fourth instar larvae, downstream processing was undertaken to purify the active agents in the extract. The major compound in the chloroform extract was purified by crystallization followed by column chromatography to yield yellow crystals. Furthermore, usnic acid (UA) was evaluated for its larvicidal potential. The major compound in the chloroform extract, UA, exhibited LC50 of 6.6 ppm (6.1 to 7.0 ppm). Therefore, UA is most likely the active principle in C. substellata. UA showed to be toxic to A. salina, a reference organism in assays to evaluate the potential toxicity hazard to invertebrates in ecosystems.
C1 [Bomfim, Rangel R.; Araujo, Adriano A. S.; Melo, Marcelia G. D.; Quintans-Junior, Lucindo J.; Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Dept Fisiol, Lab Ensaios Farmaceut & Toxicidade, Sao Cristovao, SE, Brazil.
   [Cuadros-Orellana, Sara] ITP, Lab Engn Bioproc, Aracaju, SE, Brazil.
   Univ Fed Sergipe, Dept Fisiol, Quim Farmaceut Lab, Sao Cristovao, SE, Brazil.
RP Araujo, AAS (corresponding author), Univ Fed Sergipe, Dept Fisiol, Lab Ensaios Farmaceut & Toxicidade, Sao Cristovao, SE, Brazil.
EM adriasa2001@yahoo.com.br
RI Cavalcanti, Socrates/AAQ-7004-2020; Orellana, Sara/B-3067-2013;
   Quintans, Lucindo/A-2434-2012; Cuadros-Orellana, Sara/I-7331-2012
OI Quintans, Lucindo/0000-0001-5155-938X; Cuadros-Orellana,
   Sara/0000-0002-0602-7867
FU Fundacao de Amparo a Pesquisa do Estado de Sergipe (FAPITEC-SE);
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX The authors acknowledge to Fundacao de Amparo a Pesquisa do Estado de
   Sergipe (FAPITEC-SE) and CNPq for the financial support.
CR Anderson JE, 1991, PHYTOCHEM ANALYSIS, V2, P107, DOI 10.1002/pca.2800020303
   BALANKUR.M, 1966, B WORLD HEALTH ORGAN, V35, P75
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Chiu MW, 2007, J BIOMED SCI, V14, P429, DOI 10.1007/s11373-007-9151-9
   Santos NPD, 2006, EUR J PHARM BIOPHARM, V64, P154, DOI 10.1016/j.ejpb.2006.05.018
   De Carvalho EAB, 2005, MICRON, V36, P155, DOI 10.1016/j.micron.2004.09.003
   Deciga-Campos M, 2007, J ETHNOPHARMACOL, V110, P334, DOI 10.1016/j.jep.2006.10.001
   Dharmagadda VSS, 2005, BIORESOURCE TECHNOL, V96, P1235, DOI 10.1016/j.biortech.2004.10.020
   Fournet A, 1997, COMP BIOCHEM PHYS C, V116, P51, DOI 10.1016/S0742-8413(96)00127-2
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Huneck S, 1999, NATURWISSENSCHAFTEN, V86, P559, DOI 10.1007/s001140050676
   Huneck S., 1996, IDENTIFICATION LICHE
   Ingolfsdottir K, 1998, EUR J PHARM SCI, V6, P141, DOI 10.1016/S0928-0987(97)00078-X
   KUPCHAN SM, 1975, EXPERIENTIA, V31, P625
   MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236
   Odabasoglu F, 2006, J ETHNOPHARMACOL, V103, P59, DOI 10.1016/j.jep.2005.06.043
   OKUYAMA E, 1995, PLANTA MED, V61, P113, DOI 10.1055/s-2006-958027
   Pramyothin P, 2004, J ETHNOPHARMACOL, V90, P381, DOI 10.1016/j.jep.2003.10.019
   Scirpa P, 1999, Minerva Ginecol, V51, P255
   Vijayakumar C. S., 2000, Fitoterapia, V71, P564, DOI 10.1016/S0367-326X(00)00209-4
   Yang YC, 2002, J AGR FOOD CHEM, V50, P3765, DOI 10.1021/jf011708f
NR 21
TC 10
Z9 11
U1 0
U2 3
PU COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES
PI LA PLATA
PA DEPT CIENTIFICO, CALLE 5 NO 966, LA PLATA, 00000, ARGENTINA
SN 0326-2383
J9 LAT AM J PHARM
JI Lat. Am. J. Pharm.
PD JUL-AUG
PY 2009
VL 28
IS 4
BP 580
EP 584
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 526TX
UT WOS:000272318300016
DA 2020-12-08
ER

PT J
AU Carvalho, ACCS
   Almeida, DS
   Melo, MGD
   Cavalcanti, SCH
   Marcal, RM
AF Carvalho, Ana Carla C. S.
   Almeida, Dayse S.
   Melo, Marcelia G. D.
   Cavalcanti, Socrates C. H.
   Marcal, Rosilene M.
TI Evidence of the mechanism of action of Erythrina velutina Willd
   (Fabaceae) leaves aqueous extract
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Erythrina velutina; Fabaceae; Guinea-pig ileum; Aqueous extract;
   Mechanism; GABA(A)
ID GUINEA-PIG ILEUM; HYDROALCOHOLIC EXTRACTS; MULUNGU; MUSCLE;
   ANTICONVULSANT; MORPHINE; LECTIN
AB Ethnopharmacological relevance: Erythrina velutina is traditionally used for sleepiness, convulsions and nervous system excitation in Brazil. Although central effects have been reported for Erythrina velutina, little is known about its mechanism of action.
   Aim of the study: To investigate the pharmacological evidences of mechanism of action of Erythrina velutina leaves aqueous extract (AE). Materials and methods: Terminal segments of the guinea-pig ileum (n = 5-8) were mounted in an organ bath and isotonic contractions were recorded. Phytochemical screening was carried out on AE.
   Results: AE (0.025-2.50 mg/ml) produced contractile response in the guinea-pig ileum, yielding typical concentration-response curves (EC50 = 0.63 mg/ml). Electrically evoked contractions were significantly increased in the presence of AE. AE-elicited contractions were significantly reduced by bicuculline, tetrodotoxin, atropine, verapamil or incubation in low calcium-high potassium solution. Atropine along with verapamil abolished AE contractile response. Alkaloids, catechins, steroids, flavonols, flavononols, flavonoids. phenols, saponins, tannins, triterpenoids, and xanthones were detected in AE.
   Conclusions: AE contains important constituents for pharmacological activities. AE-induced contractions seem to involve GABA(A) receptor activation. acetylcholine release, muscarinic receptor activation, augmentation of Ca2+ entry through L-type calcium channels, and calcium release from the intracellular stores. These findings provide further support for Erythrina velutina traditional uses. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Carvalho, Ana Carla C. S.; Almeida, Dayse S.; Melo, Marcelia G. D.; Marcal, Rosilene M.] Univ Fed Sergipe, Pharmacol Res Lab, Dept Physiol, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Med Chem Lab, Dept Physiol, BR-49100000 Sao Cristovao, Sergipe, Brazil.
RP Marcal, RM (corresponding author), Univ Fed Sergipe, Pharmacol Res Lab, Dept Physiol, Av Marechal Rondon S-N, BR-49100000 Sao Cristovao, Sergipe, Brazil.
EM rosilenemoretti@ufs.br
RI Cavalcanti, Socrates/AAQ-7004-2020
FU CNPqNational Council for Scientific and Technological Development (CNPq)
FX We are grateful to Professor Dr. Gilvane V. Souza for the plant
   identification. The financial support from CNPq is greatly acknowledged.
CR Bankowski Z., 1986, INT GUIDING PRINCIPL
   BERNARD PS, 1985, J PHARMACOL EXP THER, V235, P98
   DaCunha EVL, 1996, PHYTOCHEMISTRY, V43, P1371, DOI 10.1016/S0031-9422(96)00529-8
   Dantas MC, 2004, J ETHNOPHARMACOL, V94, P129, DOI 10.1016/j.jep.2004.05.007
   Ehlert FJ, 1999, LIFE SCI, V64, P387, DOI 10.1016/S0024-3205(98)00584-0
   Folkers K, 1942, J AM CHEM SOC, V64, P1892, DOI 10.1021/ja01260a040
   FRYE GD, 1990, J PHARMACOL EXP THER, V252, P474
   HABTEMARIAM S, 1993, J ETHNOPHARMACOL, V40, P195, DOI 10.1016/0378-8741(93)90068-G
   JANISZEWSKI L, 1990, POL J PHARMACOL PHAR, V42, P581
   Kamei J, 1996, LIFE SCI, V59, pPL349, DOI 10.1016/S0024-3205(96)00540-1
   Karaki H, 1997, PHARMACOL REV, V49, P157
   Marchioro M, 2005, FITOTERAPIA, V76, P637, DOI 10.1016/j.fitote.2005.07.002
   MATOS FJA, 1997, INTRO FITOQUIMICA EX, P42
   McCarson KE, 1999, NEUROPHARMACOLOGY, V38, P1767, DOI 10.1016/S0028-3908(99)00121-5
   Moraes SMD, 1996, BRAZ J MED BIOL RES, V29, P977
   Oliveira Jose Tadeu Abreu, 1998, Revista Brasileira de Fisiologia Vegetal, V10, P25
   PATON WDM, 1957, BRIT J PHARM CHEMOTH, V12, P119, DOI 10.1111/j.1476-5381.1957.tb01373.x
   QUEIROZNETO A, 1990, J ETHNOPHARMACOL, V28, P183, DOI 10.1016/0378-8741(90)90028-R
   Rabelo LA, 2001, BIOCHEM SYST ECOL, V29, P543, DOI 10.1016/S0305-1978(00)00077-6
   Ribeiro MD, 2006, BRAZ J MED BIOL RES, V39, P263, DOI 10.1590/S0100-879X2006000200013
   STOJANOVIC D, 1994, PHYTOCHEMISTRY, V37, P1069, DOI 10.1016/S0031-9422(00)89530-8
   TONINI M, 1988, ARCH INT PHARMACOD T, V296, P173
   Vasconcelos SMM, 2007, J ETHNOPHARMACOL, V110, P271, DOI 10.1016/j.jep.2006.09.023
   Vasconcelos SMM, 2004, J PHARM PHARMACOL, V56, P389, DOI 10.1211/0022357022746
   Vasconcelos SMM, 2003, BIOL PHARM BULL, V26, P946, DOI 10.1248/bpb.26.946
   Virtuoso S., 2005, Rev. bras. farmacogn., V15, P137, DOI 10.1590/S0102-695X2005000200012
NR 26
TC 15
Z9 15
U1 0
U2 12
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD MAR 18
PY 2009
VL 122
IS 2
BP 374
EP 378
DI 10.1016/j.jep.2008.12.019
PG 5
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 429DA
UT WOS:000264899800024
PM 19146942
DA 2020-12-08
ER

PT J
AU Dosea, M
   Silva, L
   Silva, MA
   Cavalcanti, SCH
AF Dosea, Marcos
   Silva, Leila
   Silva, Maria A.
   Cavalcanti, Socrates C. H.
TI Adaptive Mean-Linkage with Penalty: A new algorithm for cluster analysis
SO CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS
LA English
DT Article
DE Cluster analysis; Chemosystematics; Essential oil composition;
   Clustering
ID ESSENTIAL OIL COMPOSITION; CHEMICAL-COMPOSITION
AB A novel cluster analysis technique, so-called Adaptive Mean-Linkage with Penalty algorithm (AMLP) is proposed. The method is based on a penalty concept applied to the Euclidian distance. which determines the dissimilarity among objects when clustering data. The implementation of this technique is straightforward and provides enhanced classification in our case studies. The proposed clustering procedure was applied to a dataset of compounds from the essential oil of plants acquired for classification purpose. The potentiality of this novel technique to distinguish each plant or group of plants according to the concentration levels of compounds in the essential oil has been validated. A free web tool is available. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Silva, Maria A.; Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Dept Farm, BR-49100000 Sao Cristovao, SE, Brazil.
   [Dosea, Marcos; Silva, Leila] Univ Fed Sergipe, Dept Ciencia Computac & Estat, BR-49100000 Sao Cristovao, SE, Brazil.
RP Cavalcanti, SCH (corresponding author), Univ Fed Sergipe, Dept Farm, Campus Univ Prof Jose Aloisio de Campos, BR-49100000 Sao Cristovao, SE, Brazil.
EM socrates@ufs.br
RI Cavalcanti, Socrates/AAQ-7004-2020
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAP-SE
FX The authors wish to acknowledge CNPq and FAP-SE for supporting grants.
CR Aguiar EHA, 2003, J ESSENT OIL RES, V15, P130, DOI 10.1080/10412905.2003.9712089
   Araujo ECC, 2003, J AGR FOOD CHEM, V51, P3760, DOI 10.1021/jf021074s
   Azevedo NR, 2002, BIOCHEM SYST ECOL, V30, P205, DOI 10.1016/S0305-1978(01)00075-8
   Baumgartner C, 2005, J DIGIT IMAGING, V18, P219, DOI 10.1007/s10278-004-1048-9
   Beebe KR, 1998, CHEMOMETRICS PRACTIC
   BOCHANG Y, 1985, J GEOCHEM EXPLOR, V23, P281
   DeGaetano AT, 1996, J CLIMATE, V9, P1765, DOI 10.1175/1520-0442(1996)009<1765:DOMCZI>2.0.CO;2
   EDWARDS AWF, 1965, BIOMETRICS, V21, P362, DOI 10.2307/2528096
   Ezer N, 1996, PHYTOCHEMISTRY, V41, P203, DOI 10.1016/0031-9422(95)00601-X
   Forina A, 2002, ANAL CHIM ACTA, V454, P13, DOI 10.1016/S0003-2670(01)01517-3
   Gosling J., 2005, JAVA LANGUAGE SPECIF
   Jacobson I, 1999, IEEE SOFTWARE, V16, P96
   Karousou R, 1998, BIOCHEM SYST ECOL, V26, P889, DOI 10.1016/S0305-1978(98)00033-7
   Lopez AG, 2002, J ESSENT OIL RES, V14, P179, DOI 10.1080/10412905.2002.9699816
   Magalhaes NSS, 1999, EUR J MED CHEM, V34, P83, DOI 10.1016/S0223-5234(99)80043-9
   Marino M, 2001, INT J FOOD MICROBIOL, V67, P187, DOI 10.1016/S0168-1605(01)00447-0
   Otto M., 1999, CHEMOMETRICS STAT CO
   Ozcan M, 2001, FOOD CHEM, V75, P459, DOI 10.1016/S0308-8146(01)00225-4
   PerezAlonso MJ, 1996, BIOCHEM SYST ECOL, V24, P571, DOI 10.1016/0305-1978(96)00064-6
   SerratoValenti G, 1997, ANN BOT-LONDON, V79, P329, DOI 10.1006/anbo.1996.0348
   Sivropoulou A, 1997, J AGR FOOD CHEM, V45, P3197, DOI 10.1021/jf970031m
   Theodoridis S., 2003, PATTERN RECOGNITION
NR 22
TC 2
Z9 4
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-7439
EI 1873-3239
J9 CHEMOMETR INTELL LAB
JI Chemometrics Intell. Lab. Syst.
PD NOV 15
PY 2008
VL 94
IS 1
BP 1
EP 8
DI 10.1016/j.chemolab.2008.05.007
PG 8
WC Automation & Control Systems; Chemistry, Analytical; Computer Science,
   Artificial Intelligence; Instruments & Instrumentation; Mathematics,
   Interdisciplinary Applications; Statistics & Probability
SC Automation & Control Systems; Chemistry; Computer Science; Instruments &
   Instrumentation; Mathematics
GA 408OD
UT WOS:000263443400001
DA 2020-12-08
ER

PT J
AU Silva, WJ
   Doria, GAA
   Maia, RT
   Nunes, RS
   Carvalho, GA
   Blank, AF
   Alves, PB
   Marcal, RM
   Cavalcanti, SCH
AF Silva, W. J.
   Doria, G. A. A.
   Maia, R. T.
   Nunes, R. S.
   Carvalho, G. A.
   Blank, A. F.
   Alves, P. B.
   Marcal, R. M.
   Cavalcanti, S. C. H.
TI Effects of essential oils on Aedes aegypti larvae: Alternatives to
   environmentally safe insecticides
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Hyptis ftuticosa; Lippia gracilis; Hyptis pectinata; larvicidal;
   carvacrol
ID LIPPIA-SIDOIDES CHAM.; LARVICIDAL ACTIVITY; RESISTANCE; TEMEPHOS;
   ALBOPICTUS; BRAZIL
AB The essential oils from leaves of Hyptis fruticosa (Lamiaceae) Salzm., H. pectinata (Lamiaccae) Poit., and Lippia gracilis (Verbenaceae) HBK were investigated for their larvicidal activity against Aedes aegypti and analyzed by GC/MS. Fifty-nine compounds, representing 91.28-98.39% of the essential oils, have been identified. A standard solution was used to make 20 mL solutions ranging from 30 to 2000 ppm. Twenty larvae between third and fourth stages were added to the essential oil solution. A mortality count was conducted 24 h after treatment. Essential oils LC50 and their confidence limits at 95% probability were calculated by the methods of Reed-Muench and Pizzi, respectively. The essential oil of Lippia gracilis showed potent insecticidal effect against Aedes aegypti larvae, the vector of dengue fever. Carvacrol and caryophyllene oxide were the main responsible for the activity of L. gracilis and H. pectinata. Minor compounds are probably acting synergistically to achieve H. fruiticosa activity. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Silva, W. J.; Doria, G. A. A.; Nunes, R. S.; Marcal, R. M.; Cavalcanti, S. C. H.] Univ Fed Sergipe, Dept Physiol, BR-49000197 Aracaju, Brazil.
   [Alves, P. B.] Univ Fed Sergipe, Dept Chem, BR-49000197 Aracaju, Brazil.
   [Blank, A. F.] Univ Fed Sergipe, Dept Agr Engn, BR-49000197 Aracaju, Brazil.
   [Maia, R. T.; Carvalho, G. A.] Univ Fed Rural Pernambuco, Parasit Dis Lab, Vet Dept, BR-52171900 Recife, PE, Brazil.
RP Cavalcanti, SCH (corresponding author), Univ Fed Sergipe, Dept Physiol, Caixa Postal 52, BR-49000197 Aracaju, Brazil.
EM socrates@ufs.br
RI Cavalcanti, Socrates/AAQ-7004-2020; Blank, Arie F/C-7537-2013; Nunes,
   Rogeria RSN/R-5248-2018; Alves, Pericles/S-8768-2019
OI Blank, Arie F/0000-0003-2888-2239; Nunes, Rogeria
   RSN/0000-0001-6681-2042; Alves, Pericles/0000-0002-8955-9614; Doria,
   Grace/0000-0002-2454-6775
CR Adams RP, 1995, IDENTIFICATION ESSEN
   Aguiar EHA, 2003, J ESSENT OIL RES, V15, P130, DOI 10.1080/10412905.2003.9712089
   Araujo ECC, 2003, J AGR FOOD CHEM, V51, P3760, DOI 10.1021/jf021074s
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Carvalho AFU, 2003, MEM I OSWALDO CRUZ, V98, P569, DOI 10.1590/S0074-02762003000400027
   Chantraine JM, 1998, PHYTOTHER RES, V12, P350, DOI 10.1002/(SICI)1099-1573(199808)12:5&lt;350::AID-PTR311&gt;3.0.CO;2-7
   Dharmagadda VSS, 2005, BIORESOURCE TECHNOL, V96, P1235, DOI 10.1016/j.biortech.2004.10.020
   EDWARDS MG, 1948, J SOC CHEM IND-L, V67, P379, DOI 10.1002/jctb.5000671004
   GODIN PJ, 1966, VIS J CHEM SOC C, P332
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Hitmi A, 2000, CRIT REV BIOCHEM MOL, V35, P317, DOI 10.1080/10409230091169230
   Kabir KE, 2003, J APPL ENTOMOL, V127, P112, DOI 10.1046/j.1439-0418.2003.00716.x
   Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020
   MALAN K, 1988, PLANTA MED, P531, DOI 10.1055/s-2006-962540
   Pietschmann M., 1998, Journal of Essential Oil Research, V10, P550
   PIZZI M, 1950, Hum Biol, V22, P151
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rodriguez MM, 2002, J MED ENTOMOL, V39, P882, DOI 10.1603/0022-2585-39.6.882
   Romi R, 2003, J AM MOSQUITO CONTR, V19, P419
   Silva OS, 2004, J AM MOSQUITO CONTR, V20, P456
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Sousa EMBD, 2002, BRAZ J CHEM ENG, V19, P229, DOI 10.1590/S0104-66322002000200003
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   Wirth MC, 1999, J AM MOSQUITO CONTR, V15, P315
NR 24
TC 126
Z9 147
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
EI 1873-2976
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD MAY
PY 2008
VL 99
IS 8
BP 3251
EP 3255
DI 10.1016/j.biortech.2007.05.064
PG 5
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 275LF
UT WOS:000254072200072
PM 17662602
DA 2020-12-08
ER

PT J
AU Santos, TC
   Marques, MS
   Menezes, IAC
   Dias, KS
   Silva, ABL
   Mello, ICM
   Carvalho, ACS
   Cavalcanti, SCH
   Antoniolli, AR
   Marcal, RM
AF Santos, Thiago C.
   Marques, Maxsuel S.
   Menezes, Igor A. C.
   Dias, Kellyane S.
   Silva, Aline B. L.
   Mello, Iderjane C. M.
   Carvalho, Ana C. S.
   Cavalcanti, Sorates C. H.
   Antoniolli, Angelo R.
   Marcal, Rosilene M.
TI Antinociceptive effect and acute toxicity of the Hyptis suaveolens
   leaves aqueous extract on mice
SO FITOTERAPIA
LA English
DT Article
DE Hyptis suaveolens; antinociceptive effect; acute toxicity
ID ESSENTIAL OILS; CHEMICAL-COMPOSITION; AROMATIC PLANTS; TRITERPENE ACID;
   FORMALIN TEST; POIT; ANIMALS; SEEDS; PAIN
AB The aqueous extract of Hyptis suaveolens leaves was studied for their antinociceptive property in chemical and thermal models of nociception in mice. Oral administration of the aqueous extract (100, 200, and 400 mg/kg) dose-dependently reduced the number of writhings induced by acetic acid, decreased the licking activity of the early phase in formalin test and increased the reaction time in hot-plate test. The antinociceptive effect was significantly antagonized by naloxone (3 mg/kg; i.p.). Preliminary acute toxicity study showed that no animal death with doses up to 5 g/kg (p.o.). (c) 2007 Elsevier B.V. All rights reserved.
C1 Univ Fed Sergipe, Fac Pharmaceut Sci, Dept Physiol, Sao Cristovao, Brazil.
RP Santos, TC (corresponding author), Caixa Postal 52, BR-49001970 Sergipe, Brazil.
EM thc_santos80@hotmail.com
RI Cavalcanti, Socrates/AAQ-7004-2020; Antoniolli, Angelo/B-5741-2015
CR Aguirre C, 2004, COMP BIOCHEM PHYS B, V138, P81, DOI 10.1016/j.cbpc.2004.02.011
   ANKIER SI, 1974, EUR J PHARMACOL, V27, P1, DOI 10.1016/0014-2999(74)90195-2
   Asekun Olayinka Taiwo, 1999, Fitoterapia, V70, P440, DOI 10.1016/S0367-326X(99)00067-2
   ASPINALL GO, 1991, CARBOHYD RES, V214, P107, DOI 10.1016/S0008-6215(00)90534-2
   Azevedo NR, 2002, BIOCHEM SYST ECOL, V30, P205, DOI 10.1016/S0305-1978(01)00075-8
   BIRD GWG, 1960, BRIT J HAEMATOL, V6, P151, DOI 10.1111/j.1365-2141.1960.tb06226.x
   BIRD GWG, 1959, NATURE, V184, P109, DOI 10.1038/184109a0
   Bispo MD, 2001, J ETHNOPHARMACOL, V76, P81, DOI 10.1016/S0378-8741(01)00172-6
   CORREA MP, 1931, IMPRENSA NACL, V5, P194
   DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0
   Eshilokun AO, 2005, FLAVOUR FRAG J, V20, P528, DOI 10.1002/ffj.1452
   Grassi P, 2005, FLAVOUR FRAG J, V20, P131, DOI 10.1002/ffj.1393
   HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1
   IWU M M, 1990, International Journal of Crude Drug Research, V28, P73
   KOSTER R, 1959, FED PROC, V18, P412
   Le Bars D, 2001, PHARMACOL REV, V53, P597
   LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480
   MALLIKA M, 1978, J BIOCH BIOPHYS, V15, P4
   MISRA TN, 1981, J NAT PROD, V44, P735, DOI 10.1021/np50018a023
   MISRA TN, 1983, PHYTOCHEMISTRY, V22, P2557, DOI 10.1016/0031-9422(83)80163-0
   MUKHERJEE KS, 1984, J NAT PROD, V47, P377, DOI 10.1021/np50032a025
   Peerzada N, 1997, MOLECULES, V2, P165, DOI 10.3390/21100165
   Raja N, 2005, CURR SCI INDIA, V88, P220
   RAO KVR, 1990, PHYTOCHEMISTRY, V29, P1326
   Sidibe L, 2001, J ESSENT OIL RES, V13, P55, DOI 10.1080/10412905.2001.9699605
   SINGH G, 1993, J SCI IND RES INDIA, V52, P676
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
   Zollo PHA, 1998, FLAVOUR FRAG J, V13, P107, DOI 10.1002/(SICI)1099-1026(199803/04)13:2&lt;107::AID-FFJ701&gt;3.0.CO;2-G
NR 28
TC 20
Z9 21
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0367-326X
J9 FITOTERAPIA
JI Fitoterapia
PD JUL
PY 2007
VL 78
IS 5
BP 333
EP 336
DI 10.1016/j.fitote.2007.01.006
PG 4
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 197EV
UT WOS:000248538300001
PM 17512135
DA 2020-12-08
ER

PT J
AU Menezes, IAC
   Marques, MS
   Santos, TC
   Dias, KS
   Silva, ABL
   Mello, ICM
   Lisboa, ACCD
   Alves, PB
   Cavalcanti, SCH
   Marcal, RM
   Antoniolli, AR
AF Menezes, Igor A. C.
   Marques, Maxsuel S.
   Santos, Thiago C.
   Dias, Kellyane S.
   Silva, Aline B. L.
   Mello, Iderjane C. M.
   Lisboa, Ana C. C. D.
   Alves, Pericles B.
   Cavalcanti, Socrates C. H.
   Marcal, Rosilene M.
   Antoniolli, Angelo R.
TI Antinociceptive effect and acute toxicity of the essential oil of Hyptis
   fruticosa in mice
SO FITOTERAPIA
LA English
DT Article
DE Hyptis fruticosa; essential oil; antinociceptive
ID ANTIMICROBIAL ACTIVITY; ANTIFUNGAL ACTIVITY; OVALIFOLIA; ANIMALS; RATS
AB The essential oil of the Hyptis fruticosa leaves was analyzed by GC/MS and evaluated for antinociceptive property as well as acute toxicity in mice. The essential oil, at doses of 100, 200, and 400 mg/kg (s.c.), produced significant inhibition of acetic acid-induced writhing, but did not manifest a significant effect in hot-plate test. There was no acute toxicity at doses up to 5 g/kg. Bicyclogermacrene, 1,8-cineole, a-pinene, and p-caryophyllene were the major compounds detected in the essential oil. (C) 2007 Elsevier B.V. All rights reserved.
C1 Univ Fed Sergipe, CCBS, DFS, Dept Physiol, BR-49001470 Sergipe, Brazil.
   Univ Fed Sergipe, Dept Chem, Sao Cristovao, Brazil.
RP Menezes, IAC (corresponding author), Univ Fed Sergipe, CCBS, DFS, Dept Physiol, Caixa Postal 52, BR-49001470 Sergipe, Brazil.
EM igormenezes@bol.com.br
RI Alves, Pericles/S-8768-2019; Antoniolli, Angelo/B-5741-2015; Cavalcanti,
   Socrates/AAQ-7004-2020
OI Alves, Pericles/0000-0002-8955-9614; 
CR Adams RP, 1995, IDENTIFICATION ESSEN
   ANKIER SI, 1974, EUR J PHARMACOL, V27, P1, DOI 10.1016/0014-2999(74)90195-2
   BARBOSA PPP, 1992, PHYTOTHER RES, V6, P114, DOI 10.1002/ptr.2650060214
   Bispo MD, 2001, J ETHNOPHARMACOL, V76, P81, DOI 10.1016/S0378-8741(01)00172-6
   Correa MP, 1931, DICIONARIO PLANTAS U
   De Araujo M D, 1974, Rev Inst Antibiot (Recife), V14, P101
   de Oliveira CMA, 2004, J BRAZIL CHEM SOC, V15, P756, DOI 10.1590/S0103-50532004000500023
   FUKAWA K, 1980, J PHARMACOL METHOD, V4, P251
   KOSTER R, 1959, FED PROC, V18, P412
   LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480
   MALAN K, 1988, PLANTA MED, P531, DOI 10.1055/s-2006-962540
   Malele RS, 2003, J ESSENT OIL RES, V15, P438, DOI 10.1080/10412905.2003.9698633
   MARLETTI F, 1976, GAZZ CHIM ITAL, V106, P119
   MONACHE FD, 1977, GAZZ CHIM ITAL, V107, P319
   ROJAS A, 1992, J ETHNOPHARMACOL, V35, P275, DOI 10.1016/0378-8741(92)90025-M
   Souza LKH, 2003, MEM I OSWALDO CRUZ, V98, P963, DOI 10.1590/S0074-02762003000700018
   VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
NR 18
TC 32
Z9 34
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0367-326X
EI 1873-6971
J9 FITOTERAPIA
JI Fitoterapia
PD APR
PY 2007
VL 78
IS 3
BP 192
EP 195
DI 10.1016/j.fitote.2006.11.020
PG 4
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 167WP
UT WOS:000246483500005
PM 17350178
DA 2020-12-08
ER

PT J
AU Lisboa, ACCD
   Mello, ICM
   Nunes, RS
   dos Santos, MA
   Antoniolli, AR
   Marcal, RM
   Cavalcanti, SCD
AF Lisboa, Ana C. C. D.
   Mello, Iderjane C. M.
   Nunes, Rogeria S.
   dos Santos, Marques A.
   Antoniolli, Angelo R.
   Marcal, Rosilene M.
   Cavalcanti, Socrates C. de H.
TI Antinociceptive effect of Hyptis pectinata leaves extracts
SO FITOTERAPIA
LA English
DT Article
DE Hyptis pectinata; analgesy; naloxone
ID STEREOCHEMISTRY; ANIMALS; PLANTS
AB Oral administration of hexanes, chloroform, and ethyl acetate extracts of the leaves of Hyptis pectinata significantly reduced the number of writhing induced by acetic acid and increased the response to thermal stimuli in hot-plate test. Such effect was completely reversed by the opioid antagonist naloxone. (c) 2006 Elsevier B.V. All rights reserved.
C1 Fed Univ Sergipe, Dept Physiol, Sergipe, Brazil.
RP Lisboa, ACCD (corresponding author), Caixa Postal 52, BR-49001970 Aracaju, Sergipe, Brazil.
EM anacarlaufs@yahoo.com.br
RI Cavalcanti, Socrates/AAQ-7004-2020; Nunes, Rogeria RSN/R-5248-2018;
   Antoniolli, Angelo/B-5741-2015
OI Nunes, Rogeria RSN/0000-0001-6681-2042; 
CR ANKIER SI, 1974, EUR J PHARMACOL, V27, P1, DOI 10.1016/0014-2999(74)90195-2
   Bispo MD, 2001, J ETHNOPHARMACOL, V76, P81, DOI 10.1016/S0378-8741(01)00172-6
   Fragoso-Serrano M, 2005, PLANTA MED, V71, P278, DOI 10.1055/s-2005-837831
   KOSTER R, 1959, FED PROC, V18, P412
   MALAN K, 1988, PLANTA MED, P531, DOI 10.1055/s-2006-962540
   Melo GB, 2005, DIGEST DIS SCI, V50, P949, DOI 10.1007/s10620-005-2670-1
   PEREDAMIRANDA R, 1991, ABSTR PAP AM CHEM S, V202, P60
   PEREDAMIRANDA R, 1993, J NAT PROD, V56, P583, DOI 10.1021/np50094a019
   ROJAS A, 1992, J ETHNOPHARMACOL, V35, P275, DOI 10.1016/0378-8741(92)90025-M
   Tchoumbougnang F, 2005, FLAVOUR FRAG J, V20, P340, DOI 10.1002/ffj.1441
   YAKSH TL, 1977, J PHARMACOL EXP THER, V202, P411
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
NR 12
TC 15
Z9 15
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0367-326X
EI 1873-6971
J9 FITOTERAPIA
JI Fitoterapia
PD SEP
PY 2006
VL 77
IS 6
BP 439
EP 442
DI 10.1016/j.fitote.2006.06.001
PG 4
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 086TE
UT WOS:000240695100007
PM 16908108
DA 2020-12-08
ER

PT J
AU Marcal, RM
   Ptak, DM
   Krempser, RR
   Krempser, MR
   Floresta, SV
   Moreno, MPN
   Cavalcanti, SCH
   Fernandes, JB
AF Marcal, R. M.
   Ptak, D. M.
   Krempser, R. R.
   Krempser, M. R.
   Floresta, S., V
   Moreno, M. P. N.
   Cavalcanti, S. C. H.
   Fernandes, J. B.
TI Antinociceptive profile of ethyl acetate extract of Hyptis fruticosa
   Salzm. ex Benth. (Labiatae)
SO PLANTA MEDICA
LA English
DT Meeting Abstract
CT 54th Annual Congress on Medicinal Plant Research
CY AUG 29-SEP 02, 2006
CL Helsinki, FINLAND
SP Soc Medicinal Plant Res, Univ Helsinki Fac Pharm
C1 Univ Fed Sergipe, Dept Physiol, BR-49100000 Sao Cristovao, SE, Brazil.
   Univ Fed Sao Carlos, Dept Chem, BR-13056590 Sao Carlos, SP, Brazil.
RI Cavalcanti, Socrates/AAQ-7004-2020; Fernandes, Joao/C-8134-2012
CR ANKIER SI, 1974, EUR J PHARMACOL, V27, P1, DOI 10.1016/0014-2999(74)90195-2
   HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1
   KOSTER R, 1959, FED PROC, V18, P412
NR 3
TC 0
Z9 0
U1 0
U2 2
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0032-0943
J9 PLANTA MED
JI Planta Med.
PD SEP
PY 2006
VL 72
IS 11
MA P078
BP 1007
EP 1007
PG 1
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 095TJ
UT WOS:000241330900158
DA 2020-12-08
ER

PT J
AU Bazmi, HZ
   Hammond, JL
   Cavalcanti, SCH
   Chu, CK
   Schinazi, RF
   Mellors, JW
AF Bazmi, HZ
   Hammond, JL
   Cavalcanti, SCH
   Chu, CK
   Schinazi, RF
   Mellors, JW
TI In vitro selection of mutations in the human immunodeficiency virus type
   1 reverse transcriptase that decrease susceptibility to
   (-)-beta-D-dioxolane-guanosine and suppress resistance to 3 '-azido-3
   '-deoxythymidine
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID INHIBITORS; MECHANISM; PHARMACOKINETICS; SENSITIVITY; LYMPHOCYTES;
   METABOLITE; DIOXOLANE; FOSCARNET; VARIANTS; THERAPY
AB Human immunodeficiency virus type 1 (HIV-1) isolates resistant to (-)-beta-D-dioxolane-guanosine (DXG), a potent and selective nucleoside analog HIV-1 reverse transcriptase (RT) inhibitor, were selected by serial passage of HIV-1(LAI) in increasing drug concentrations (maximum concentration, 30 mu M) Two independent selection experiments were performed, Viral isolates for which the DXG median effective concentrations (EC(50)s) increased 7.3- and 12.2-fold were isolated after 13 and 14 passages, respectively. Cloning and DNA sequencing of the RT region from the first resistant isolate identified a K65R mutation (AAA to AGA) in 10 of 10 clones. The role of this mutation in DXG resistance was confirmed by site-specific mutagenesis of HIV-1(LAI). The K65R mutation also conferred greater than threefold cross-resistance to 2',3'-dideoxycytidine, 2',3'-dideoxyinosine, 2',3'-dideoxy-3'-thiacytidine, 9-(2-phosphonylmethoxyethyl)adenine, 2-amino-6-chloropurine dioxolane, dioxolanyl-5-fluorocytosine, and diaminopurine dioxolane but had only marginal effects on 3'-azido-3'-deoxthymidine (AZT) susceptibility. However, when introduced into a genetic background for AZT resistance (D67N, K70R, T215Y, T219Q), the K65R mutation reversed the AZT resistance. DNA sequencing of RT clones derived from the second resistant isolate identified the L74V mutation, previously reported to cause ddI resistance. The L74V mutation also decreased the AZT resistance when the mutation was introduced into a genetic background for AZT resistance (D67N, K70R, T215Y, T219Q) but to a lesser degree than the K65R mutation did. These findings indicate that DXG and certain 2',3'-dideoxy compounds (e.g., ddI) can select for the same resistance mutations and thus may not be optimal for use in combination. However, the combination of AZT with DXG or its orally bioavailable prodrug (-)-beta-D-2,6-diaminopurine-dioxolane should be explored because of the suppressive effects of the K65R and L74V mutations on AZT resistance.
C1 Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.
   Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA.
   Univ Georgia, Ctr Drug Discovery, Athens, GA 30602 USA.
   Univ Georgia, Dept Pharmaceut & Biochem Sci, Athens, GA 30602 USA.
   Vet Affairs Med Ctr, Pittsburgh, PA USA.
   Emory Univ, Sch Med, Dept Pediat, Decatur, GA 30033 USA.
   Vet Affairs Med Ctr, Georgia Vet Affairs Res Ctr AIDS & HIV Infect, Decatur, GA 30033 USA.
RP Mellors, JW (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, 603 Parran Hall,130 DeSoto St, Pittsburgh, PA 15261 USA.
RI Schinazi, Raymond F/B-6777-2017; Cavalcanti, Socrates/AAQ-7004-2020
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI025899, R37AI041980, R01AI041980, R01AI025899, R37AI041980,
   R37AI041980, R01AI025899, R01AI025899, R01AI025899, R01AI025899,
   R37AI041980, R37AI041980, R01AI025899, R01AI025899, R37AI041980,
   R01AI025899, R01AI025899, R01AI025899, R01AI041980, R37AI041980,
   R01AI041980, R01AI025899, R37AI041980, R37AI041980, R37AI041980,
   R37AI041980, R01AI025899, R37AI041980, R01AI025899, R01AI025899,
   R01AI025899] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI025899, R01 AI041980, AI-41980, R37 AI041980, R01 AI-25899]
   Funding Source: Medline
CR Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e
   BALZARINI J, 1993, J VIROL, V67, P5353, DOI 10.1128/JVI.67.9.5353-5359.1993
   BUCKHEIT RW, 1995, ANTIMICROB AGENTS CH, V39, P2718, DOI 10.1128/AAC.39.12.2718
   Chen HC, 1996, ANTIMICROB AGENTS CH, V40, P2332, DOI 10.1128/AAC.40.10.2332
   CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0
   DECLERCQ E, 1994, BIOCHEM PHARMACOL, V47, P155, DOI 10.1016/0006-2952(94)90001-9
   Gu ZX, 1999, ANTIMICROB AGENTS CH, V43, P2376, DOI 10.1128/AAC.43.10.2376
   GU ZX, 1994, ANTIMICROB AGENTS CH, V38, P275, DOI 10.1128/AAC.38.2.275
   Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669
   KIM HO, 1993, J MED CHEM, V36, P30, DOI 10.1021/jm00053a004
   Kinjerski TL, 1997, ANTIVIR RES, V33, P109, DOI 10.1016/S0166-3542(96)01008-X
   Kleim JP, 1997, VIROLOGY, V231, P112, DOI 10.1006/viro.1997.8513
   LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804
   LARDER BA, 1992, ANTIMICROB AGENTS CH, V36, P2664, DOI 10.1128/AAC.36.12.2664
   LARDER BA, 1995, J ACQUIR IMMUNE D S1, V10, P28
   MARTIN JL, 1993, P NATL ACAD SCI USA, V90, P6135, DOI 10.1073/pnas.90.13.6135
   MELLORS JW, 1992, MOL PHARMACOL, V41, P446
   MELLORS JW, 1995, ANTIMICROB AGENTS CH, V39, P1087, DOI 10.1128/AAC.39.5.1087
   MELLORS JW, 1993, MOL PHARMACOL, V43, P11
   Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471
   NGUYEN MH, 1994, ANTIMICROB AGENTS CH, V38, P2409, DOI 10.1128/AAC.38.10.2409
   Rajagopalan P, 1996, ANTIVIR CHEM CHEMOTH, V7, P65, DOI 10.1177/095632029600700202
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   RICHMAN DD, 1993, ANTIMICROB AGENTS CH, V37, P1207, DOI 10.1128/AAC.37.6.1207
   Schinazi R. F., 1997, International Antiviral News, V5, P129
   Schinazi R. F., 1994, Antiviral Research, V23, P81
   SCHINAZI RF, 1990, ANTIMICROB AGENTS CH, V34, P1061, DOI 10.1128/AAC.34.6.1061
   STCLAIR MH, 1991, SCIENCE, V253, P1557, DOI 10.1126/science.1716788
   Tachedjian G, 1996, J VIROL, V70, P7171, DOI 10.1128/JVI.70.10.7171-7181.1996
   ZHANG XD, 1994, IEEE PARALL DISTRIB, V2, P3
NR 30
TC 78
Z9 81
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JUL
PY 2000
VL 44
IS 7
BP 1783
EP 1788
DI 10.1128/AAC.44.7.1783-1788.2000
PG 6
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 330KN
UT WOS:000087961400003
PM 10858331
OA Green Published, Bronze
DA 2020-12-08
ER

PT J
AU Pierra, C
   Olgen, S
   Cavalcanti, SCH
   Cheng, YC
   Schinazi, RF
   Chu, CK
AF Pierra, C
   Olgen, S
   Cavalcanti, SCH
   Cheng, YC
   Schinazi, RF
   Chu, CK
TI Synthesis and antiviral activities of enantiomeric
   1-[2-(hydroxymethyl)cyclopropyl] methyl nucleosides
SO NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
LA English
DT Article
ID CARBOCYCLIC NUCLEOSIDES; CYCLOBUT-G; CYCLOPROPYL; ANALOG; POTENT; AGENT
AB Cyclopropyl carbocyclic nucleosides have been synthesized from the key intermediate 2 which was converted to the mesylated cyclopropyl methyl alcohol 3. Condensation of compound 3 with various purine and pyrimidine bases gave the desired nucleosides. All synthesized nucleosides were evaluated for antiviral activity and cellular toxicity. Among them adenine 22 and guanine 23 derivatives showed moderate antiviral activity against HIV-I and HBV. None of the other compounds showed any significant antiviral activities against HIV-1 HBV, HSV-1 and HSV-2 in vitro up to 100 mu M.
C1 Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.
   Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.
   Emory Univ, Sch Med, Vet Adm Med Ctr, Dept Pediat, Decatur, GA 30033 USA.
RP Chu, CK (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.
RI Schinazi, Raymond F/B-6777-2017; Cavalcanti, Socrates/AAQ-7004-2020
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI 33655, AI 32351] Funding Source:
   Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI033655, R01AI033655, R01AI033655, R01AI032351,
   R01AI032351, R01AI032351, R01AI033655, R01AI032351, R01AI032351,
   R01AI032351, R01AI032351, R01AI033655, R01AI032351, R01AI033655,
   R01AI033655, R01AI032351, R01AI032351, R01AI033655, R01AI032351,
   R01AI032351, R01AI032351, R01AI032351, R01AI033655] Funding Source: NIH
   RePORTER
CR ASHTON WT, 1988, J MED CHEM, V31, P2304, DOI 10.1021/jm00120a010
   CSUK R, 1995, TETRAHEDRON, V51, P7193, DOI 10.1016/0040-4020(95)00367-H
   DECLERCQ E, 1985, ANTIMICROB AGENTS CH, V28, P84, DOI 10.1128/AAC.28.1.84
   DENMARK SE, 1991, J ORG CHEM, V56, P6974, DOI 10.1021/jo00025a007
   ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716
   FIELD AK, 1983, P NATL ACAD SCI-BIOL, V80, P4139, DOI 10.1073/pnas.80.13.4139
   HAYASHI S, 1990, ANTIMICROB AGENTS CH, V34, P287, DOI 10.1128/AAC.34.2.287
   IWAYAMA S, 1988, ANTIMICROB AGENT CHE, P1666
   KATAGIRI N, 1992, NUCLEOS NUCLEOT, V11, P707, DOI 10.1080/07328319208021735
   LEE M, 1995, TETRAHEDRON LETT, V36, P3499, DOI 10.1016/0040-4039(95)00575-W
   Lee MG, 1997, J ORG CHEM, V62, P1991, DOI 10.1021/jo961523l
   MACKEITH RA, 1993, J CHEM SOC PERK T 1, P313, DOI 10.1039/p19930000313
   NORBECK DW, 1990, J MED CHEM, V33, P1281, DOI 10.1021/jm00167a002
   NORBECK DW, 1992, J CHEM SOC CHEM COMM, P128, DOI 10.1039/c39920000128
   NORBECK DW, 1988, J AM CHEM SOC, V110, P7217, DOI 10.1021/ja00229a048
   QUI YL, 1997, 10 INT C ANT RES ATL
   Sekiyama T, 1998, J MED CHEM, V41, P1284, DOI 10.1021/jm9705869
   VINCE R, 1988, BIOCHEM BIOPH RES CO, V156, P1046, DOI 10.1016/S0006-291X(88)80950-1
   Yang TF, 1996, TETRAHEDRON LETT, V37, P8849, DOI 10.1016/S0040-4039(96)02060-6
   ZHAO YF, 1995, J ORG CHEM, V60, P5236, DOI 10.1021/jo00121a047
   ZHAO YF, 1994, TETRAHEDRON LETT, V35, P5405, DOI 10.1016/S0040-4039(00)73511-8
NR 21
TC 5
Z9 6
U1 1
U2 2
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1525-7770
J9 NUCLEOS NUCLEOT NUCL
JI Nucleosides Nucleotides Nucleic Acids
PY 2000
VL 19
IS 1-2
BP 253
EP 268
DI 10.1080/15257770008033007
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 311BC
UT WOS:000086863600017
PM 10772713
DA 2020-12-08
ER

PT J
AU Magalhaes, NSS
   Cavalcanti, SCD
   De Menezes, IRA
   Araujo, AAD
   De Oliveira, HM
   Alves, AJ
AF Magalhaes, NSS
   Cavalcanti, SCD
   De Menezes, IRA
   Araujo, AAD
   De Oliveira, HM
   Alves, AJ
TI Automated search for potentially active compounds by using cluster trees
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE cluster analysis; QSAR; adaptive mean-linkage algorithm;
   phenylguanidines
ID SIMILARITY-MATRICES; BIOLOGICAL-ACTIVITY; DRUG DESIGN; SELECTION;
   SUBSTITUENTS; INHIBITORS; QSAR
AB A new agglomerative (bottom-up) hierarchical cluster technique referred to as the Adaptive Mean-Linkage algorithm is derived. Cluster algorithms are also offered as a tool to explore the descriptor space knowing the quantitative structure-activity relationship (QSAR). The substituents are clustered building a dendrogram (cluster tree) per site. Choosing appropriate pathways on such cluster trees according to the QSAR equation, an automated search for potentially active substituted compounds can be performed. Applications to a series of substituted phenylguanidines with anticancer activity are focused illustrating this approach. (C) Elsevier, Paris.
C1 Univ Fed Pernambuco, Dept Farm, BR-51740520 Recife, PE, Brazil.
   Univ Fed Pernambuco, Dept Elect, BR-51711970 Recife, PE, Brazil.
RP Alves, AJ (corresponding author), Univ Fed Pernambuco, Dept Farm, Rua Prof Artur Sa S-N,Cidade Univ, BR-51740520 Recife, PE, Brazil.
RI Magalhaes, Nereide/U-2342-2019; SANTOS-MAGALHAES, Nereide/C-5801-2013;
   Cavalcanti, Socrates/AAQ-7004-2020; Alves, Antonio/C-3061-2019; de
   Oliveira, Helio Magalhaes./B-1460-2010; de Menezes, Irwin Rose
   Alencar/A-6777-2012
OI Magalhaes, Nereide/0000-0002-2576-4213; SANTOS-MAGALHAES,
   Nereide/0000-0002-2576-4213; Alves, Antonio/0000-0002-2668-6931; de
   Oliveira, Helio Magalhaes./0000-0002-6843-0635; de Menezes, Irwin Rose
   Alencar/0000-0003-1065-9581
CR BENIGNI R, 1994, MUTAT RES, V306, P181, DOI 10.1016/0027-5107(94)90029-9
   BENIGNI R, 1995, J MED CHEM, V38, P629, DOI 10.1021/jm00004a009
   CRAIG PN, 1971, J MED CHEM, V14, P680, DOI 10.1021/jm00290a004
   DAVIS AM, 1994, MED CHEM PRINCIPLES, P98
   DIDAY E, 1976, UNSUPERVISED LEARNIN, P211
   Franke R., 1984, THEORETICAL DRUG DES, V7
   GAMBINO J, 1992, J MED CHEM, V35, P2979, DOI 10.1021/jm00094a007
   GOOD AC, 1993, J MED CHEM, V36, P2929, DOI 10.1021/jm00072a012
   HadjipavlouLitina D, 1995, PHARMAZIE, V50, P796
   HANSCH C, 1973, J PHARM SCI-US, V62, P1, DOI 10.1002/jps.2600620102
   HANSCH C, 1973, J MED CHEM, V16, P1217, DOI 10.1021/jm00269a004
   Hansch C., 1995, ACS PROFESSIONAL REF
   Kubinyi H, 1979, Prog Drug Res, V23, P97
   KUBINYI H, 1995, PHARMAZIE, V50, P647
   LANGE AW, 1995, QSAR ENV RES, V3, P171
   LEO A, 1985, ENVIRON HEALTH PERSP, V61, P275, DOI 10.2307/3430078
   MACFARLAND JWL, 1970, J MED CHEM, V20, P625
   MARTIN YC, 1971, PROG DRUG RES, V15, P123
   Martin YC, 1978, QUANTITATIVE DRUG DE
   NORRINGTON FE, 1975, J MED CHEM, V18, P604, DOI 10.1021/jm00240a016
   ROMIJN CAFM, 1993, ECOTOX ENVIRON SAFE, V26, P61, DOI 10.1006/eesa.1993.1041
   SONNACOTT TH, 1990, INTRO STAT
   TAYLOR JB, 1993, MODERN MED CHEM
   TOPLISS JG, 1972, J MED CHEM, V15, P1066, DOI 10.1021/jm00280a017
   Van de Waterbeemd H, 1993, Drug Des Discov, V9, P277
   WOOTTON R, 1975, J MED CHEM, V18, P607, DOI 10.1021/jm00240a017
   YANG H, 1990, J MED CHEM, V33, P2956, DOI 10.1021/jm00173a008
   YAPEL JRA, 1972, AM CHEM SOC, P183
NR 28
TC 5
Z9 5
U1 0
U2 5
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD FEB
PY 1999
VL 34
IS 2
BP 83
EP 92
DI 10.1016/S0223-5234(99)80043-9
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 188MT
UT WOS:000079828800001
DA 2020-12-08
ER

PT J
AU Cavalcanti, SCH
   Xiang, YJ
   Newton, MG
   Schinazi, RF
   Cheng, YC
   Chu, CK
AF Cavalcanti, SCH
   Xiang, YJ
   Newton, MG
   Schinazi, RF
   Cheng, YC
   Chu, CK
TI Synthesis of 2 ',3 '-dideoxy-2 '-fluoro-L-threo-pentafuranosyl
   nucleosides as potential antiviral agents
SO NUCLEOSIDES & NUCLEOTIDES
LA English
DT Article
ID HEPATITIS-B VIRUS; ANTI-HIV; HBV ACTIVITIES; IN-VITRO; REPLICATION;
   ENANTIOMERS; INHIBITION; INVITRO; ANALOGS; TYPE-1
AB A series of 2',3'-dideoxy-2'-fluoro-L-threo-pentofuranosyl nucleosides has been synthesized as potential antiviral agents. The synthesized compounds were evaluated against HIV-1, HBV, HSV-1, and HSV-2. Among the synthesized analogues, only the cytosine derivative showed moderate antiviral activity against HIV and HBV.
C1 Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Ctr Drug Discovery, Athens, GA 30602 USA.
   Univ Georgia, Dept Chem, Athens, GA 30602 USA.
   Emory Univ, Sch Med, Vet Affairs Med Ctr, Dept Pediat, Decatur, GA 30033 USA.
   Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.
RP Chu, CK (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Ctr Drug Discovery, Athens, GA 30602 USA.
RI Schinazi, Raymond F/B-6777-2017; Cavalcanti, Socrates/AAQ-7004-2020
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI32351, AI33655] Funding Source: Medline;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI033655, R01AI032351, R01AI032351, R01AI032351, R01AI032351,
   R01AI033655, R01AI033655, R01AI032351, R01AI033655, R01AI033655,
   R01AI032351, R01AI033655, R01AI032351, R01AI032351, R01AI032351,
   R01AI032351, R01AI032351, R01AI032351, R01AI033655, R01AI033655,
   R01AI032351, R01AI032351, R01AI033655] Funding Source: NIH RePORTER
CR CHANG CN, 1992, J BIOL CHEM, V267, P22414
   CHANG CN, 1992, J BIOL CHEM, V267, P13938
   CHU CK, 1995, ANTIMICROB AGENTS CH, V39, P979, DOI 10.1128/AAC.39.4.979
   COATES JAV, 1992, ANTIMICROB AGENTS CH, V36, P733, DOI 10.1128/AAC.36.4.733
   DOONG SL, 1991, P NATL ACAD SCI USA, V88, P8495, DOI 10.1073/pnas.88.19.8495
   FURMAN PA, 1992, ANTIMICROB AGENTS CH, V36, P2686, DOI 10.1128/AAC.36.12.2686
   GOSSELIN G, 1994, ANTIMICROB AGENTS CH, V38, P1292, DOI 10.1128/AAC.38.6.1292
   GROVE KL, 1995, CANCER RES, V55, P3008
   KIM HO, 1992, TETRAHEDRON LETT, V33, P6899, DOI 10.1016/S0040-4039(00)60890-0
   KIM HO, 1993, J MED CHEM, V36, P519, DOI 10.1021/jm00057a001
   LIN TS, 1994, J MED CHEM, V37, P798, DOI 10.1021/jm00032a013
   Ma TW, 1996, J MED CHEM, V39, P2835, DOI 10.1021/jm960098l
   MARQUEZ VE, 1990, J MED CHEM, V33, P978, DOI 10.1021/jm00165a015
   MISRA S, 1990, NUCLEOS NUCLEOT, V9, P837, DOI 10.1080/15257779008043149
   NAIR V, 1978, J ORG CHEM, V43, P5013, DOI 10.1021/jo00420a027
   Pai SB, 1996, ANTIMICROB AGENTS CH, V40, P380, DOI 10.1128/AAC.40.2.380
   Pelicano H, 1997, J MED CHEM, V40, P3969, DOI 10.1021/jm9701482
   SCHINAZI RF, 1994, ANTIMICROB AGENTS CH, V38, P2172, DOI 10.1128/AAC.38.9.2172
   SHANMUGANATHAN K, 1994, J MED CHEM, V37, P821, DOI 10.1021/jm00032a017
   SIDDIQUI MA, 1992, J MED CHEM, V35, P2195, DOI 10.1021/jm00090a008
   Townsend L. B., 1988, CHEM NUCLEOSIDES NUC, V1
   WRIGHT JD, 1995, PHARMACEUT RES, V12, P1350, DOI 10.1023/A:1016234009624
   XIANG YJ, 1995, BIOORG MED CHEM LETT, V5, P877, DOI 10.1016/0960-894X(95)00133-E
NR 23
TC 3
Z9 3
U1 0
U2 2
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0732-8311
J9 NUCLEOS NUCLEOT
JI Nucleosides Nucleotides
PY 1999
VL 18
IS 10
BP 2233
EP 2252
DI 10.1080/07328319908044878
PG 20
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 254PK
UT WOS:000083621200008
PM 10616728
DA 2020-12-08
ER

PT J
AU Kotra, LP
   Wang, PP
   Bartlett, MG
   Shanmuganathan, K
   Xu, ZS
   Cavalcanti, S
   Newton, MG
   Chu, CK
AF Kotra, LP
   Wang, PP
   Bartlett, MG
   Shanmuganathan, K
   Xu, ZS
   Cavalcanti, S
   Newton, MG
   Chu, CK
TI 4-azido-2-pyrimidinone nucleosides and related chemistry
SO JOURNAL OF ORGANIC CHEMISTRY
LA English
DT Article
ID 2'-F-ARA-DDI
AB As a part of azide prodrug approach, we synthesized a 4-azido analog of ara-C (4) as a prodrug for ara-C. The compound 4 was obtained from 1-(beta-D-arabinofuranosyl)uracil (1) in three steps. At pH 7.0 and 11.0, a loss of UV absorption of the compound 4 was observed resulting from a transformation that was proved by identifying the transformed product 5 by 1-D, and 2-D NMR as well as tandem mass spectral studies. In NMR studies, changes in the chemical shifts were observed at positions 5, 6, 1', and 2' between the compounds 4 and 5. A molecular peak at m/z 270.1 (MH+) was observed in the mass spectra of compounds 4 and the transformed product 5. A fragment at 180.2 was identified to be the compound 6, containing the 6,2'-anhydro linkage of compound 5. The X-ray analysis indicated that compound 4 exists as 1-(beta-D-arabinofuranosyl)tetrazolo[4,5-c]pyrimidin-2-one, with the azide moiety cyclized. To understand if the chemical instability of the nucleoside 4 was due to the arabino configuration of 2'-OH or due to the azido moiety, we also studied 1-(2,3-dideoxy-2-fluoro-beta-D-arabinofuranosyl)tetrazolo[4,5-c]pyrimidin-2-one (11) and 4-azido-1-methyl-2-pyrimidinone (15). At pH 2.0 and 7.0, similar UV profiles were observed for compounds 11 and 15. However, at pH 11.0, lambda(max) shifted slowly to lower wavelength for both compounds 11 and 15. In a separate kinetic study, they were stable at pH 7.4 for up to 2.45 h. From the NMR and high-resolution mass spectral studies, It was concluded that in the presence of ammonium hydroxide, an addition of amine occurred at 6-position of compound 11. Thus, the stability profiles of compounds 4, 11, and 15 were different. The instability and the formation of 2',6-anhydro bond in compound 4 in nonacidic media was due to the presence of 2'-OH in the arabino configuration and probably not due to the azide group.
C1 UNIV GEORGIA,COLL PHARM,DEPT MED CHEM,ATHENS,GA 30602.
   UNIV GEORGIA,COLL PHARM,DEPT CHEM,ATHENS,GA 30602.
RI Bartlett, Michael G/J-1065-2016; Cavalcanti, Socrates/AAQ-7004-2020
CR FOX JJ, 1966, TETRAHEDRON LETT, P4627
   Kotra LP, 1996, J MED CHEM, V39, P5202, DOI 10.1021/jm960339p
   Koudriakova T, 1996, J MED CHEM, V39, P4676, DOI 10.1021/jm960140c
   MAJOR PP, 1982, BIOCHEM PHARMACOL, V31, P861, DOI 10.1016/0006-2952(82)90475-0
   MARTIN JA, 1990, J MED CHEM, V33, P2137, DOI 10.1021/jm00170a015
   NAPOLI LD, 1986, J HETEROCYCLIC CHEM, V23, P1401
   ROBERTS WK, 1967, J ORG CHEM, V32, P816, DOI 10.1021/jo01278a069
   SCHINAZI RF, 1979, J MED CHEM, V22, P1273, DOI 10.1021/jm00196a025
   SHANMUGANATHAN K, 1994, J MED CHEM, V37, P821, DOI 10.1021/jm00032a017
   STERZYCKI RZ, 1990, J MED CHEM, V33, P2150, DOI 10.1021/jm00170a017
NR 10
TC 10
Z9 10
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0022-3263
J9 J ORG CHEM
JI J. Org. Chem.
PD OCT 17
PY 1997
VL 62
IS 21
BP 7267
EP 7271
DI 10.1021/jo970761t
PG 5
WC Chemistry, Organic
SC Chemistry
GA YC657
UT WOS:A1997YC65700043
PM 11671839
DA 2020-12-08
ER

PT J
AU Cavalcanti, SCH
   Cheng, YC
   Chu, CK
AF Cavalcanti, SCH
   Cheng, YC
   Chu, CK
TI Synthesis and anti-HIV activity of
   2',3'-dideoxy-2'-fluoro-L-threo-pentofuranosyl nucleosides
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 UNIV GEORGIA,COLL PHARM,ATHENS,GA 30602.
   YALE UNIV,SCH MED,NEW HAVEN,CT 06510.
RI Cavalcanti, Socrates/AAQ-7004-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 7
PY 1997
VL 214
BP 80
EP CARB
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA XQ857
UT WOS:A1997XQ85700546
DA 2020-12-08
ER

PT J
AU Moreno, MDN
   Magalhaes, NSS
   Cavalcanti, SCH
   Alves, AJ
AF Moreno, MDN
   Magalhaes, NSS
   Cavalcanti, SCH
   Alves, AJ
TI Hierarquical cluster analysis applied to drug design
SO QUIMICA NOVA
LA Portuguese
DT Article
DE cluster analysis; biological activity; indandiones derivatives; QSAR
ID PATTERN-RECOGNITION; CHEMICAL DATA; SELECTION; MODEL
AB An algorithm is introduced which allows a substituents choice for the original compound of a chemical series in order to achieve a high biological activity, This procedure is based upon a relationship between the biological activity and physicochemical parameters. Substituents are classified by cluster analysis, building a cluster tree for each site, Active compounds are obtained by a choice of paths in these trees, This framework is particularly suitable in chemical series having two or more sites, dealing with a large number of possible substituents per site, It has a great flexibility and easy interpretation, Application to a series of 2-aryl-1,3-indandiones illustrates that approach.
RP Moreno, MDN (corresponding author), UNIV FED PERNAMBUCO,DEPT FARM,AV PROF ARTUR SA,S-N,CID UNIV,BR-51740520 RECIFE,PE,BRAZIL.
RI Cavalcanti, Socrates/AAQ-7004-2020; Magalhaes, Nereide/U-2342-2019;
   Alves, Antonio/C-3061-2019; SANTOS-MAGALHAES, Nereide/C-5801-2013
OI Magalhaes, Nereide/0000-0002-2576-4213; Alves,
   Antonio/0000-0002-2668-6931; SANTOS-MAGALHAES,
   Nereide/0000-0002-2576-4213
CR ALLEN MT, 1991, PSYCHOSOM MED, V53, P272, DOI 10.1097/00006842-199105000-00002
   BERG GVD, 1975, EUR J MED CHEM, V3, P242
   Bouroche Saporta J.-M., 1980, ANAL DONNEES
   BOWDEN K, 1972, BIOL CORRELATIONS HA, P130
   CAVALCANTI SCH, 1994, THESIS U FEDERAL PER
   CAYUELA DA, 1990, GAC SANIT, V4, P227
   CRAIG PN, 1971, J MED CHEM, V14, P680, DOI 10.1021/jm00290a004
   CULASSO F, 1991, ARCH ANDROLOGY, V26, P163, DOI 10.3109/01485019108987639
   Diday E, 1976, CLUSTERING ANAL DIGI, P47
   FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887
   GAMBINO J, 1992, J MED CHEM, V35, P2979, DOI 10.1021/jm00094a007
   GIACCA M, 1987, EUR J EPIDEMIOL, V3, P155
   HANSCH C, 1980, SUBSTITUENT CONSTANT
   KOWALSKI BR, 1972, J AM CHEM SOC, V94, P5632, DOI 10.1021/ja00771a016
   KOWALSKI BR, 1973, J AM CHEM SOC, V95, P686, DOI 10.1021/ja00784a007
   MAES M, 1990, PSYCHONEUROENDOCRINO, V15, P29, DOI 10.1016/0306-4530(90)90044-A
   MORENO MPN, 1995, THESIS U FEDERAL PER
   NAITO Y, 1992, EUR J MED CHEM, V27, P645, DOI 10.1016/0223-5234(92)90084-E
   PEKAS JC, 1991, J NUTR, V121, P231
   SCHNUR RC, 1991, J MED CHEM, V34, P1975, DOI 10.1021/jm00111a009
   TOPLISS JG, 1972, J MED CHEM, V15, P1006, DOI 10.1021/jm00280a002
   UNGER SH, 1973, J MED CHEM, V16, P745, DOI 10.1021/jm00265a001
   WOOTTON R, 1975, J MED CHEM, V18, P607, DOI 10.1021/jm00240a017
   YAPEL AF, 1972, BIOL CORRELATIONS HA, P183
NR 24
TC 3
Z9 4
U1 0
U2 1
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0100-4042
J9 QUIM NOVA
JI Quim. Nova
PD NOV-DEC
PY 1996
VL 19
IS 6
BP 594
EP 599
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA VR865
UT WOS:A1996VR86500003
DA 2020-12-08
ER

PT J
AU XIANG, YJ
   CAVALCANTI, S
   CHU, CK
AF XIANG, YJ
   CAVALCANTI, S
   CHU, CK
TI ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND ANTI-HEPATITIS-B
   VIRUS (HBV) ACTIVITIES OF
   (2,3-DIDEOXY-2-FLUORO-BETA-L-THREO-PENTOFURANOSYL)NUCLEOSIDES
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
ID ASYMMETRIC-SYNTHESIS; AGENTS; NUCLEOSIDES; REPLICATION; PYRIMIDINE;
   INHIBITION; INVITRO; ANALOGS; POTENT; DDC
AB 1-or-9-(2,3-Dideoxy-2-fluoro-beta-L-threo-pentofuransoyl)- cytosine (F-beta-ara-ddC) and-adenine (F-B-L-ara-ddA) were synthesized and their anti-HIV and anti-HBV activities were evaluated.
C1 EMORY UNIV,SCH MED,DEPT PEDIAT,DECATUR,GA 30033.
   VET AFFAIRS MED CTR,DECATUR,GA 30033.
   YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510.
RP XIANG, YJ (corresponding author), UNIV GEORGIA,COLL PHARM,DEPT MED CHEM,ATHENS,GA 30602, USA.
RI Cavalcanti, Socrates/AAQ-7004-2020
CR BELLEAU B, 1990, JUN INT C AIDS MONTR
   BELLEAU BR, 1992, TETRAHEDRON LETT, V33, P6949, DOI 10.1016/S0040-4039(00)60903-6
   CHANG CN, 1992, J BIOL CHEM, V267, P22414
   CHANG CN, 1992, J BIOL CHEM, V267, P13938
   CHEN YQ, 1992, NUCLEOS NUCLEOT, V11, P693, DOI 10.1080/07328319208021734
   CHU CK, 1995, IN PRESS ANTIVIRAL A
   COATES JAV, 1992, ANTIMICROB AGENTS CH, V36, P733, DOI 10.1128/AAC.36.4.733
   CONDREAY LD, 1994, ANTIMICROB AGENTS CH, V38, P616, DOI 10.1128/AAC.38.3.616
   DOONG SL, 1991, P NATL ACAD SCI USA, V88, P8495, DOI 10.1073/pnas.88.19.8495
   FURMAN PA, 1992, ANTIMICROB AGENTS CH, V36, P2686, DOI 10.1128/AAC.36.12.2686
   GOSSELIN G, 1993, J HETEROCYCLIC CHEM, V30, P1229, DOI 10.1002/jhet.5570300510
   GOSSELIN G, 1994, ANTIMICROB AGENTS CH, V38, P1292, DOI 10.1128/AAC.38.6.1292
   JEONG LS, 1993, J MED CHEM, V36, P181, DOI 10.1021/jm00054a001
   KIM HO, 1992, TETRAHEDRON LETT, V33, P6899, DOI 10.1016/S0040-4039(00)60890-0
   KIM HO, 1993, J MED CHEM, V36, P519, DOI 10.1021/jm00057a001
   KUMAR A, 1994, NUCLEOS NUCLEOT, V13, P1049, DOI 10.1080/15257779408011878
   LIN TS, 1994, J MED CHEM, V37, P798, DOI 10.1021/jm00032a013
   MANSURI MM, 1991, BIOORG MED CHEM LETT, V1, P65, DOI 10.1016/S0960-894X(01)81093-3
   MARQUEZ VE, 1990, J MED CHEM, V33, P978, DOI 10.1021/jm00165a015
   MISRA S, 1990, NUCLEOS NUCLEOT, V9, P837, DOI 10.1080/15257779008043149
   SCHINAZI RF, 1994, ANTIMICROB AGENTS CH, V38, P2172, DOI 10.1128/AAC.38.9.2172
   SHANMUGANATHAN K, 1994, J MED CHEM, V37, P821, DOI 10.1021/jm00032a017
   STERZYCKI RZ, 1990, J MED CHEM, V33, P2150, DOI 10.1021/jm00170a017
   VANDRAANEN NA, 1994, ANTIMICROB AGENTS CH, V38, P868, DOI 10.1128/AAC.38.4.868
   WATANABE KA, 1990, J MED CHEM, V33, P2145, DOI 10.1021/jm00170a016
NR 25
TC 10
Z9 10
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0960-894X
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD APR 20
PY 1995
VL 5
IS 8
BP 877
EP 880
DI 10.1016/0960-894X(95)00133-E
PG 4
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA QX041
UT WOS:A1995QX04100021
DA 2020-12-08
ER

EF